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Abstract 
The distal parts of the renal tubule play a critical role in maintaining homeostasis of extracellular 
fluids. In this review, we present an in-depth analysis of microarray-based gene expression 
profiles available for microdissected mouse distal nephron segments, i.e., the distal convoluted 
tubule (DCT) and the connecting tubule (CNT), and for the cortical portion of the collecting duct 
(CCD) (Zuber et al., 2009). Classification of expressed transcripts in 14 major functional gene 
categories demonstrated that all principal proteins involved in maintaining of salt and water 
balance are represented by highly abundant transcripts. However, a significant number of 
transcripts belonging, for instance, to categories of G protein-coupled receptors (GPCR) or 
serine-threonine kinases exhibit high expression levels but remain unassigned to a specific renal 
function. We also established a list of genes differentially expressed between the DCT/CNT and 
the CCD. This list is enriched by genes related to segment-specific transport functions and by 
transcription factors directing the development of the distal nephron or collecting ducts. 
Collectively, this in silico analysis provides comprehensive information about relative abundance 
and tissue specificity of the DCT/CNT and the CCD expressed transcripts and identifies new 
candidate genes for renal homeostasis. 
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Introduction 
The final adjustment of urine composition takes place in the distal parts of the renal tubule, i.e. in 
the distal nephron and in the collecting duct. Over the last decades, research efforts in the field 
allowed identification of many essential proteins (channels, transporters, receptors, etc.) involved 
in this process. The majority of these proteins were first discovered by expression cloning, an 
approach based on the a priori available information about function and tissue expression 
distribution of the candidate gene. The aquaporin-2 water channel (aqp-2), the V2-type of 
vasopressin receptor (Avpr2), the Ca2+-sensing receptor (CaSR), the thiazide-sensitive sodium-
chloride co-transporter (NCC), the secretory potassium channel (ROMK), the amiloride-sensitive 
sodium channel (ENaC) and the epithelial calcium channel (Trpv5) are just a few out of many 
examples of proteins identified by this approach. Moreover, a growing list of functionally 
important genes has been added from human genetic association studies. The latter includes 
WNK1 and WNK4 serine-threonine kinases [1], the FXYD2 subunit of the Na,K-ATPase [2], the 
KCNJ10 and KCNA1 potassium channels and the pro-EGF [3-5]. Significant progress in 
deciphering regulatory pathways in the distal nephron and/or collecting ducts has been made with 
the development of methods allowing global view of all expressed transcripts (transcriptome) or 
proteins (proteome) and their dynamics. For example, the aldosterone or vasopressin signaling 
pathways were extensively characterized by the serial analysis of gene expression (SAGE) and 
microarray hybridization [6, 7]. Various proteome tools were used for identification, of 
vasopressin-dependent phosphorylation sites within aqp-2 or for detection of lithium-induced 
changes in the proteome of the inner medullary collecting ducts (IMCD) [8, 9].   
In order to identify new genes involved in renal homeostatic mechanisms we used an in 
silico approach based on the analysis of transcript abundance in several major functional gene 
categories most relevant to secretion/reabsorption processes in the distal nephron and/or the 
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collecting duct. This analysis was performed on a recently obtained microarray-based dataset of 
gene expression profiles of the mouse distal convoluted tubule (DCT), the connecting tubule 
(CNT) and the cortical collecting duct (CCD) [10]. The principal characteristics of this dataset 
are the following: (i) the DCT/CNT and the CCD samples were obtained by microdissection; the 
DCT and CNT were microdissected together because of the gradual transition between these two 
segments in mice; (ii) samples were prepared from animals sacrificed for microdissection every 
four hours throughout a 12 h/12 h light-dark cycle (a total of 6 time-points); this protocol allows 
detection of all expressed transcripts independently of diurnal variations in their expression 
levels; (iii) a total of 30 animals were used for microdissection of DCT/CNT and CCD samples 
(5 animals/time-point); (iv) 12 microarray hybridizations were performed for both DCT/CNT and 
CCD (2 hybridizations/time-point). The quality of microdissection was validated by the analysis 
of expression levels of several nephron segment-enriched transcripts (see [10] and below). 
Altogether, this dataset represents a complete and reliable source of information on the genes 
expressed in the distal nephron and the CCD (see below). 
Functional classification and analysis of transcript abundance allowed us to identify a new 
set of highly abundant transcripts encoding proteins potentially relevant to the homeostasis of 
water and/or electrolytes. Finally, comparison of the DCT/CNT and the CCD transcriptomes 
revealed a number of previously uncharacterized transcripts exhibiting significantly different 
expression levels between these parts of the renal tubule. These data could be further used for the 
functional characterization of the identified candidates. 
 
1. Functional classification of DCT/CNT and CCD transcripts.        Functional classification of 
DCT/CNT and CCD transcripts was performed using the PANTHER Classification System, a 
database allowing subdivision of proteins and mRNA transcripts into functionally related 
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categories (www.pantherdb.org). A similar approach was previously used by Uawithya et al. for 
the transcriptional profiling of rat inner medullary collecting ducts (IMCD) [11]. The 
classification data are presented in tables in which only the 20 most abundant transcripts per 
category are listed for space purposes. If more than 20 transcripts per category fitted the cut-off 
criteria (see below), a full list of transcripts can be viewed in associated supplementary tables. 
The transcripts are ranked by their abundance calculated as log2 normalized microarray 
hybridization signal intensity (A-values)  [12]. Hence, a difference in one unit of A_values 
corresponds to the 2-fold difference in the transcript expression levels. The median microarray 
signal intensity (5.8 units of A_value, for both the DCT/CNT and the CCD transcriptomes) was 
chosen as an arbitrary cut-off value above which expression of a transcript was assigned as 
significant. The data are discussed in terms of expression levels or transcripts abundance. 
However, we have to emphasize that microarray signal intensities and sequencing-based 
quantification of mRNA abundance have been shown to exhibit a correlation coefficient of  ~ 0.7 
[13]. To assess this correlation in the DCT/CNT and the CCD datasets we performed qPCR 
analysis of transcripts abundance in one of the selected gene categories, namely G protein-
coupled receptors (GPCR). As shown in Figure 1A and 1B, both, DCT/CNT and CCD datasets 
exhibit a good correlation between microarray signal intensities and Ct values of qPCR 
amplification (correlation coefficients of 0.769 and 0.823, respectively). These data also 
demonstrate that transcripts with A-values below the median cut-off level exhibit significantly 
lower correlation between microarray and qPCR data. 
 
1.1. G protein-coupled receptors (GPCRs). Most GPCRs that have been previously identified in 
the DCT/CNT and/or the CCD are abundantly represented in the respective transcriptomes (Table 
1 and Supplemental Table 1). These include vasopressin receptors type 1a (Avpr1a) and type 2 
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(Avpr2), prostaglandin E receptors type 3 (Ptger3), type 1 (Ptger1) and type 4 (Ptger4), 
prostaglandin F receptor (Ptgfr), glucagon receptor (Gcgr), proteinase-activated receptor 2 
(F2rl1), calcium-sensing receptor (Casr), endothelin receptor type B (Ednrb), parathyroid 
hormone receptor 1 (Pth1r), adenosine A1 receptor (Adora1) and adrenergic receptors type beta 1 
(Adrb1), beta 2 (Adrb2) and alpha 2a (Adra2a). This analysis also revealed the presence of a 
number of highly abundant GPCRs with yet unassigned function in the kidney. For instance, 
both, DCT/CNT and CCD exhibit high expression levels of several chemokine GPCRs, including 
Ccrl1, Cxcr4 and Gpr146. The Cxcr4 receptor has been shown to bind SDF-1, a chemokine 
involved in a multitude of functions, including epithelial patterning and renal morphogenesis 
[14]. However, the role of chemokine GPCRs in the adult kidney remains unknown. The 
DCT/CNT and the CCD transcriptomes are enriched by orphan receptors belonging to a subclass 
of adhesion-GPCRs (Celsr2, Gpr116, Gpr56 and Celsr1). Adhesion-GPCRs constitute a novel 
subclass of GPCRs characterized by the presence in their N-termini of cadherin-like cell adhesion 
modules. These receptors are critical for the normal development of the central nervous system 
and for the immune response. Several adhesion-GPCRs are involved in human diseases. For 
example, deletion of the Gpr56 gene in human causes the autosomal recessive bilateral 
frontoparietal polymicrogyria (BFPP), a disease characterized by severe neurological dysfunction 
[15]. However, a renal phenotype in these patients, if any, has not yet been communicated. Both 
the DCT/CNT and the CCD transcriptomes revealed high expression levels of Gprc5C and 
Gprc5B, two receptors related to the family C of GPCRs, which also includes the metabotropic 
glutamate receptors, the GABA(B) receptors, several pheromone receptors and the calcium 
sensing receptor [16]. However, in contrast to other members of the family, both, Gprc5C and 
Gprc5B still remain orphan. Our analysis also revealed a high expression of three receptors 
belonging to the class A of the rhodopsin-like GPCRs, namely the oxoglutarate receptor 1 
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(Oxgr1), the estrogen receptor (Gper or Gpr30) and the apelin receptor. Several pieces of 
evidence indicate that these receptors may have an important role in the regulation of tubular 
solute transport.  Oxgr1 (also known as Gpr80 or Gpr99) is a specific receptor to α-ketoglutarate, 
a citric acid cycle intermediate [17]. Interestingly, urinary concentration of α-ketoglutarate varies 
significantly upon perturbation of systemic acid-base balance, being significantly increased in 
alkalosis and significantly decreased in acidosis [18]. This suggests a possible role for Oxgr1 in 
sensing acid-base disequilibrium. Gper is a recently identified plasma membrane estrogen 
receptor which mediates non-genomic effect of estrogen. As it was recently hypothesized, Gper 
may be involved in the rapid magnesiotropic effects of estrogen in the distal nephron [19]. Apelin 
is a recently discovered peptide which mediates a multitude of biological functions including 
vasoconstriction, cardiac myogenesis, glucose metabolism and vasopressin synthesis/release in 
the brain. Knockout of apelin receptor in mice leads to abnormal fluid homeostasis, resulting in 
disturbance of both, kidney urinary concentration capacity and drinking behaviour [20]. The role 
of this receptor in the renal tubules has not yet been elucidated.  
1.2 Heterotrimeric G proteins. GPCRs transduce signals from extracellular stimuli by 
activating heterotrimeric G proteins. These latter can be grouped in four subfamilies Gαs, Gαi, 
Gαq/11 and Gα12/13, according to the structural and functional properties of their α subunits. 
Gαs and Gαi regulate intracellular cAMP levels by activating (Gαs) or inhibiting (Gαi1, Gαi2 
and Gαi3) adenylyl cyclase; Gαq and Gα11 increase intracellular Ca2+ level via activation of 
phospholipase C; and, Gα12 and Gα13 couple GPCRs to the small GTPases of the Rho family. 
As shown in Table 2, all α subunits, at the exception of Gα12, are well represented in both 
transcriptomes, thereby providing molecular basis for a variety of intracellular signalling 
pathways activated by GPCRs in these parts of the renal tubule. 
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1.3 Nucleotide cyclases. Chabardès et al. have shown that cortical and outer medullary 
collecting ducts exhibit high expression levels of Ca2+-inhibitable adenylyl cyclases 6 (Adcy6) 
and 5 (Adcy5) [21]. Our data support these findings and extend the Adcy6 and Adcy5 
distribution to the DCT/CNT (Table 3). Both the DCT/CNT and the CCD also show a high 
expression of Adcy9, a cyclase which can be either potentiated or inhibited by the intracellular 
Ca2+ [22]. Collectively, these cyclases represent a point of cross-talk between the cAMP- and 
Ca2+-dependent signalling pathways. Similar to what was found in the IMCD, both, the 
DCT/CNT and the CCD exhibit low expression of guanylate cyclases (only Gucy1a3 fit the cut-
off criteria) and none of the nitric acid synthase isoforms were detected (data not shown) [11].  
1.4 Cyclic nucleotide phosphodiesterases.      Cyclic nucleotide phosphodiesterases (Pde) 
participate in attenuation of GPCR signalling by degrading cellular cAMP and/or cGMP.  As 
shown in Table 4, both, the DCT/CNT and the CCD exhibit high expression levels of several 
cAMP-specific phosphodiesterases, including Ca2+-activated Pde1a and cGMP-inhibited Pde3b. 
A significant expression of 3-isobutyl-1-methylxanthine (IBMX)-insensitive Pde8a and Pde8b 
provides a molecular basis for the IBMX-insensitive fraction of phosphodiesterase activity. The 
rolipram-sensitive cAMP-specific Pde4b and Pde4a have been proposed as important regulators 
of Avpr2-induced signalling cascade [23]. However, in the DCT/CNT and the CCD 
transcriptomes presented here they are expressed only at moderate levels.   
1.5 Protein kinases. More than 350 protein kinases have been found in the transcriptomes of the 
DCT/CNT and the CCD (Table 5 and Supplemental Table 2). Most of them (~ 300, Table 5A and 
Supplemental Table 2) belong to the class of serine/threonine protein kinases. Importantly, 
kinases that have been previously reported to strongly influence the secretion/reabsorption 
processes in DCT/CNT and/or the CCD are abundantly represented. WNK1, WNK4, SPAK 
(STK39) and Sgk1 have been involved in maintaining salt balance and are present within the 20 
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most abundant serine-threonine kinases. Both, the DCT/CNT and the CCD also exhibit moderate 
to high expression levels of protein kinase A (Prkaa2, Prkacb, Prkaca and Prkaa1), protein kinase 
C (Prkcd, Prkci, Prkch, Prkca and Prkcz), casein kinases (Csnk1d, Csnk1a1, Csnk2a1, Csnk1g2 
and Csnk2a2), Gsk3β and G protein-coupled receptor kinases 6, 5 and 4. Interestingly, several in 
vitro studies have demonstrated that the activity of the DCT-specific sodium-chloride co-
transporter (NCC) is regulated by WNK3 [24], a kinase which is expressed at background levels 
in our data (A_values of 3.8 and 2.8 in DCT/CNT and CCD, respectively). Accordingly, WNK3 
is also absent in microarray-based rat IMCD transcriptome [11]. Collectively, these results 
indicate that WNK3 distribution in the kidney requires a detailed re-evaluation. By contrast, both 
the DCT/CNT and the CCD exhibit strong expression of various serine-threonine kinases with 
yet unattributed function in the kidney. These include Pctk1, Pim3, Pak4, Aak1, Taok3, Rock1 
and several MAP kinases. In the kidney, tyrosine kinases (Table 5B) and receptor tyrosine 
kinases (Table 5C) have been mostly involved in tubulogenesis, cell differentiation and in 
maintaining cell polarity. However, the fibroblast growth factor receptor 1 (Fgfr1), which is 
specifically expressed in the distal nephron and the collecting duct, has been recently shown as 
the predominant receptor for the hypophosphatemic action of FGF23 [25].  
1.6 Protein phosphatases.  Protein phosphatases participate in intracellular signalling by 
reversing protein kinases-dependent events. All protein phosphatases can be grouped into three 
subfamilies: serine/threonine phosphatases, phosphotyrosine-specific protein tyrosine 
phosphatases and dual specificity (serine/threonine/tyrosine) phosphatases. As shown in Table 6 
and Supplemental Table 3, both, DCT/CNT and CCD express a variety of highly abundant 
phosphatases representing all three subfamilies. However, despite high expression levels and, 
presumably, significant functional role, only a limited number of phosphatases have been 
characterized in the kidney. Several studies have shown that calcineurin (Ppp3ca), a 
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serine/threonine phosphatase with broad substrate specificity, is involved in the regulation of 
transport proteins, including the Na,K-ATPase, aqp-2, ROMK and acid-base transporters [26-29]. 
The ROMK has been also shown as a substrate of tyrosine phosphatases [30]. Dual specificity 
phosphatases are thought to participate in renal function mainly by dephosphorylating kinases 
involved in the stress response (e.g. MAP kinases).  
1.7 A kinase anchoring proteins.  A kinase anchoring proteins (AKAPs) constitute a family of 
scaffold proteins involved in the targeting of protein kinase A to its substrates. The AKAPs have 
been extensively studied for their role in the PKA-dependent regulation of aqp-2 and ENaC 
activity. Henn et al., and Okutsu et al., have demonstrated that aqp-2 is co-localized with AKAP7 
(AKAP18) and AKAP11 (AKAP220) in subapical vesicles of the principal cell [31, 32]. 
Bengrine et al., have shown that AKAP7 is also involved in the feedback inhibition of ENaC 
[33]. It has been proposed that these AKAPs are required for compartmentalization of cAMP 
signalling in the principal cell. As shown in Table 7, we found both AKAP7 and AKAP11 in the 
DCT/CNT and CCD transcriptomes. However, the role of the more abundant AKAPs 2, 9 and 8 
has not yet been assessed.  
1.8 Phospholipases. Phospholipases play important roles in transmembrane signaling processes 
activated by GPCRs and receptor tyrosine kinases. Receptor-mediated activation of 
phospholipases results in hydrolysis of membrane phospholipids and generation of phospholipid-
derived second messengers. Phospholipases C (PLC) is a family of enzymes which catalyses the 
hydrolysis of phosphatidylinositol 4,5-biphosphate to produce diacyglycerol (DAG) and inositol 
1,4,5-trisphosphate (IP3). In the DCT/CNT and/or the CCD several targets of PLC/DAG/PKC 
cascade have been identified, including TRPV5 calcium channel, aqp-2, ROMK and ENaC [34-
37]. We found that the most abundant phospholipase in the DCT/CNT and the CCD is Plcg1, a 
PLC activated by a variety of growth factors including platelet-derived growth factor (PDGF), 
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hepatocyte growth factor (HGF) and fibroblast growth factor (FGF) (Table 8). Recently, 
Irarrazabal et al., have shown that Plcg1 contributes to the osmoprotective effect of 
TonEBP/OREBP transcriptional factor in the kidney [38]. Analysis of both transcriptomes also 
revealed expression of Ca2+-sensitive PLC isoforms Plcd3 and Plcd1 but only a low amount of 
Gq-activated Plcb1. Phospholipases A2 (PLA2) catalyze the hydrolysis of phospholipids to 
generate free fatty acids and lysophospholipids. One of the principal products of PLA2 activity is 
the arachidonic acid, a precursor in the biosynthesis of prostaglandins and other eicosanoids. 
Prostaglandins are known to regulate water and solutes transport in an autocrine or paracrine 
manner by activating apical or basolateral GPCRs. According to our data, the principal PLA2 
isoforms expressed in the DCT/CNT and the CCD are Pla2g4a, Pla2g15 and Pla2g6 (Table 8). 
Phospholipase D (PLD) isoforms which are also abundantly represented in both trancriptomes 
have been recently shown to be important regulators of endocytosis and endosomal recycling 
pathways [39].  
1.9 Small GTP-binding proteins. Small GTP-binding proteins are low-molecular weight 
GTPases (20-25 kDa) that control a variety of cellular processes including vesicle transport, 
cytoskeleton dynamics, cell division and immune response. All small GTPases can be divided in 
five subfamilies, namely the Rab subfamily, the Arf subfamily, the Rho/Rac/Cdc42 subfamily, 
the Ras/Ral/Rap subfamily and the Ran GTPase. More than 50 members of the Rab subfamily 
were found to be expressed at significant levels (Table 9A and Supplemental Table 4). The 
members of this family are implicated in the transport, docking and fusion of endocytotic 
vesicles. Van de Graaf et al. have shown that Rab11a is required for the intracellular trafficking 
of TRPV5 and TRPV6 calcium channels to the cell surface [40]. Curtis and Gluck have 
demonstrated that Rab11 and Rab20 are mainly expressed in V-ATPase expressing intercalated 
cells of the collecting duct, whereas principal cells of the collecting duct and of the distal nephron 
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are enriched in Rab18 and Rab5a [41]. Several evidence indicate that Rab(s) could be involved in 
trafficking of CFTR, ENaC and aqp-2 [42]. However, functional role of many highly abundant 
Rab(s) in DCT/CNT and CCD remains unknown. ADP-ribosylating factors (Arfs) are 
participating in the formation of coated transport vesicles. El-Annan et al. have shown abundant 
expression of Arf1 and Arf6 in the distal nephron and the collecting duct and have demonstrated 
that Arf1 is mostly localized to the apical membrane whereas Arf6 appeared to be mainly 
expressed at the basolateral membrane [43]. Arf6 was further demonstrated as a factor promoting 
Avpr2 recycling [44]. Our data confirm high expression levels of Arf1 and Arf6 and reveal 
abundant expression of several Arf(s) (Arf3, Arl1, Arl3, etc., see Table 9B) with yet unassigned 
function in the renal tubule. As shown in Table 9C, both the DCT/CNT and the CCD also exhibit 
high expression levels of several Rho GTPases, including Cdc42, RhoA and Rac1. The main 
function of Rho GTPases consists in the control of cytoskeleton dynamics and assembly. Thus, it 
was logically proposed that Rho(s) could be involved in trafficking of aqp-2, a process which 
requires remodelling of microtubules and filaments. However, evidence that support this 
hypothesis remains limited to a few in vitro studies [45, 46]. Members of Ras subfamily share the 
highest degree of homology with Ras, one of the most frequently mutated oncogenes in cancer. 
Ras, Ral and Rap have been shown to play an important role in cellular proliferation and 
differentiation by influencing a number of intracellular signalling pathways. Ras GTPases have 
been also shown to influence activity or expression of several important DCT/CNT and/or CCD 
transporters, including NCC (H-ras), H,K-ATPase (Rap1), ENaC (K-ras) and aqp-2 (Rap1) [47-
50]. As shown in Table 9D, H-ras, K-ras and Rap1 are present within the 10 most abundant 
members of the Ras subfamily. However, role of several other highly abundant Ras GTPases, 
including the most abundant Rragd, remain unknown.   
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1.10 SNAREs and SNARE-related proteins. SNARE proteins participate in trafficking of renal 
transporters by mediating fusion of intracellular vesicles to the target membranes. Molecular 
composition of SNARE complexes has been extensively studied for aquaporins involved in renal 
urine concentration mechanism. Mistry et al., have shown that aqp-2 sorting to the apical 
membrane requires snapin (SNAPAP), SNAP23 and syntaxin-3, whereas syntaxin-4 is 
preferentially involved in cell surface expression of aqp-3 [51]. SNAP23/syntaxin-1a complex 
has been also proposed to regulate cell surface expression of ENaC. However, in our data, 
expression levels of syntaxin-1a are low (A_values of 4.7 and 5.0 in the DCT/CNT and the CCD, 
respectively). Accordingly, only a low signal intensity for syntaxin-1a was detected in the IMCD 
hybridization data [11]. As shown in Table 10 and Supplemental Table 5, both the DCT/CNT and 
the CCD exhibit high expression of SNAPAP, SNAP23, syntaxin-3 and syntaxin-4. High 
expression levels were also detected for vesicle associated membrane proteins (VAMP) – 2, 8 
and 3. VAMP2 and VAMP3 proteins were previously identified in aqp-2-containing intracellular 
vesicles indicating their involvement in aqp-2 trafficking [52]. Recently, Wang et al. have shown 
that mice devoid of VAMP8 gene exhibit a diabetes insipidus-like phenotype and a significantly 
reduced membrane expression of aqp-2 in collecting duct cells [53]. 
1.11 Clathrin, clathrin adaptors and dynamin-like GTPases.  Clathrin-coated vesicles are 
major protein carriers in protein endocytotic pathways. Clathrin-coated vesicles mediate 
endocytosis of many essential DCT/CNT and/or CCD transporting proteins including ROMK, 
Na,K-ATPase, ENaC, aqp-2 and Trpv5 [54-58]. As shown in Table 11A, both the DCT/CNT and 
the CCD exhibit high expression levels of clathrin light and heavy chains (Clta, Cltb and, Cltc, 
respectively) as well as several clathrin adaptor subunits (Ap1s3, Ap2s1 and Ap3s1). Similar to 
the IMCD [11], our data show a high abundance of Picalm, a clathrin adaptor which was recently 
shown to direct VAMP2 trafficking during endocytosis [59]. Dynamins are high molecular 
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weight GTPases (~ 100 kDa) that mediate the fission of clathrin-coated vesicles from the 
membrane. As shown in Figure 11B, both transcriptomes reveal a high expression of dynamin 2 
(Dnm2) and dynamin 1-like (Dnm1l) and low expression of dynamins 1 and 3 (Dnm1 and Dnm3, 
respectively). Interestingly, this distribution of dynamins differs significantly from that of IMCD 
in which only dynamin-like GTPases Mx1 and Mx2 demonstrated high signal intensities [11]. In 
the DCT/CNT and the CCD transcriptomes, both Mx1 and Mx2 exhibit low expression levels 
(Mx1: A_values of 4.3 and 3.8 in DCT/CNT and CCD, respectively; Mx2: A_values of 3.5 and 
3.0 in DCT/CNT and CCD, respectively). 
1.12 Cytoskeletal proteins and cytoskeletal regulators. Cytoskleletal proteins mediate a wide 
variety of essential renal functions. During foetal kidney development, the assembly and 
contraction of microtubules and microfilaments has been proposed as part of a mechanism that 
drives branching morphogenesis of the uteric bud [60]. In the adult kidney, cytoskeleton 
remodelling has been shown to influence cell surface expression and/or activity of a number of 
proteins involved in maintaining balance of water and electrolytes, including ENaC, aqp-2, Na,K-
ATPase, secretory K channels and chloride channels [61-65]. A significant number of 
cytoskeletal proteins have been recently identified by a proteomic approach in the aqp-2-
containing vesicles in the IMCD [52]. As shown in Table 12 and Supplemental Table 6, ~ 300 
different transcripts encoding cytoskeletal and cytoskeletal-related proteins are present in our 
data. The overall distribution and abundance of cytoskeletal transcripts in the DCT/CNT and the 
CCD is largely similar to that identified in the IMCD. However, for several major transcripts a 
significant difference was observed. For instance, moesin, an actin-binding protein which has 
been shown to modulate activity of aqp-2, Na,K-ATPase and CFTR in different models of 
epithelial cells, was undetectable in IMCD transcriptome [11, 66-68]. In our study, moesin is 
abundantly present in both the DCT/CNT and the CCD (see subcategory actin and actin-binding 
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proteins, Table 12A). Also our data reveal high expression of myosin VI (Myo6), a myosin 
which has been shown as a prerequisite for the clathrin-dependent endocytosis of CFTR in the 
intestine [69] (see subcategory myosin and myosin-like proteins, Table 12B). The role of Myo6 in 
the kidney has not yet been investigated. In subcategory microtubule and microtubule-related 
proteins (Table 12C) we found strong expression of tubulins 1b and 1a (Tuba1b and Tuba1a), 
two tubulins that were not detected in the IMCD. Again, despite a high abundance of these 
transcripts, their role in the kidney remains unknown. Finally, in subcategory intermediate 
filaments and related proteins (Table 12D), we detected several keratins not present in the IMCD 
transcriptome (Krt10, Krt80, Krt23 and Krt34).  
1.13 Transporters and channels.  As shown in Table 13 and Supplemental Table 7, more than 
250 transcripts encoding water/solutes transporting proteins are expressed at significant levels in 
the DCT/CNT and/or the CCD, confirming the variety of solutes transported across the 
epithelium of these segments. In subcategory water channels (Table 13A), aquaporins are 
abundantly represented by plasma membrane expressed aquaporins 2, 3 and 4, as well as by the 
intracellular aquaporins 6 and 11. As expected, expression of aquaporins 2 and 4 is significantly 
lower in the DCT/CNT than in the CCD, whereas aquaporin-3 is equally represented in both 
transcriptomes. Surprisingly, our analysis also revealed a low, but significant, expression of 
aquaporin 1, a channel which is present, according to immunohistochemical analyses, only in the 
proximal tubule and descending thin limb. Interestingly, the aquaporin 1 RNA has also been 
detected in human DCT, at levels of ~ 10% of those in the proximal tubule [70]. However, in 
both, human and mouse transcriptomes, the expression levels of aquaporin 1 RNA in the distal 
nephron are significantly lower than those of other water channels. For instance, in mouse 
DCT/CNT the difference between the aquaporin 3 and aquaporin 1 RNA expression is ~ 130-fold 
(13.11 units of A-value vs. 6.09 units of A-value, respectively, Table 13A).   
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 In subcategory ion channels and transporters excluding SLC (Table 13B), all principal 
genes involved in maintaining ion balance are represented (e.g. Na,K-ATPase, αβγENaC 
(Scnn1), ROMK (Kcnj1), Kir5.1 (Kcnj16), Kir 4.1 (Kcnj10), Clcnkb, Clc3, Trpv5, PMCA2 
(ATP2b2), Trpm6 and various H+-ATPases). Analysis of the transcripts belonging to this 
subcategory also revealed a number of highly abundant transcripts with yet unassigned function 
in the kidney. For instance, both the DCT/CNT and the CCD exhibit high expression levels of 
Tmem16f, a functionally uncharacterized paralogue of a recently identified calcium-activated 
chloride channel Tmem16a [71]. Also, both transcriptomes reveal abundant expression of several 
voltage-gated ion channels, including Kcnq1, Kcne1, Kcnj10, Cacna1d, Cacnab4, Kcnh3 and 
Cacna2d1. Importantly, mutations in two voltage-gated potassium channels (Kcnj10 and Kcna1) 
have been recently shown to cause electrolyte imbalance in human [3, 4]. To what extent other 
voltage-gated channels identified in our study can participate in the physiology/pathophysiology 
of distal nephron and/or collecting duct remains to be established.  
 In subcategory solute carrier proteins (SLC) (Table 13C), the most abundant transcript is 
pendrin (Slc26a4), a chloride/bicarbonate exchanger located at the apical membrane of the CNT 
and CCD cells. Also highly abundant is Slc2a9, a recently identified urate transporter [72]. 
Interestingly, analysis of the SLC(s) expressed in the DCT/CNT and/or the CCD revealed the 
presence of several transcripts whose expression was previously considered as restricted to the 
proximal tubule or to Henle’s loop. For example, a high expression of the glucose transporter 
Glut1 (Slc2a1) and the sodium-glucose co-transporter Sglt2 (Slc2a5) and, a moderate expression 
of the sodium-potassium-chloride co-transporter NKCC2 (Slc12a1) and the sodium-phosphate 
co-transporter NaPi-IIa (Slc34a2) were detected in distal nephron. Glut1 and NKCC2 transcripts 
were also detected in the IMCD transcriptome [11]. Expression of NaPi-IIa, NKCC2 and Sglt2 in 
the DCT has been validated by RT-PCT analysis (D.Firsov, unpublished observations). The 
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correlation between transcript and protein expression of these genes remains unknown. However, 
this information might be important for selection of tissue-specific promoters in transgenic 
experiments.  
1.14 Transcription factors.  More than 1’000 transcription factors are expressed in DCT/CNT 
and/or CCD above median levels (Table 14 and Supplemental Table 8). Only a small fraction of 
them has been assigned to a specific renal function. For instance, Homeobox-containing 
transcriptional factors (Hox) are largely involved in morphogenesis of different parts of the renal 
tubule (see below). Mineralocorticoid receptor (Nr3c2), glucocorticoid receptor (Nr3c2), vitamin 
D receptor (Vdr), cAMP response element-binding proteins (Creb(s) and Atf(s)), peroxisome 
proliferator-activated receptors (PPARs), TonEBP (Nfat5), Jun, Fos, Edf1, Jag have been shown 
to participate in the regulation of secretion/reabsorption processes along the distal nephron and 
the collecting duct. Recently, we have shown that transcriptional factors of the circadian clock 
(arntl (bmal1), clock, npas2, dbp, hlf, tef) are playing a major role in DCT/CNT and CCD 
homeostatic function [10].  
 
2. Comparison of DCT/CNT and CCD transcriptomes.     To identify genes differentially 
expressed between the DCT/CNT and the CCD we performed a comparative analysis of the 
normalized DCT/CNT and CCD transcriptomes. A 3-fold difference in expression levels and a 
false discovery rate (FDR) of 5% were used as cut-off criteria. Overall, 122 DCT/CNT transcripts 
(corresponding to 82 distinct genes) and 118 CCD transcripts (corresponding to 91 distinct genes) 
met this criterion (Supplemental Figure 1).  
2.1 Transcripts enriched in DCT/CNT. Analysis of differentially expressed transcripts 
revealed two major groups of genes enriched in DCT/CNT: (i) genes of the Homeobox (Hox) 
family of transcriptional factors that play an essential role during embryonic kidney development 
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[73] and, (ii) genes involved in the secretion/reabsorption of different solutes along the nephron 
(Table 15 and Supplemental Table 8). The Hox genes have been shown to determine the segment 
identity of the renal tubule, being principal genes of formation and patterning of the uteric bud 
and the metanephric mesenchyme. However, their role in the adult kidney is less clear. Our data 
demonstrate that Hox genes which are specifically involved in the nephron formation during the 
embryogenesis (Hoxa9, Hoxd10, Hoxd11, Hoxa10, Hoxa3 and Hoxc9) remain enriched in the 
DCT/CNT of the adult kidney [74]. In contrast, analysis of the CCD enriched transcripts (Table 
16) shows that Hox genes specifically involved in the development of the uteric bud are either not 
expressed in the CCD of the adult kidney (Hoxd1) or show comparable expression levels in the 
DCT/CNT and CCD (Hoxb7, Hoxd8) [74].   
At least 15 out of 83 DCT/CNT enriched genes have been shown to participate in renal 
solute homeostasis. For instance, the thiazide-sensitive sodium-chloride cotransporter (NCC or 
Slc12a3) and the WNK1 (with-no-lysine (K)) serine-threonine kinase are critically involved in 
sodium/chloride reabsorption and potassium secretion in the distal nephron segments [75]. The 
Glut9 (Slc2a9) transporter has been recently shown as a principal transporter involved in the 
renal handling of urate in both human and mice [76]. A significant number of the DCT/CNT 
enriched genes are involved in the transepithelial reabsorption of calcium and magnesium. These 
latter include the genes coding for the sodium-calcium exchanger (Slc8a1), parvalbumin (Pvalb), 
the tissue kallikrein (Klk1), the parathyroid hormone 1 receptor (Pth1r), klotho (Kl), the vitamin 
D receptor (Vdr), the calcium binding proteins calbindin-28K (Calb1) and S100 (S100g), the 
epidermal growth factor (Egf), the FXYD domain-containing ion transport regulator 2 (Fxyd2), 
the transient receptor potential cation channels Trpv5 and Trpm6 [77]. A secreted species of 
klotho has been shown to mediate the paracrine regulation of phosphate reabsorption in the 
proximal tubule [78].    
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 This analysis also revealed several DCT/CNT-enriched transcripts potentially involved in 
renal solutes handling. For example, the Secreted Frizzled-Related Protein 1 (Sfrp1) belongs to a 
small family of secreted proteins acting as antagonist of the Wnt signaling pathway. Importantly, 
one of the Sfrp, namely Sfrp4, is one of the most potent tumor-derived antagonists of phosphate 
reabsorption in the proximal tubule As Sfrp1 strongly expressed in the kidney in normal 
physiological state, we believe that this gene might be an interesting candidate for maintaining 
phosphate balance by the kidney. Another interesting transcript is the cytochrome P450 2j11 
(Cyp2j11) which shares a high degree of homology (80%) with the human Cyp2j2 protein. 
Several studies have provided evidence for an association of Cyp2j2 polymorphisms with a 
susceptibility to essential hypertension in man [79-81]. The Cyp2j2 has been proposed to regulate 
renal fluid-electrolyte transport by catalyzing production of cis-epoxyeicosatrienoic acids (EETs) 
from the arachidonic acid. In vitro, the EETs have been shown to inhibit the activity of ENaC 
[82]. However, other renal targets of EETs as well as the in vivo role of Cyp2j2/Cyp2j11 in the 
kidney remain unknown. Two other remarkable DCT/CNT enriched genes are the small GTPase 
Rab27a which is involved in the intracellular vesicle docking and membrane trafficking and, the 
Uscher syndrome 1C homolog (Ush1C), a ciliary protein which contributes to establishing the 
sensitivity to displacement of mechanotransduction channels in the hair cells [83, 84]. The 
functional relevance of these two proteins in the kidney remains unclear.  
2.2 Transcripts enriched in CCD.  The CCD transcriptome is also enriched in transcripts 
involved in different stages of tubulogenesis (Table 16 and Supplemental Table 9). These include 
an agonist of the frizzled receptors (Wnt9b), the enzymes of retinoic acid synthetic pathway 
(Aldh1a1 and Aldh1a7), the metallopeptidase inhibitor 2 (Timp2), the insulin-like growth factor 
1 (Igf1), a ligand of the epidermal growth factor receptor (betacellulin), the arginase 2 (Arg2) and 
the axon guidance receptor homolog 1 (Robo1). Several enriched transcripts encode proteins 
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participating in tubular water/solute transport (aqp-4, aqp-2, Fxyd4, Fxyd3, Slc26a7 and Ptger1). 
Interestingly, CCD cells exhibit significant expression of Gpr126, an orphan GPCR controlling 
the Gs/cAMP signaling pathway in Schwann cells [85]. In the kidney, neither function nor 
cellular localization of Gpr126 had been determined thus far. However, this receptor is expressed 
at high levels in mCCD cells, a model of principal cells of the collecting duct (Heidi Fodstad, 
unpublished microarray hybridization data, personal communication). This finding, if confirmed 
in human principal cells, raises an interesting possibility of using Gpr126 for bypassing 
malfunctioning V2R signaling pathway in X-linked nephrogenic diabetes insipidus (NDI). Both, 
the DCT/CNT and the CCD transcriptomes are enriched by enzymes involved in sulfation of 
glycoproteins (Sulf2 and Chst11 in DCT/CNT and, Chst9 and Hs3st3b1 in CCD). Sulfation is a 
posttranslational modification known to contribute to the functional heterogeneity of 
glycoproteins by modifying their binding capacities to glycans, glycolipids or to other 
glycoproteins. In the kidney, sulfation has been shown to affect many important biological 
processes including immune response, cell-cell adhesion and hormonal signaling. Yet, the 
specific targets of the above-mentioned enzymes along the nephron and in the collecting duct 
remain unknown.  
Overall, this in-depth analysis of the mouse transcriptomes of the DCT/CNT and CCD 
opens new avenues in the comprehensive interpretation of molecular mechanisms underlying 
renal homeostasis. More studies are needed that will decipher the exact roles and interactions of 
the genes expressed in the distal part of the nephron and in the CCD. 
FIGURE LEGEND 
Figure 1.    Correlation between qPCR- and microarray- based expression levels of GPCRs 
expressed in the DCT/CNT (A) and the CCD (B). Negative mean normalized Ct values (x-axis) 
are plotted against normalized expression values measured by Affymetrix microarrays (y-axis). 
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Genes with the Ct values of 36 or above are not plotted. Loess curves are indicated with a red 
line. Genes considered as expressed from the microarray data are indicated with a red dot. 
Several genes discussed in the text are indicated with a green dot. Two outliers are Cxcr7 (a) and 
S1pr3 (b). The qPCR was performed on Mouse GPCR array from Applied Biosystems. 
 
Supplementary Figure 1 
A. Scatter plot of average expression value in the DCT/CNT samples versus average expression 
value in CCD samples. Dashed red lines: 2-fold change cut-off. Solid green line: loess curve. B. 
Density distribution of the moderated t-statistics for the expression in DCT/CNT versus CCD. 
Black line: t-statistics calculated on the normalized values not corrected for batch effect. Red 
line: t-statistics calculated on the normalized values after correction for batch effect. 
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Supplemental Table 1. G protein-coupled receptors (GPCR)
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
arginine vasopressin receptor 1A Avpr1a 12.23 12.44
cadherin, EGF LAG seven-pass G-type receptor 2 Celsr2 11.27 12.06
chemokine (C-X-C motif) receptor 7 Cxcr7 11.03 12.34
G protein-coupled receptor 116 Gpr116 10.79 11.34
G protein-coupled receptor 56 Gpr56 10.68 11.60
chemokine (C-X-C motif) receptor 4 Cxcr4 10.39 10.65
prostaglandin E receptor 3 (subtype EP3) Ptger3 10.29 9.04
G protein-coupled receptor, family C, group 5, member C Gprc5c 10.25 11.11
arginine vasopressin receptor 2 Avpr2 9.89 11.61
oxoglutarate (alpha-ketoglutarate) receptor 1 Oxgr1 9.69 9.44
xenotropic and polytropic retrovirus receptor 1 Xpr1 9.68 9.92
prostaglandin F receptor Ptgfr 9.61 10.28
G protein-coupled receptor, family C, group 5, member B Gprc5b 9.41 10.53
glucagon receptor Gcgr 9.28 8.77
coagulation factor II (thrombin) receptor-like 1 F2rl1 9.25 9.97
calcium-sensing receptor Casr 9.16 9.42
endothelin receptor type B Ednrb 9.01 9.35
prostaglandin E receptor 1 (subtype EP1) Ptger1 8.85 9.43
parathyroid hormone 1 receptor Pth1r 8.82 6.73
G protein-coupled receptor 108 Gpr108 8.81 9.05
G protein-coupled estrogen receptor 1 Gper 8.43 8.64
adrenergic receptor, beta 1 Adrb1 8.41 8.45
prostaglandin E receptor 4 (subtype EP4) Ptger4 8.30 9.48
adrenergic receptor, beta 2 Adrb2 8.29 8.16
adrenergic receptor, alpha 2a Adra2a 8.24 8.79
apelin receptor Aplnr 8.24 7.45
sphingosine-1-phosphate receptor 3 S1pr3 8.23 9.32
smoothened homolog (Drosophila) Smo 8.23 8.25
gamma-aminobutyric acid (GABA) B receptor, 1 Gabbr1 8.21 7.83
coagulation factor II (thrombin) receptor F2r 8.16 7.94
adenosine A1 receptor Adora1 8.14 9.81
G protein-coupled receptor 146 Gpr146 8.13 9.14
RIKEN cDNA 2310046K01 gene 2310046K01Rik 8.09 9.51
G protein-coupled receptor 89 Gpr89 8.09 8.50
cadherin, EGF LAG seven-pass G-type receptor 1 Celsr1 8.04 8.68
G protein-coupled receptor 172B Gpr172b 8.03 7.91
latrophilin 1 Lphn1 7.96 8.60
G protein-coupled receptor 107 Gpr107 7.90 8.35
vomeronasal 2, receptor 29 Vmn2r29 7.84 7.37
EGF, latrophilin seven transmembrane domain containing 1 Eltd1 7.81 7.80
component of Sp100-rs /// predicted gene, EG665317 Csprs 7.59 7.04
G protein-coupled receptor 125 Gpr125 7.57 7.64
complement component 5a receptor 1 C5ar1 7.51 7.26
neuropeptide Y receptor Y6 Npy6r 7.44 8.96
vomeronasal 2, receptor 4 Vmn2r4 7.33 6.10
adrenergic receptor, alpha 2c Adra2c 7.31 7.51
lysophosphatidic acid receptor 1 Lpar1 7.30 9.04
transducin (beta)-like 3 Tbl3 7.30 7.75
G protein-coupled receptor 126 Gpr126 7.18 9.40
progestin and adipoQ receptor family member VIII Paqr8 7.13 8.07
KISS1 receptor Kiss1r 7.12 6.37
CD97 antigen Cd97 7.04 6.99
histamine receptor H2 Hrh2 7.01 6.49
purinergic receptor P2Y, G-protein coupled, 5 P2ry5 6.98 7.55
G protein-coupled receptor 63 Gpr63 6.97 7.96
calcitonin receptor-like Calcrl 6.87 6.35
lysophosphatidic acid receptor 2 Lpar2 6.80 7.27
secretin receptor Sctr 6.76 6.11
vomeronasal 1 receptor, D14 V1rd14 6.64 5.41*
purinergic receptor P2Y, G-protein coupled, 14 P2ry14 6.59 8.04
calcitonin gene-related peptide-receptor component protein Crcp 6.56 6.83
sphingosine-1-phosphate receptor 4 S1pr4 6.41 5.83
G protein-coupled receptor 39 Gpr39 6.29 6.88
5-hydroxytryptamine (serotonin) receptor 1B Htr1b 6.27 6.99
Melanin-concentrating hormone receptor 1 (Mchr1), mRNA Mchr1 6.18 6.21
sphingosine-1-phosphate receptor 1 S1pr1 6.06 5.70*
G protein-coupled receptor 135 Gpr135 6.06 3.38*
opsin 3 Opn3 6.04 6.20
chemokine (C-C motif) receptor 5 Ccr5 5.99 4.76*
cannabinoid receptor 1 (brain) Cnr1 5.95 5.03*
G protein-coupled receptor 97 Gpr97 5.94 6.67
G protein-coupled receptor 37 Gpr37 5.94 6.57
Bradykinin receptor, beta 2 (Bdkrb2), mRNA Bdkrb2 5.87 5.73*
complement component 3a receptor 1 C3ar1 5.85 5.64*
G protein-coupled receptor 110 Gpr110 5.81 4.75*
G protein-coupled receptor 64 Gpr64 5.15* 6.46
purinergic receptor P2Y, G-protein coupled 2 P2ry2 4.86* 6.43
* - the A-value is below the cut-off level 
Supplemental Table 2. Protein kinases
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
Table 5A. Serine/threonine kinases
calcium/calmodulin-dependent protein kinase II, beta Camk2b 12.95 13.41
PCTAIRE-motif protein kinase 1 Pctk1 12.51 12.68
WNK lysine deficient protein kinase 1 Wnk1 12.48 11.27
proviral integration site 3 Pim3 12.43 12.20
serum/glucocorticoid regulated kinase 1 Sgk1 11.98 12.86
mitogen-activated protein kinase kinase kinase 12 Map3k12 11.85 11.90
MAP kinase-interacting serine/threonine kinase 2 Mknk2 11.54 12.23
p21 (CDKN1A)-activated kinase 4 Pak4 11.53 12.31
AP2 associated kinase 1 Aak1 11.50 11.93
serum/glucocorticoid regulated kinase 2 Sgk2 11.42 10.91
TAO kinase 3 Taok3 11.34 10.85
glycogen synthase kinase 3 beta Gsk3b 11.28 12.04
casein kinase 1, delta Csnk1d 11.20 11.79
Rho-associated coiled-coil containing protein kinase 1 Rock1 11.13 11.28
mitogen-activated protein kinase-activated protein kinase 3 Mapkapk3 11.07 11.40
NIMA (never in mitosis gene a)-related expressed kinase 7 Nek7 11.02 11.20
casein kinase 1, alpha 1 Csnk1a1 11.01 11.56
WNK lysine deficient protein kinase 4 Wnk4 10.99 10.46
p21 (CDKN1A)-activated kinase 2 Pak2 10.91 11.60
pyruvate dehydrogenase kinase, isoenzyme 2 Pdk2 10.80 10.80
serine/threonine kinase 39, STE20/SPS1 homolog (yeast) Stk39 10.75 11.46
homeodomain interacting protein kinase 2 Hipk2 10.71 10.91
serine/threonine kinase 24 (STE20 homolog, yeast) Stk24 10.58 11.01
mitogen-activated protein kinase 14 Mapk14 10.53 11.07
calcium/calmodulin-dependent protein kinase kinase 2, beta Camkk2 10.40 11.59
mitogen-activated protein kinase kinase 7 Map2k7 10.35 10.47
CDC like kinase 4 Clk4 10.33 10.54
cyclin-dependent kinase-like 1 (CDC2-related kinase) Cdkl1 10.29 11.16
STE20-like kinase (yeast) Slk 10.28 11.05
mitogen-activated protein kinase kinase kinase 5 Map3k5 10.28 10.80
protein kinase N2 Pkn2 10.27 10.50
nemo like kinase Nlk 10.26 10.87
bone morphogenetic protein receptor, type 1B Bmpr1b 10.22 11.13
CDC-like kinase 3 Clk3 10.21 10.92
cyclin G associated kinase Gak 10.18 10.61
protein kinase, AMP-activated, alpha 2 catalytic subunit Prkaa2 10.18 10.61
MAPK scaffold protein 1 Mapksp1 10.10 10.30
protein kinase C, delta Prkcd 10.09 10.58
pyruvate dehydrogenase kinase, isoenzyme 1 Pdk1 10.02 9.71
bone morphogenic protein receptor, type II (serine/threonine kinase) Bmpr2 10.02 10.57
mitogen-activated protein kinase kinase kinase kinase 3 Map4k3 10.01 10.76
serine/threonine kinase 17b (apoptosis-inducing) Stk17b 10.00 10.35
leucine-rich PPR-motif containing Lrpprc 9.99 9.98
CDC42 binding protein kinase gamma (DMPK-like) Cdc42bpg 9.96 10.60
tousled-like kinase 2 (Arabidopsis) Tlk2 9.89 10.60
NIMA (never in mitosis gene a)-related expressed kinase 9 Nek9 9.88 10.46
CDC-like kinase 1 Clk1 9.87 10.79
protein kinase, X-linked Prkx 9.85 10.42
casein kinase 2, alpha 1 polypeptide Csnk2a1 9.83 10.37
homeodomain interacting protein kinase 3 Hipk3 9.81 10.10
serine/threonine kinase 38 Stk38 9.80 10.53
large tumor suppressor 2 Lats2 9.76 10.35
integrin linked kinase Ilk 9.74 10.27
mitogen-activated protein kinase kinase kinase 3 Map3k3 9.72 9.88
nuclear receptor binding protein 2 Nrbp2 9.69 10.16
MAP/microtubule affinity-regulating kinase 2 Mark2 9.68 10.50
tousled-like kinase 1 Tlk1 9.68 9.92
mitogen-activated protein kinase kinase kinase 7 Map3k7 9.65 9.97
Rous sarcoma oncogene Src 9.65 9.35
activin receptor IIA Acvr2a 9.63 10.01
serine/arginine-rich protein specific kinase 1 Srpk1 9.61 9.89
homeodomain interacting protein kinase 1 Hipk1 9.58 10.66
SNF related kinase Snrk 9.55 10.13
mitogen-activated protein kinase 3 Mapk3 9.54 9.97
adrenergic receptor kinase, beta 2 Adrbk2 9.52 9.68
similar to Yamaguchi sarcoma viral (v-yes-1) oncogene homolog Lyn 9.52 10.33
transforming growth factor, beta receptor II Tgfbr2 9.50 10.89
translocated promoter region Tpr 9.47 10.48
mitogen-activated protein kinase kinase kinase 1 Map3k1 9.45 10.45
CDC2-related kinase, arginine/serine-rich Crkrs 9.42 9.95
serine/threonine kinase 3 (Ste20, yeast homolog) Stk3 9.41 9.38
serine/threonine kinase 11 Stk11 9.40 10.54
mitogen-activated protein kinase kinase 2 Map2k2 9.35 9.68
protein kinase, cAMP dependent, catalytic, beta Prkacb 9.33 9.32
mitogen-activated protein kinase 9 Mapk9 9.31 9.24
cyclin-dependent kinase 9 (CDC2-related kinase) Cdk9 9.29 9.82
FK506 binding protein 12-rapamycin associated protein 1 Frap1 9.27 9.47
serine/threonine kinase 4 Stk4 9.27 9.70
protein kinase C, iota Prkci 9.26 9.77
receptor-interacting serine-threonine kinase 4 Ripk4 9.24 9.53
3-phosphoinositide dependent protein kinase-1 Pdpk1 9.22 9.94
eukaryotic translation initiation factor 2-alpha kinase 2 Eif2ak2 9.22 9.28
PRP4 pre-mRNA processing factor 4 homolog B (yeast) Prpf4b 9.22 9.57
kinase insert domain protein receptor Kdr 9.21 9.22
serine/threonine kinase 40 Stk40 9.18 9.28
interleukin-1 receptor-associated kinase 1 Irak1 9.18 9.07
oxidative-stress responsive 1 Oxsr1 9.12 10.15
conserved helix-loop-helix ubiquitous kinase Chuk 9.12 9.97
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) Erbb3 9.12 9.94
RIO kinase 2 (yeast) Riok2 9.12 9.45
mitogen-activated protein kinase kinase kinase 2 Map3k2 9.10 9.49
plexin B1 Plxnb1 9.06 10.17
casein kinase 1, gamma 2 Csnk1g2 9.02 9.31
mitogen-activated protein kinase 6 Mapk6 9.01 9.66
protein kinase, cAMP dependent, catalytic, alpha Prkaca 9.01 9.51
serum/glucocorticoid regulated kinase 3 Sgk3 8.98 8.57
cyclin-dependent kinase 7 Cdk7 8.97 9.02
pyruvate dehydrogenase kinase, isoenzyme 4 Pdk4 8.95 9.65
myosin, light polypeptide kinase Mylk 8.95 10.12
mitogen-activated protein kinase kinase 1 Map2k1 8.94 9.34
protein kinase C, eta Prkch 8.94 10.04
Unc-51 like kinase 1 (C. elegans) Ulk1 8.94 9.03
plexin B2 Plxnb2 8.93 10.28
phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 4,p150 Pik3r4 8.93 9.38
kit oncogene Kit 8.91 9.80
CDC-like kinase 2 /// secretory carrier membrane protein 3 Clk2 /Scamp3 8.86 9.21
RIO kinase 3 (yeast) Riok3 8.86 9.31
Braf transforming gene Braf 8.86 9.44
activin A receptor, type 1B Acvr1b 8.85 9.04
large tumor suppressor Lats1 8.85 9.49
TAO kinase 1 Taok1 8.85 9.61
testis-specific kinase 2 Tesk2 8.84 8.95
eukaryotic elongation factor-2 kinase Eef2k 8.84 10.36
protein kinase D3 Prkd3 8.78 9.31
microtubule associated serine/threonine kinase 2 Mast2 8.76 9.13
dual serine/threonine and tyrosine protein kinase Dstyk 8.75 9.44
TAF1 RNA polymerase II Taf1 8.75 9.37
calcium/calmodulin-dependent protein kinase I Camk1 8.74 9.21
CDC42 binding protein kinase alpha Cdc42bpa 8.72 9.13
protein kinase C, alpha Prkca 8.71 9.10
NUAK family, SNF1-like kinase, 2 Nuak2 8.71 10.00
protein kinase C, zeta Prkcz 8.68 9.20
NIMA (never in mitosis gene a)-related expressed kinase 4 Nek4 8.68 8.76
eukaryotic translation initiation factor 2 alpha kinase 1 Eif2ak1 8.67 8.97
SH3-domain binding protein 4 Sh3bp4 8.66 9.12
doublecortin-like kinase 3 Dclk3 8.64 9.84
cyclin-dependent kinase 4 Cdk4 8.63 9.27
Yamaguchi sarcoma viral (v-yes) oncogene homolog 1 Yes1 8.62 9.07
mitogen-activated protein kinase 1 Mapk1 8.61 9.10
cDNA sequence BC033915 BC033915 8.61 8.75
TANK-binding kinase 1 Tbk1 8.61 9.01
serine/arginine-rich protein specific kinase 2 Srpk2 8.60 8.97
serine/threonine kinase 16 Stk16 8.59 8.90
pyruvate dehydrogenase kinase, isoenzyme 3 Pdk3 8.59 8.86
casein kinase 2, alpha prime polypeptide Csnk2a2 8.59 9.20
Fyn proto-oncogene Fyn 8.55 9.65
cyclin-dependent kinase (CDC2-like) 10 Cdk10 8.55 9.09
cell division cycle 2-like 1 Cdc2l1 8.54 9.16
cyclin-dependent kinase 6 Cdk6 8.53 8.98
death associated protein kinase 1 Dapk1 8.50 7.62
colony stimulating factor 1 receptor Csf1r 8.48 8.46
Endoplasmic reticulum (ER) to nucleus signalling 1 (Ern1), mRNA Ern1 8.48 8.49
cyclin-dependent kinase 8 Cdk8 8.42 8.45
MAP kinase-activated protein kinase 5 Mapkapk5 8.40 8.84
G protein-coupled receptor kinase 6 Grk6 8.40 8.08
salt inducible kinase 2 Sik2 8.39 8.62
mitogen-activated protein kinase kinase kinase kinase 4 Map4k4 8.37 8.48
ribosomal protein S6 kinase polypeptide 3 Rps6ka3 8.37 8.97
serine/threonine kinase 25 (yeast) Stk25 8.35 9.60
v-raf murine sarcoma 3611 viral oncogene homolog Araf 8.33 8.83
v-raf-leukemia viral oncogene 1 Raf1 8.32 8.67
RIKEN cDNA B230120H23 gene B230120H23 8.32 8.90
mitogen-activated protein kinase kinase kinase 9 Map3k9 8.32 8.46
mitogen-activated protein kinase kinase kinase 4 Map3k4 8.32 8.89
glycogen synthase kinase 3 alpha Gsk3a 8.31 8.61
cyclin-dependent kinase 5 Cdk5 8.30 8.76
proviral integration site 1 Pim1 8.28 9.18
ataxia telangiectasia mutated homolog (human) Atm 8.27 9.11
mitogen-activated protein kinase kinase kinase kinase 5 Map4k5 8.24 8.59
protein serine kinase H1 Pskh1 8.21 8.38
microtubule associated serine/threonine kinase 3 Mast3 8.17 9.24
vaccinia related kinase 1 Vrk1 8.14 8.50
phosphorylase kinase, gamma 2 (testis) Phkg2 8.14 8.37
protein kinase C, epsilon Prkce 8.14 8.00
adrenergic receptor kinase, beta 1 Adrbk1 8.14 8.39
casein kinase 1, gamma 3 Csnk1g3 8.11 9.15
receptor (TNFRSF)-interacting serine-threonine kinase 1 Ripk1 8.06 8.45
mitogen-activated protein kinase kinase 3 Map2k3 8.02 8.32
membrane protein, palmitoylated Mpp1 8.01 8.17
NIMA (never in mitosis gene a)-related expressed kinase 1 Nek1 8.01 8.68
WEE 1 homolog 1 (S. pombe) Wee1 8.00 7.63
Fas-activated serine/threonine kinase Fastk 7.99 8.56
inhibitor of kappaB kinase beta Ikbkb 7.98 8.73
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 Erbb2 7.97 8.47
plexin A1 Plxna1 7.97 8.50
serine/threonine kinase 38 like Stk38l 7.97 8.58
tribbles homolog 3 (Drosophila) Trib3 7.97 7.93
cDNA sequence BC021891 BC021891 7.95 8.84
interleukin-1 receptor-associated kinase 4 Irak4 7.95 8.97
Rho-associated coiled-coil containing protein kinase 2 Rock2 7.94 8.76
vaccinia related kinase 3 Vrk3 7.93 8.23
mitogen-activated protein kinase kinase kinase 10 Map3k10 7.93 8.75
mitogen-activated protein kinase kinase 4 Map2k4 7.92 8.64
thymoma viral proto-oncogene 3 Akt3 7.92 8.15
Unc-51 like kinase 2 (C. elegans) Ulk2 7.92 8.23
PCTAIRE-motif protein kinase 2 Pctk2 7.88 8.35
thymoma viral proto-oncogene 1 Akt1 7.87 8.69
tribbles homolog 1 (Drosophila) Trib1 7.86 8.87
ribosomal protein S6 kinase polypeptide 1 Rps6ka1 7.82 8.69
v-abl Abelson murine leukemia viral oncogene homolog 2 Abl2 7.80 8.30
cyclin-dependent kinase-like 2 (CDC2-related kinase) Cdkl2 7.79 8.11
protein kinase N3 Pkn3 7.76 7.46
leucine-rich repeat kinase 1 Lrrk1 7.76 8.62
PFTAIRE protein kinase 1 Pftk1 7.75 8.38
CDC42 binding protein kinase beta Cdc42bpb 7.75 8.20
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase Smg1 7.73 8.39
BMP2 inducible kinase Bmp2k 7.73 7.78
nuclear receptor binding protein 1 Nrbp1 7.65 8.00
testis specific protein kinase 1 Tesk1 7.65 8.38
salt inducible kinase 1 Sik1 7.64 7.16
branched chain ketoacid dehydrogenase kinase Bckdk 7.63 8.01
LIM motif-containing protein kinase 2 Limk2 7.62 7.81
misshapen-like kinase 1 (zebrafish) Mink1 7.60 7.70
ribosomal protein S6 kinase, polypeptide 1 Rps6kb1 7.60 8.16
thymoma viral proto-oncogene 2 Akt2 7.59 8.29
NIMA (never in mitosis gene a)-related expressed kinase 8 Nek8 7.53 8.34
calcium/calmodulin-dependent protein kinase II, delta Camk2d 7.52 8.15
mitogen-activated protein kinase kinase kinase 11 Map3k11 7.51 7.86
serine/threonine kinase 32B Stk32b 7.48 5.65
mitogen-activated protein kinase 13 Mapk13 7.46 8.18
RIKEN cDNA C230081A13 gene C230081A13 7.43 8.41
G protein-coupled receptor kinase 5 Grk5 7.42 8.18
tau tubulin kinase 2 Ttbk2 7.41 7.71
cell division cycle 2-like 5 Cdc2l5 7.39 7.99
SPEG complex locus Speg 7.38 6.90
mitogen-activated protein kinase kinase 6 Map2k6 7.37 7.61
mitogen-activated protein kinase kinase kinase kinase 2 Map4k2 7.36 8.01
vaccinia related kinase 2 Vrk2 7.34 8.10
MAP/microtubule affinity-regulating kinase 4 Mark4 7.34 7.79
SH3-binding kinase 1 Sbk1 7.28 7.06
mitogen-activated protein kinase 8 Mapk8 7.27 7.97
p21 (CDKN1A)-activated kinase 6 Pak6 7.26 8.86
Death-associated protein kinase 3 (Dapk3), mRNA Dapk3 7.23 7.40
serine/threonine kinase 35 Stk35 7.21 7.24
ribosomal protein S6 kinase polypeptide 1 Rps6kc1 7.21 8.05
renal tumor antigen Rage 7.21 7.51
NIMA (never in mitosis gene a)-related expressed kinase 6 Nek6 7.19 7.13
cell division cycle 2-like 6 (CDK8-like) Cdc2l6 7.19 7.87
STE20-related kinase adaptor alpha Strada 7.18 7.70
RIO kinase 1 (yeast) Riok1 7.17 7.54
protein kinase, AMP-activated, alpha 1 catalytic subunit Prkaa1 7.17 7.27
MAP kinase-interacting serine/threonine kinase 1 Mknk1 7.16 7.67
dystrophia myotonica-protein kinase Dmpk 7.14 6.75
LIM-domain containing, protein kinase Limk1 7.12 6.71
ribosomal protein S6 kinase, polypeptide 2 Rps6kb2 7.09 7.50
MAP kinase-activated protein kinase 2 Mapkapk2 7.09 7.69
serine/threonine kinase 10 Stk10 7.08 7.61
phosphorylase kinase gamma 1 Phkg1 7.08 8.63
PDLIM1 interacting kinase 1 like Pdik1l 7.08 7.82
polo-like kinase 4 (Drosophila) Plk4 7.04 6.75
casein kinase 1, gamma 1 Csnk1g1 6.99 7.54
ATM interactor Atmin 6.99 7.62
mitogen-activated protein kinase kinase 5 Map2k5 6.94 7.37
plexin A2 Plxna2 6.92 6.12
protein kinase C, theta Prkcq 6.90 8.32
STE20-related kinase adaptor beta Stradb 6.86 7.08
protein kinase D2 Prkd2 6.80 7.49
cell division cycle 2 homolog A (S. pombe) Cdc2a 6.80 6.65
activin A receptor, type II-like 1 Acvrl1 6.79 6.80
leucine-rich repeat kinase 2 Lrrk2 6.77 7.15
pigeon homolog (Drosophila) Pion 6.76 6.24
casein kinase 1, epsilon Csnk1e 6.69 7.31
cell division cycle 7 (S. cerevisiae) Cdc7 6.69 6.12
unc-51-like kinase 3 (C. elegans) Ulk3 6.67 6.14
MAP/microtubule affinity-regulating kinase 1 Mark1 6.67 6.41
kinase suppressor of ras 1 Ksr1 6.66 6.25
PCTAIRE-motif protein kinase 3 Pctk3 6.58 7.46
calcium/calmodulin-dependent protein kinase II alpha Camk2a 6.56 5.99
mitogen-activated protein kinase kinase kinase 14 Map3k14 6.54 6.50
mitogen-activated protein kinase kinase kinase kinase 1 Map4k1 6.51 6.85
ribosomal protein S6 kinase, polypeptide 4 Rps6ka4 6.51 7.53
tribbles homolog 2 (Drosophila) Trib2 6.50 6.28
mitogen-activated protein kinase 4 Mapk4 6.50 6.71
NUAK family, SNF1-like kinase, 1 Nuak1 6.50 6.67
protein kinase N1 Pkn1 6.49 6.29
microtubule associated serine/threonine kinase family member 4 Mast4 6.48 6.86
eukaryotic translation initiation factor 2 alpha kinase 4 Eif2ak4 6.46 7.40
receptor-interacting serine-threonine kinase 3 Ripk3 6.43 6.09
cyclin-dependent kinase 2 Cdk2 6.36 7.03
activin receptor IIB Acvr2b 6.35 6.41
PDZ binding kinase Pbk 6.35 6.15
ribosomal protein S6 kinase, polypeptide 5 Rps6ka5 6.34 6.73
microtubule associated serine/threonine kinase-like Mastl 6.33 6.09
aurora kinase A Aurka 6.30 6.21
plexin D1 Plxnd1 6.25 6.49
polo-like kinase 2 (Drosophila) Plk2 6.21 7.35
protein kinase, cGMP-dependent, type II Prkg2 6.21 5.04*
intestinal cell kinase Ick 6.16 6.83
ribosomal protein S6 kinase, polypeptide 2 Rps6ka2 6.07 5.76*
budding uninhibited by benzimidazoles 1 homolog, beta Bub1b 6.06 5.99
DnaJ (Hsp40) homolog, subfamily C, member 6 Dnajc6 6.05 4.44*
mitogen-activated protein kinase 12 Mapk12 6.05 6.93
citron Cit 6.04 6.37
p21 (CDKN1A)-activated kinase 1 Pak1 6.03 6.19
anti-Mullerian hormone type 2 receptor Amhr2 6.01 6.13
NIMA (never in mitosis gene a)-related expressed kinase 3 Nek3 6.00 6.67
protein kinase, DNA activated, catalytic polypeptide Prkdc 5.99 7.21
WNK lysine deficient protein kinase 2 Wnk2 5.99 6.00
PAS domain containing serine/threonine kinase Pask 5.93 5.75*
zeta-chain (TCR) associated protein kinase Zap70 5.82 5.24*
testis-specific serine kinase 3 Tssk3 5.80 5.27*
plexin A4 Plxna4 5.72* 6.37
serine/threonine kinase 36 (fused homolog, Drosophila) Stk36 5.65* 6.59
CHK2 checkpoint homolog (S. pombe) Chek2 5.63* 6.46
G protein-coupled receptor kinase 4 Grk4 5.58* 5.84
calcium/calmodulin-dependent protein kinase IV Camk4 5.48* 6.02
p21 (CDKN1A)-activated kinase 3 Pak3 5.47* 6.92
mitogen-activated protein kinase 11 Mapk11 4.83* 5.98
Table 5B. Non-receptor tyrosine kinases
fyn-related kinase Frk 10.1 10.91
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a Dyrk1a 9.55 10.59
PTK2 protein tyrosine kinase 2 Ptk2 9.15 10.02
PTK2 protein tyrosine kinase 2 beta Ptk2b 8.81 8.85
lemur tyrosine kinase 2 Lmtk2 8.73 9.99
fer (fms/fps related) protein kinase, testis specific 2 Fert2 8.73 9.47
Janus kinase 2 Jak2 8.66 9.12
Janus kinase 1 Jak1 8.46 9.24
tyrosine kinase, non-receptor, 1 Tnk1 8.25 8.78
FMS-like tyrosine kinase 1 Flt1 8.24 7.46
FMS-like tyrosine kinase 4 Flt4 8.18 7.82
tyrosine kinase, non-receptor, 2 Tnk2 7.83 8.34
tec protein tyrosine kinase Tec 7.76 7.94
tyrosine kinase 2 Tyk2 7.18 7.53
c-mer proto-oncogene tyrosine kinase Mertk 7.12 6.24
c-src tyrosine kinase Csk 7.02 7.59
serine/threonine/tyrosine kinase 1 Styk1 6.99 8.85
PTK7 protein tyrosine kinase 7 Ptk7 6.53 6.49
Aatyk3 mRNA for apoptosis-associated tyrosine kinase 3 Lmtk3 6.29 6.04
Table 5C. Tyrosine kinase receptors
met proto-oncogene Met 11.36 11.87
discoidin domain receptor family, member 1 receptor Ddr1 11.35 11.45
fibroblast growth factor receptor 2 Fgfr2 10.31 11.30
insulin receptor Insr 9.52 9.83
insulin receptor-related receptor Insrr 9.50 10.06
insulin-like growth factor I receptor Igf1r 9.04 9.99
endothelial-specific receptor tyrosine kinase Tek 8.85 9.32
fibroblast growth factor receptor 1 Fgfr1 8.82 8.93
Eph receptor B4 Ephb4 8.63 8.87
receptor-like tyrosine kinase Ryk 8.21 8.45
Eph receptor A1 Epha1 7.37 7.72
Eph receptor B2 Ephb2 7.14 7.07
fibroblast growth factor receptor 3 Fgfr3 7.04 7.03
epidermal growth factor receptor Egfr 7.01 8.54
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 Tie1 6.91 6.73
Eph receptor B3 Ephb3 6.63 6.11
c-abl oncogene 1, receptor tyrosine kinase Abl1 6.62 7.24
AXL receptor tyrosine kinase Axl 6.23 5.93
receptor tyrosine kinase-like orphan receptor 1 Ror1 5.84 6.21
Eph receptor A4 Epha4 5.74* 6.31
Eph receptor B6 Ephb6 5.20* 6.04
TXK tyrosine kinase Txk 4.15* 5.80
* - the A-value is below the cut-off level 
Supplemental Table 3. Protein phosphatases
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
Table 6A. Serine-threonine phosphatases
protein phosphatase 2 (formerly 2A), alpha isoform Ppp2r1a 12.51 12.72
protein phosphatase 1, catalytic subunit, gamma isoform Ppp1cc 11.76 12.14
protein phosphatase 1, catalytic subunit, beta isoform Ppp1cb 11.35 11.90
protein phosphatase 1, catalytic subunit, alpha isoform Ppp1ca 11.17 11.79
protein phosphatase 1B, magnesium dependent, beta isoform Ppm1b 11.15 11.49
protein phosphatase 1H (PP2C domain containing) Ppm1h 10.87 11.35
protein phosphatase 2, alpha isoform Ppp2r5a 10.85 11.19
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform Ppp2ca 10.68 10.96
PTC7 protein phosphatase homolog (S. cerevisiae) Pptc7 10.37 10.32
protein phosphatase 1A, magnesium dependent, alpha isoform Ppm1a 10.20 10.66
protein phosphatase 1K (PP2C domain containing) Ppm1k 10.13 10.67
protein phosphatase 2, epsilon isoform Ppp2r5e 9.82 10.29
protein phosphatase 2 (formerly 2A), alpha isoform Ppp2r2a 9.80 10.36
protein phosphatase 2, gamma isoform Ppp2r5c 9.55 10.18
protein phosphatase 6, catalytic subunit Ppp6c 9.55 9.76
protein phosphatase 2, regulatory subunit B, delta isoform Ppp2r2d 9.44 9.41
protein phosphatase 3, catalytic subunit, alpha isoform Ppp3ca 9.41 9.52
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma is Ppm1g 9.37 10.02
protein phosphatase 2 (formerly 2A), beta isoform Ppp2r1b 9.25 9.58
protein phosphatase 5, catalytic subunit Ppp5c 9.19 9.30
CTD (carboxy-terminal domain) phosphatase, subunit 1 Ctdp1 9.02 9.52
integrin-linked kinase-associated serine/threonine phosphatase 2C Ilkap 8.94 9.78
protein phosphatase 3, catalytic subunit, beta isoform Ppp3cb 8.89 9.20
protein phosphatase 1 (formerly 2C)-like Ppm1l 8.78 9.20
protein phosphatase 4, regulatory subunit 1 Ppp4r1 8.50 9.01
protein phosphatase 3, regulatory subunit B, (calcineurin B, type I) Ppp3r1 7.86 8.20
cell division cycle 25 homolog A (S. pombe) Cdc25a 7.74 8.41
protein phosphatase 2C, magnesium dependent, catalytic subunit Ppm2c 7.66 8.28
protein phosphatase 4, catalytic subunit Ppp4c 7.42 8.27
cell division cycle 25 homolog B (S. pombe) Cdc25b 7.14 6.99
protein phosphatase 3, catalytic subunit, gamma isoform Ppp3cc 7.11 6.82
protein phosphatase 2, delta isoform Ppp2r5d 6.74 7.43
protein phosphatase 2 (formerly 2A), beta isoform Ppp2r2b 6.72 7.74
protein phosphatase 1M Ppm1m 6.55 6.90
protein phosphatase 2 (formerly 2A), alpha Ppp2r3a 6.10 7.20
protein phosphatase 2, beta isoform Ppp2r5b 6.02 6.16
protein phosphatase 1F (PP2C domain containing) Ppm1f 5.95 6.36
Table 6B. Tyrosine phosphatases
acid phosphatase 1, soluble Acp1 12.20 12.28
protein tyrosine phosphatase 4a2 Ptp4a2 11.67 12.30
protein tyrosine phosphatase, receptor type, F Ptprf 10.74 11.32
protein tyrosine phosphatase, receptor type, J Ptprj 10.60 11.51
protein tyrosine phosphatase, non-receptor type 11 Ptpn11 10.44 10.73
protein tyrosine phosphatase, receptor type, S Ptprs 10.26 10.29
protein tyrosine phosphatase, non-receptor type 1 Ptpn1 9.40 9.53
protein tyrosine phosphatase, non-receptor type 2 Ptpn2 9.26 9.67
protein tyrosine phosphatase, receptor type, K Ptprk 9.11 9.22
protein tyrosine phosphatase, receptor type, A Ptpra 8.96 9.64
protein tyrosine phosphatase, non-receptor type 9 Ptpn9 8.95 9.38
protein tyrosine phosphatase, mitochondrial 1 Ptpmt1 8.88 8.98
protein tyrosine phosphatase, non-receptor type 13 Ptpn13 8.83 9.61
protein tyrosine phosphatase, non-receptor type 14 Ptpn14 8.75 9.59
similar to protein tyrosine phosphatase, receptor type, G Ptprg 8.53 7.55
protein tyrosine phosphatase, receptor type, D Ptprd 8.48 8.11
protein tyrosine phosphatase, receptor type, C Ptprc 8.36 8.46
protein tyrosine phosphatase, receptor type, M Ptprm 8.36 8.97
protein tyrosine phosphatase, non-receptor type 21 Ptpn21 8.13 8.83
protein tyrosine phosphatase, receptor type, G Ptprg 7.91 8.01
protein tyrosine phosphatase, non-receptor type 18 Ptpn18 7.86 8.59
protein tyrosine phosphatase, non-receptor type 23 Ptpn23 7.62 8.04
protein tyrosine phosphatase, non-receptor type 12 Ptpn12 7.35 7.75
protein tyrosine phosphatase, non-receptor type 6 Ptpn6 7.28 7.21
protein tyrosine phosphatase, receptor type, U Ptpru 6.86 6.92
protein tyrosine phosphatase domain containing 1 Ptpdc1 6.73 6.97
protein tyrosine phosphatase 4a3 Ptp4a3 6.10 6.19
protein tyrosine phosphatase, receptor type, E Ptpre 5.90 6.32
Table 6C. Dual-specificity phosphatases
dual specificity phosphatase 1 Dusp1 11.46 11.73
dual specificity phosphatase 3 Dusp3 10.47 10.92
slingshot homolog 1 (Drosophila) Ssh1 9.19 9.73
dual specificity phosphatase 16 Dusp16 8.91 9.64
CDC14 cell division cycle 14 homolog A (S. cerevisiae) Cdc14a 8.68 9.04
dual specificity phosphatase 19 Dusp19 8.40 9.32
dual specificity phosphatase 22 Dusp22 8.02 8.08
dual specificity phosphatase 6 Dusp6 7.69 7.86
dual specificity phosphatase 7 Dusp7 7.49 8.11
CDC14 cell division cycle 14 homolog B (S. cerevisiae) Cdc14b 7.41 8.17
dual specificity phosphatase 23 Dusp23 7.40 7.18
dual specificity phosphatase 26 (putative) Dusp26 7.30 6.08
dual specificity phosphatase 12 Dusp12 7.28 7.84
slingshot homolog 2 (Drosophila) Ssh2 7.06 7.57
dual specificity phosphatase 28 Dusp28 7.04 7.04
dual specificity phosphatase 18 Dusp18 6.92 6.69
slingshot homolog 2 (Drosophila) Ssh2 6.58 7.73
dual specificity phosphatase 8 Dusp8 6.41 6.54
slingshot homolog 3 (Drosophila) Ssh3 6.39 6.72
dual specificity phosphatase 4 Dusp4 6.28 5.61*
epilepsy, progressive myoclonic epilepsy, type 2 gene alpha Epm2a 6.04 6.16
dual specificity phosphatase 10 Dusp10 5.88 6.40
* - the A-value is below the cut-off level 
Supplemental Table 4. Small GTPases
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
Table 9A. Rab small GTP-binding proteins
RAB1, member RAS oncogene family Rab1 12.58 12.82
RAB14, member RAS oncogene family Rab14 11.96 12.08
RAB7, member RAS oncogene family Rab7 11.69 12.07
RAB10, member RAS oncogene family Rab10 11.68 11.85
RAB2A, member RAS oncogene family Rab2a 11.67 11.90
RAB21, member RAS oncogene family Rab21 11.29 11.53
RAB18, member RAS oncogene family Rab18 10.68 11.30
RAB11a, member RAS oncogene family Rab11a 10.44 10.77
RAB28, member RAS oncogene family Rab28 10.41 11.10
RAB22A, member RAS oncogene family Rab22a 10.23 10.42
RAB9, member RAS oncogene family Rab9 9.98 10.24
RAB4A, member RAS oncogene family Rab4a 9.94 10.23
RAB11B, member RAS oncogene family Rab11b 9.83 10.88
RAB17, member RAS oncogene family Rab17 9.74 10.19
RAB6B, member RAS oncogene family Rab6b 9.73 10.27
RAB25, member RAS oncogene family Rab25 9.61 10.31
RAB6, member RAS oncogene family Rab6 9.60 9.96
RAB20, member RAS oncogene family Rab20 9.54 10.82
RAB5A, member RAS oncogene family Rab5a 9.48 10.06
RAB5B, member RAS oncogene family Rab5b 9.46 10.01
RAB15, member RAS oncogene family Rab15 9.35 10.12
RAB3A, member RAS oncogene family Rab3a 9.16 8.83
RAB8A, member RAS oncogene family Rab8a 9.14 9.39
RAB33B, member of RAS oncogene family Rab33b 9.05 9.66
RAB35, member RAS oncogene family Rab35 9.01 9.42
RAB24, member RAS oncogene family Rab24 8.88 9.37
RAB, member of RAS oncogene family-like 3 Rabl3 8.83 8.94
RAB8B, member RAS oncogene family Rab8b 8.80 9.40
RAB27A, member RAS oncogene family Rab27a 8.70 7.01
RAB12, member RAS oncogene family Rab12 8.58 9.09
RAB, member of RAS oncogene family-like 2A Rabl2a 8.33 8.47
Rab40c, member RAS oncogene family Rab40c 8.28 8.38
RAB5C, member RAS oncogene family Rab5c 8.23 8.05
RAB, member of RAS oncogene family-like 4 Rabl4 8.08 8.41
RAB31, member RAS oncogene family Rab31 8.02 8.04
RAB39B, member RAS oncogene family Rab39b 7.87 8.02
RAB34, member of RAS oncogene family Rab34 7.85 7.66
RAB1B, member RAS oncogene family Rab1b 7.79 8.09
RAB23, member RAS oncogene family Rab23 7.67 8.04
RAB13, member RAS oncogene family Rab13 7.66 8.08
RAB7, member RAS oncogene family-like 1 Rab7l1 7.46 8.09
RAB3D, member RAS oncogene family Rab3d 7.41 8.46
RAB4B, member RAS oncogene family Rab4b 7.38 7.85
RAB27b, member RAS oncogene family Rab27b 7.35 7.86
RAB19, member RAS oncogene family Rab19 7.13 7.69
RAB43, member RAS oncogene family Rab43 6.79 7.17
RAB2B, member RAS oncogene family Rab2b 6.63 7.24
RAB32, member RAS oncogene family Rab32 6.55 7.45
RAB38, member of RAS oncogene family Rab38 6.38 6.71
Rab40b, member RAS oncogene family Rab40b 6.33 6.98
TBC1 domain family, member 7 Tbc1d7 6.30 6.73
RAB36, member RAS oncogene family Rab36 5.87 6.21
Table 9B. Arf small GTP-binding proteins
ADP-ribosylation factor 6 Arf6 12.58 13.00
ADP-ribosylation factor 1 Arf1 11.89 11.93
ADP-ribosylation factor 3 Arf3 11.64 12.25
ADP-ribosylation factor-like 1 Arl1 11.61 11.94
ADP-ribosylation factor-like 3 Arl3 11.46 11.73
SAR1 gene homolog A (S. cerevisiae) Sar1a 11.46 12.09
SAR1 gene homolog B (S. cerevisiae) Sar1b 10.69 11.12
ADP-ribosylation factor 4 Arf4 10.48 10.99
ADP-ribosylation factor-like 4C Arl4c 10.07 9.25
ADP-ribosylation factor-like 5A Arl5a 9.72 10.22
ADP-ribosylation factor-like 8B Arl8b 9.53 10.18
ADP-ribosylation factor-like 4A Arl4a 9.18 9.27
ADP-ribosylation factor related protein 1 Arfrp1 9.05 9.73
ADP-ribosylation factor-like 6 Arl6 8.90 9.54
ADP-ribosylation factor-like 8A Arl8a 8.87 9.33
ADP-ribosylation factor 2 Arf2 8.52 9.15
ADP-ribosylation factor-like 2 Arl2 7.85 8.20
ADP-ribosylation factor-like 4D Arl4d 7.38 9.24
ADP-ribosylation factor-like 5B Arl5b 7.17 7.52
tripartite motif-containing 23 Trim23 6.07 6.90
ADP-ribosylation factor-like 10 Arl10 5.49* 6.61
Table 9C. Rho small GTP-binding proteins
cell division cycle 42 homolog (S. cerevisiae) Cdc42 12.89 12.74
ras homolog gene family, member A Rhoa 11.66 11.84
RAS-related C3 botulinum substrate 1 Rac1 11.32 11.81
ras homolog gene family, member B Rhob 9.80 10.14
ras homolog gene family, member U Rhou 9.77 10.58
ras homolog gene family, member Q Rhoq 8.74 9.34
Rho family GTPase 3 Rnd3 8.16 9.13
ras homolog gene family, member T2 Rhot2 8.06 8.88
ras homolog gene family, member T1 Rhot1 8.05 8.84
Rho-related BTB domain containing 1 Rhobtb1 7.44 8.02
Rho-related BTB domain containing 2 Rhobtb2 7.39 7.54
ras homolog gene family, member C Rhoc 7.35 8.05
Rho family GTPase 2 Rnd2 7.18 7.67
ras homolog gene family, member D Rhod 6.74 7.87
ras homolog gene family, member J Rhoj 6.70 6.50
Rho-related BTB domain containing 3 Rhobtb3 6.63 7.56
ras homolog gene family, member G Rhog 5.83 6.67
RAS-related C3 botulinum substrate 3 Rac3 5.71* 6.03
Table 9D. Ras and Ras-related small GTP-binding proteins
Ras-related GTP binding D Rragd 12.40 12.60
RAS related protein 1b Rap1b 10.75 11.28
RAS-related protein-1a Rap1a 10.33 10.80
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog Kras 10.32 10.57
RAN, member RAS oncogene family Ran 9.81 10.39
v-ral simian leukemia viral oncogene homolog A (ras related) Rala 9.34 9.79
Harvey rat sarcoma virus oncogene 1 Hras1 9.18 9.21
Ras-related GTP binding C Rragc 9.14 9.67
v-ral simian leukemia viral oncogene homolog B (ras related) Ralb 9.08 10.30
neuroblastoma ras oncogene Nras 9.02 9.38
NFKB inhibitor interacting Ras-like protein 1 Nkiras1 8.78 9.10
Ras-related GTP binding A Rraga 8.50 8.68
RAS related protein 2a Rap2a 8.24 8.82
RAP2B, member of RAS oncogene family Rap2b 8.20 9.23
Harvey rat sarcoma oncogene, subgroup R Rras 8.04 8.51
Ras-like without CAAX 1 Rit1 7.79 8.31
RAS-like, family 11, member B Rasl11b 7.73 9.02
muscle and microspikes RAS Mras 7.64 7.79
NFKB inhibitor interacting Ras-like protein 2 Nkiras2 7.60 7.79
RAS, dexamethasone-induced 1 Rasd1 7.40 7.76
related RAS viral (r-ras) oncogene homolog 2 Rras2 7.40 8.50
Ras-related associated with diabetes Rrad 6.87 8.55
RASD family, member 2 Rasd2 6.59 7.38
RAS and EF hand domain containing Rasef 6.04 6.66
GTP binding protein (gene overexpressed in skeletal muscle) Gem 5.96 6.32
RAS-like, family 2, locus 9 Rasl2-9 5.69* 6.29
RAS-like, family 11, member A Rasl11a 5.09* 7.22
* - the A-value is below the cut-off level 
Supplemental Table 4. Small GTPases
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
Table 9A. Rab small GTP-binding proteins
RAB1, member RAS oncogene family Rab1 12.58 12.82
RAB14, member RAS oncogene family Rab14 11.96 12.08
RAB7, member RAS oncogene family Rab7 11.69 12.07
RAB10, member RAS oncogene family Rab10 11.68 11.85
RAB2A, member RAS oncogene family Rab2a 11.67 11.90
RAB21, member RAS oncogene family Rab21 11.29 11.53
RAB18, member RAS oncogene family Rab18 10.68 11.30
RAB11a, member RAS oncogene family Rab11a 10.44 10.77
RAB28, member RAS oncogene family Rab28 10.41 11.10
RAB22A, member RAS oncogene family Rab22a 10.23 10.42
RAB9, member RAS oncogene family Rab9 9.98 10.24
RAB4A, member RAS oncogene family Rab4a 9.94 10.23
RAB11B, member RAS oncogene family Rab11b 9.83 10.88
RAB17, member RAS oncogene family Rab17 9.74 10.19
RAB6B, member RAS oncogene family Rab6b 9.73 10.27
RAB25, member RAS oncogene family Rab25 9.61 10.31
RAB6, member RAS oncogene family Rab6 9.60 9.96
RAB20, member RAS oncogene family Rab20 9.54 10.82
RAB5A, member RAS oncogene family Rab5a 9.48 10.06
RAB5B, member RAS oncogene family Rab5b 9.46 10.01
RAB15, member RAS oncogene family Rab15 9.35 10.12
RAB3A, member RAS oncogene family Rab3a 9.16 8.83
RAB8A, member RAS oncogene family Rab8a 9.14 9.39
RAB33B, member of RAS oncogene family Rab33b 9.05 9.66
RAB35, member RAS oncogene family Rab35 9.01 9.42
RAB24, member RAS oncogene family Rab24 8.88 9.37
RAB, member of RAS oncogene family-like 3 Rabl3 8.83 8.94
RAB8B, member RAS oncogene family Rab8b 8.80 9.40
RAB27A, member RAS oncogene family Rab27a 8.70 7.01
RAB12, member RAS oncogene family Rab12 8.58 9.09
RAB, member of RAS oncogene family-like 2A Rabl2a 8.33 8.47
Rab40c, member RAS oncogene family Rab40c 8.28 8.38
RAB5C, member RAS oncogene family Rab5c 8.23 8.05
RAB, member of RAS oncogene family-like 4 Rabl4 8.08 8.41
RAB31, member RAS oncogene family Rab31 8.02 8.04
RAB39B, member RAS oncogene family Rab39b 7.87 8.02
RAB34, member of RAS oncogene family Rab34 7.85 7.66
RAB1B, member RAS oncogene family Rab1b 7.79 8.09
RAB23, member RAS oncogene family Rab23 7.67 8.04
RAB13, member RAS oncogene family Rab13 7.66 8.08
RAB7, member RAS oncogene family-like 1 Rab7l1 7.46 8.09
RAB3D, member RAS oncogene family Rab3d 7.41 8.46
RAB4B, member RAS oncogene family Rab4b 7.38 7.85
RAB27b, member RAS oncogene family Rab27b 7.35 7.86
RAB19, member RAS oncogene family Rab19 7.13 7.69
RAB43, member RAS oncogene family Rab43 6.79 7.17
RAB2B, member RAS oncogene family Rab2b 6.63 7.24
RAB32, member RAS oncogene family Rab32 6.55 7.45
RAB38, member of RAS oncogene family Rab38 6.38 6.71
Rab40b, member RAS oncogene family Rab40b 6.33 6.98
TBC1 domain family, member 7 Tbc1d7 6.30 6.73
RAB36, member RAS oncogene family Rab36 5.87 6.21
Table 9B. Arf small GTP-binding proteins
ADP-ribosylation factor 6 Arf6 12.58 13.00
ADP-ribosylation factor 1 Arf1 11.89 11.93
ADP-ribosylation factor 3 Arf3 11.64 12.25
ADP-ribosylation factor-like 1 Arl1 11.61 11.94
ADP-ribosylation factor-like 3 Arl3 11.46 11.73
SAR1 gene homolog A (S. cerevisiae) Sar1a 11.46 12.09
SAR1 gene homolog B (S. cerevisiae) Sar1b 10.69 11.12
ADP-ribosylation factor 4 Arf4 10.48 10.99
ADP-ribosylation factor-like 4C Arl4c 10.07 9.25
ADP-ribosylation factor-like 5A Arl5a 9.72 10.22
ADP-ribosylation factor-like 8B Arl8b 9.53 10.18
ADP-ribosylation factor-like 4A Arl4a 9.18 9.27
ADP-ribosylation factor related protein 1 Arfrp1 9.05 9.73
ADP-ribosylation factor-like 6 Arl6 8.90 9.54
ADP-ribosylation factor-like 8A Arl8a 8.87 9.33
ADP-ribosylation factor 2 Arf2 8.52 9.15
ADP-ribosylation factor-like 2 Arl2 7.85 8.20
ADP-ribosylation factor-like 4D Arl4d 7.38 9.24
ADP-ribosylation factor-like 5B Arl5b 7.17 7.52
tripartite motif-containing 23 Trim23 6.07 6.90
ADP-ribosylation factor-like 10 Arl10 5.49* 6.61
Table 9C. Rho small GTP-binding proteins
cell division cycle 42 homolog (S. cerevisiae) Cdc42 12.89 12.74
ras homolog gene family, member A Rhoa 11.66 11.84
RAS-related C3 botulinum substrate 1 Rac1 11.32 11.81
ras homolog gene family, member B Rhob 9.80 10.14
ras homolog gene family, member U Rhou 9.77 10.58
ras homolog gene family, member Q Rhoq 8.74 9.34
Rho family GTPase 3 Rnd3 8.16 9.13
ras homolog gene family, member T2 Rhot2 8.06 8.88
ras homolog gene family, member T1 Rhot1 8.05 8.84
Rho-related BTB domain containing 1 Rhobtb1 7.44 8.02
Rho-related BTB domain containing 2 Rhobtb2 7.39 7.54
ras homolog gene family, member C Rhoc 7.35 8.05
Rho family GTPase 2 Rnd2 7.18 7.67
ras homolog gene family, member D Rhod 6.74 7.87
ras homolog gene family, member J Rhoj 6.70 6.50
Rho-related BTB domain containing 3 Rhobtb3 6.63 7.56
ras homolog gene family, member G Rhog 5.83 6.67
RAS-related C3 botulinum substrate 3 Rac3 5.71* 6.03
Table 9D. Ras and Ras-related small GTP-binding proteins
Ras-related GTP binding D Rragd 12.40 12.60
RAS related protein 1b Rap1b 10.75 11.28
RAS-related protein-1a Rap1a 10.33 10.80
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog Kras 10.32 10.57
RAN, member RAS oncogene family Ran 9.81 10.39
v-ral simian leukemia viral oncogene homolog A (ras related) Rala 9.34 9.79
Harvey rat sarcoma virus oncogene 1 Hras1 9.18 9.21
Ras-related GTP binding C Rragc 9.14 9.67
v-ral simian leukemia viral oncogene homolog B (ras related) Ralb 9.08 10.30
neuroblastoma ras oncogene Nras 9.02 9.38
NFKB inhibitor interacting Ras-like protein 1 Nkiras1 8.78 9.10
Ras-related GTP binding A Rraga 8.50 8.68
RAS related protein 2a Rap2a 8.24 8.82
RAP2B, member of RAS oncogene family Rap2b 8.20 9.23
Harvey rat sarcoma oncogene, subgroup R Rras 8.04 8.51
Ras-like without CAAX 1 Rit1 7.79 8.31
RAS-like, family 11, member B Rasl11b 7.73 9.02
muscle and microspikes RAS Mras 7.64 7.79
NFKB inhibitor interacting Ras-like protein 2 Nkiras2 7.60 7.79
RAS, dexamethasone-induced 1 Rasd1 7.40 7.76
related RAS viral (r-ras) oncogene homolog 2 Rras2 7.40 8.50
Ras-related associated with diabetes Rrad 6.87 8.55
RASD family, member 2 Rasd2 6.59 7.38
RAS and EF hand domain containing Rasef 6.04 6.66
GTP binding protein (gene overexpressed in skeletal muscle) Gem 5.96 6.32
RAS-like, family 2, locus 9 Rasl2-9 5.69* 6.29
RAS-like, family 11, member A Rasl11a 5.09* 7.22
* - the A-value is below the cut-off level 
Supplemental Table 5. SNAREs
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
vesicle-associated membrane protein 2 Vamp2 11.74 11.38
vesicle-associated membrane protein 8 Vamp8 11.66 12.03
synaptosomal-associated protein 23 Snap23 11.50 11.72
synaptosomal-associated protein, 47 Snap47 11.19 11.51
vesicle transport through interaction with t-SNAREs 1B homolog Vti1b 10.68 10.94
syntaxin 7 Stx7 10.64 11.30
vesicle-associated membrane protein 3 Vamp3 10.55 10.89
syntaxin 8 Stx8 10.40 11.16
SNAP-associated protein Snapap 10.18 10.61
YKT6 homolog (S. Cerevisiae) Ykt6 9.73 10.37
syntaxin 3 Stx3 9.60 10.30
syntaxin 4A (placental) Stx4a 9.49 9.99
syntaxin 12 Stx12 9.47 10.30
blocked early in transport 1 homolog (S. cerevisiae)-like Bet1l 9.38 9.35
golgi SNAP receptor complex member 1 Gosr1 9.37 9.75
SEC22 vesicle trafficking protein homolog B (S. cerevisiae) Sec22b 9.35 9.73
syntaxin 16 Stx16 9.04 9.23
blocked early in transport 1 homolog (S. cerevisiae) Bet1 9.02 9.64
golgi SNAP receptor complex member 2 Gosr2 8.85 8.65
vesicle-associated membrane protein 4 Vamp4 8.63 8.80
syntaxin 17 Stx17 8.56 9.00
vesicle transport through interaction with t-SNAREs homolog 1A (yeast) Vti1a 8.43 8.76
syntaxin 5A Stx5a 8.39 9.16
vesicle-associated membrane protein 7 Vamp7 8.11 9.09
syntaxin 6 Stx6 7.77 8.33
syntaxin 18 Stx18 7.72 8.17
syntaxin 6 Stx6 7.69 8.65
SEC22 vesicle trafficking protein homolog C (S. cerevisiae) Sec22c 7.55 8.30
synaptosomal-associated protein 29 Snap29 7.47 8.08
vesicle-associated membrane protein 1 Vamp1 6.75 6.64
Supplemental Table 6. Cytoskeleton and cytoskeleton-related proteins
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
Table 12A. Actin and actin-binding proteins
actin, beta Actb 13.35 13.80
cofilin 1, non-muscle Cfl1 12.96 12.98
actin, gamma, cytoplasmic 1 Actg1 12.93 13.06
catenin (cadherin associated protein), beta 1 Ctnnb1 12.74 13.26
syndecan 4 Sdc4 12.61 12.99
catenin (cadherin associated protein), alpha 1 Ctnna1 12.59 13.02
tropomyosin 1, alpha Tpm1 12.30 12.87
Wiskott-Aldrich syndrome-like (human) Wasl 11.90 12.81
spectrin beta 2 Spnb2 11.76 12.23
LIM and SH3 protein 1 Lasp1 11.67 11.83
cingulin-like 1 Cgnl1 11.56 12.13
ARP2 actin-related protein 2 homolog (yeast) Actr2 11.49 12.01
tensin 1 Tns1 11.47 11.85
gelsolin Gsn 11.37 12.06
cortactin Cttn 11.33 12.17
cysteine and glycine-rich protein 1 Csrp1 11.18 11.75
cofilin 2, muscle Cfl2 11.13 11.49
utrophin Utrn 11.12 12.18
radixin Rdx 11.11 11.24
tensin 3 Tns3 11.03 11.71
actin related protein 2/3 complex, subunit 3 Arpc3 10.96 11.35
adducin 1 (alpha) Add1 10.85 11.48
ARP3 actin-related protein 3 homolog (yeast) Actr3 10.84 11.50
tropomodulin 1 Tmod1 10.80 10.99
shroom family member 3 Shroom3 10.80 11.08
ezrin Ezr 10.69 11.19
capping protein (actin filament) muscle Z-line, beta Capzb 10.68 11.15
junction plakoglobin Jup 10.65 10.97
formin binding protein 1-like Fnbp1l 10.64 11.61
filamin, beta Flnb 10.62 10.73
cysteine and glycine-rich protein 2 Csrp2 10.55 11.02
LIM domain and actin binding 1 Lima1 10.51 10.67
Coronin, actin binding protein 1C, mRNA Coro1c 10.49 10.96
spire homolog 1 (Drosophila) Spire1 10.48 10.34
actin-binding LIM protein 1 Ablim1 10.35 10.93
kelch domain containing 8A Klhdc8a 10.34 11.75
PDZ and LIM domain 5 Pdlim5 10.30 10.26
LIM domain containing preferred translocation partner in lipoma Lpp 10.27 11.27
huntingtin interacting protein 1 related Hip1r 10.22 10.43
tropomyosin 3, gamma Tpm3 10.19 10.92
capping protein (actin filament) muscle Z-line, alpha 2 Capza2 10.16 10.53
paxillin Pxn 10.16 11.18
actin related protein 2/3 complex, subunit 5-like Arpc5l 10.15 10.56
enabled homolog (Drosophila) Enah 10.11 11.08
microtubule-actin crosslinking factor 1 Macf1 10.00 10.86
actin related protein 2/3 complex, subunit 5 Arpc5 9.96 10.56
ankyrin 3, epithelial Ank3 9.92 9.74
sorbin and SH3 domain containing 2 Sorbs2 9.91 10.94
dystrophin, muscular dystrophy Dmd 9.90 10.53
twinfilin, actin-binding protein, homolog 1 (Drosophila) Twf1 9.89 10.93
ARP10 actin-related protein 10 homolog (S. cerevisiae) Actr10 9.81 10.22
actin related protein 2/3 complex, subunit 4 Arpc4 9.81 10.97
actin related protein 2/3 complex, subunit 1B Arpc1b 9.75 10.80
kelch-like 2, Mayven (Drosophila) Klhl2 9.70 10.26
ectodermal-neural cortex 1 Enc1 9.69 10.20
syndecan 2 Sdc2 9.68 10.36
parvin, alpha Parva 9.58 10.30
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) Actr1a 9.57 10.16
vinculin Vcl 9.51 9.87
myeloid/lymphoid or mixed-lineage leukemia, translocated to, 4 Mllt4 9.51 10.07
capping protein (actin filament) muscle Z-line, alpha 1 Capza1 9.48 9.87
talin 1 Tln1 9.48 10.01
adducin 3 (gamma) Add3 9.46 9.19
septin 10 sept.10 9.41 9.60
actinin alpha 4 Actn4 9.38 10.09
syndecan 1 Sdc1 9.36 9.47
ARP1 actin-related protein 1 homolog B, centractin beta (yeast) Actr1b 9.30 9.45
stomatin (Epb7.2)-like 2 Stoml2 9.23 9.55
twinfilin, actin-binding protein, homolog 2 (Drosophila) Twf2 9.16 9.13
septin 7 07.sept 9.15 9.67
catenin (cadherin associated protein), alpha-like 1 Ctnnal1 9.11 9.79
ARP8 actin-related protein 8 homolog (S. cerevisiae) Actr8 9.09 9.58
septin 9 septin 9 9.08 9.74
tropomyosin 4 Tpm4 9.07 9.80
erythrocyte protein band 4.9 Epb4.9 8.99 9.10
actin related protein 2/3 complex, subunit 1A Arpc1a 8.92 10.23
drebrin-like Dbnl 8.89 9.21
synaptopodin Synpo 8.84 9.01
actinin, alpha 1 Actn1 8.81 9.52
spectrin beta 3 Spnb3 8.79 10.27
coronin, actin binding protein 2A Coro2a 8.75 8.91
WAS protein family, member 2 Wasf2 8.71 9.64
plectin 1 Plec1 8.71 9.47
moesin Msn 8.64 8.03
caldesmon 1 Cald1 8.60 9.18
tropomodulin 3 Tmod3 8.55 9.06
septin 2 septin 2 8.53 9.58
spire homolog 2 (Drosophila) Spire2 8.41 8.88
PDZ and LIM domain 3 Pdlim3 8.34 8.33
coronin, actin binding protein 1B Coro1b 8.30 9.52
transgelin 2 Tagln2 8.22 8.76
septin 4 septin 4 8.16 8.42
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) Fscn1 8.06 8.45
tropomyosin 2, beta Tpm2 7.99 6.42
formin binding protein 1 Fnbp1 7.96 8.58
huntingtin interacting protein 1 Hip1 7.87 8.31
coronin 7 Coro7 7.86 8.58
septin 11 septin 11 7.82 8.63
formin binding protein 4 Fnbp4 7.77 8.38
calponin 2 Cnn2 7.77 9.10
talin 2 Tln2 7.76 7.78
actin-like 6A Actl6a 7.75 8.10
sorbin and SH3 domain containing 1 Sorbs1 7.69 7.77
kelch-like 12 (Drosophila) Klhl12 7.66 7.92
filamin, alpha Flna 7.62 8.41
actin, alpha 2, smooth muscle, aorta Acta2 7.59 6.16
drebrin 1 Dbn1 7.51 7.58
actin-binding LIM protein 2 Ablim2 7.48 7.16
septin 6 septin 6 7.47 6.87
kelch-like 17 (Drosophila) Klhl17 7.43 7.62
kelch-like 18 (Drosophila) Klhl18 7.38 7.17
transgelin Tagln 7.36 6.92
nebulin-related anchoring protein Nrap 7.32 6.81
septin 8 septin 8 7.29 8.11
formin-like 2 Fmnl2 7.22 8.48
synaptopodin 2-like Synpo2l 7.18 7.11
coronin, actin binding protein 1A Coro1a 7.16 7.30
espin Espn 7.12 7.11
kelch-like 20 (Drosophila) Klhl20 7.10 7.60
kelch-like 25 (Drosophila) Klhl25 7.10 7.54
syntrophin, acidic 1 Snta1 7.08 7.62
zyxin Zyx 6.97 7.90
actinin alpha 2 Actn2 6.96 7.30
kelch-like 7 (Drosophila) Klhl7 6.96 8.00
sorbin and SH3 domain containing 3 Sorbs3 6.95 7.58
capping protein (actin filament), gelsolin-like Capg 6.91 9.04
whirlin Whrn 6.89 6.36
villin-like Vill 6.86 6.46
kelch-like 8 (Drosophila) Klhl8 6.82 7.42
palladin, cytoskeletal associated protein Palld 6.73 6.35
stomatin Stom 6.71 6.53
WAS protein family, member 3 (Wasf3), mRNA Wasf3 6.71 7.48
PDZ domain containing 2 Pdzd2 6.70 6.95
stomatin-like 1 Stoml1 6.69 7.17
syntrophin, basic 2 Sntb2 6.68 6.84
Rho GTPase activating protein 6 Arhgap6 6.60 7.16
giant axonal neuropathy Gan 6.51 6.49
septin 1 septin 1 6.34 5.94
multiple PDZ domain protein Mpdz 6.23 7.01
PDZ and LIM domain 7 Pdlim7 6.22 6.06
formin-like 3 Fmnl3 6.17 8.22
syndecan 3 Sdc3 6.15 5.98
spectrin beta 1 Spnb1 5.75* 5.86
ARP6 actin-related protein 6 homolog (yeast) Actr6 5.73* 5.32*
septin 3 septin 3 5.53* 6.32
actinin alpha 3 Actn3 5.41* 6.19
villin 1 Vil1 5.40* 6.07
filamin binding LIM protein 1 Fblim1 5.24* 6.16
Table 12B. Myosin and myosin-like proteins
myosin, heavy polypeptide 9, non-muscle Myh9 12.12 12.56
myosin, light chain 12B, regulatory Myl12b 11.80 12.55
myosin X Myo10 10.70 10.60
myosin IC Myo1c 10.64 10.58
myosin VI Myo6 10.21 10.93
myosin, heavy polypeptide 10, non-muscle Myh10 10.14 11.43
myosin 1H Myo1h 9.23 10.17
myosin XVIIIA Myo18a 9.14 9.71
myosin VB Myo5b 8.56 9.06
myosin IXb Myo9b 8.52 9.12
myosin IE Myo1e 8.32 8.95
myosin, light polypeptide 9, regulatory Myl9 8.26 6.85
myosin ID Myo1d 7.95 8.73
myosin IXa Myo9a 7.89 8.72
myosin VA Myo5a 7.87 7.97
myosin VC Myo5c 7.64 8.70
myosin, heavy polypeptide 11, smooth muscle Myh11 7.43 5.61
myosin, heavy polypeptide 6, cardiac muscle, alpha Myh6 6.85 6.53
myosin, heavy polypeptide 7, cardiac muscle, beta Myh7 6.84 6.57
myosin VIIB Myo7b 6.75 6.47
myosin, light polypeptide 6B Myl6b 6.72 6.77
myosin, light polypeptide 4 Myl4 6.68 6.99
myosin IB Myo1b 6.51 7.07
myosin VIIA Myo7a 6.49 6.65
myosin IB Myo1b 6.43 7.64
myosin, heavy polypeptide 14 Myh14 6.36 6.21
myosin light chain, phosphorylatable, fast skeletal muscle Mylpf 6.31 6.85
myosin VIIA and Rab interacting protein Myrip 6.14 4.94*
myomesin 1 Myom1 5.87 5.66*
myosin IIIB Myo3b 5.46* 6.08
Table 12C. Microtubule and microtubule-related proteins
tubulin, alpha 4A Tuba4a 13.63 13.51
tubulin, alpha 1B Tuba1b 12.88 13.17
tubulin, alpha 1A Tuba1a 12.61 12.89
tubulin, beta 2A Tubb2a 12.32 12.64
gamma-aminobutyric acid (GABA(A)) receptor-associated protein-like 1 Gabarapl1 12.28 12.39
microtubule-associated protein 1 light chain 3 beta Map1lc3b 11.89 12.01
dynein light chain roadblock-type 1 Dynlrb1 11.87 11.89
dynein light chain LC8-type 1 Dynll1 11.86 12.45
dynein light chain LC8-type 1 /// predicted gene, EG627788 Dynll1 /// E 11.75 12.50
gamma-aminobutyric acid receptor associated protein Gabarap 11.50 11.62
dynein light chain Tctex-type 3 Dynlt3 11.49 11.85
dynein light chain LC8-type 2 Dynll2 11.17 11.69
tubulin, beta 2B Tubb2b 11.03 11.27
kinesin family member 5B Kif5b 11.00 11.06
microtubule-associated protein, RP/EB family, member 1 Mapre1 10.77 11.28
dynactin 6 Dctn6 10.76 11.35
tubulin folding cofactor B Tbcb 10.62 11.38
dynactin 4 Dctn4 10.58 11.20
kinesin family member 13B Kif13b 10.53 10.89
dynein cytoplasmic 1 intermediate chain 2 Dync1i2 10.36 10.55
microtubule-associated protein 1 light chain 3 alpha Map1lc3a 10.26 10.35
microtubule-associated protein, RP/EB family, member 2 Mapre2 10.26 10.24
destrin Dstn 10.25 10.99
kinesin family member 21A Kif21a 10.23 10.07
neurofilament, light polypeptide Nefl 10.21 8.28
kinesin family member 1C Kif1c 10.19 10.94
dynactin 5 Dctn5 10.15 11.03
kinesin family member 26B Kif26b 10.13 10.96
kinesin family member 1B Kif1b 10.12 10.97
tubulin, beta 5 Tubb5 10.01 10.60
dynein, cytoplasmic 1 light intermediate chain 2 Dync1li2 9.97 10.63
dynein cytoplasmic 1 heavy chain 1 Dync1h1 9.91 10.72
WD repeat domain 1 Wdr1 9.87 9.62
dynein, axonemal, light chain 1 Dnalc1 9.71 10.19
kinesin-associated protein 3 Kifap3 9.68 10.03
MAP/microtubule affinity-regulating kinase 2 Mark2 9.68 10.50
CAP-GLY domain containing linker protein 1 Clip1 9.38 9.94
tubulin, gamma complex associated protein 4 Tubgcp4 9.32 9.83
microtubule-associated protein 4 Mtap4 9.27 9.51
microtubule-associated protein 7 Mtap7 9.26 9.29
formin 1 Fmn1 9.19 9.45
tubulin, beta 2C Tubb2c 9.04 10.03
kinesin family member 16B Kif16b 9.02 9.28
dynactin 2 Dctn2 8.92 10.25
kinesin light chain 4 Klc4 8.88 9.82
microtubule-associated protein 2 Mtap2 8.84 9.77
katanin p60 (ATPase-containing) subunit A1 Katna1 8.77 9.22
tubulin tyrosine ligase Ttl 8.72 8.75
KIF13A Kif13a 8.68 9.77
kinesin family member 3A Kif3a 8.52 8.47
kinesin family member C3 Kifc3 8.29 9.22
kinesin family member 2A Kif2a 8.23 8.91
kinectin 1 Ktn1 8.21 8.76
tubulin tyrosine ligase-like family, member 4 Ttll4 8.15 8.41
microtubule-associated protein 7 domain containing 1 Mtap7d1 8.13 8.14
tubulin tyrosine ligase-like family, member 5 Ttll5 8.02 8.56
kinesin family member 3B Kif3b 7.99 8.38
kinesin family member 12 Kif12 7.91 8.72
kinesin family member 3C Kif3c 7.85 8.29
kinesin family member 22 Kif22 7.82 7.02
Dynein light chain Tctex-type 1 (Dynlt1), mRNA Dynlt1 7.79 7.98
dynactin 1 Dctn1 7.74 8.27
Tubulin, beta 6, mRNA (cDNA clone MGC:6469 IMAGE:2631779) Tubb6 7.70 8.44
tubulin tyrosine ligase-like 1 Ttll1 7.56 8.12
kinesin family member 23 Kif23 7.54 7.66
kinesin family member 20A Kif20a 7.48 7.39
kinesin light chain 2 Klc2 7.44 7.45
dynein, axonemal, light chain 4 Dnalc4 7.36 8.05
WD repeat domain 78 Wdr78 7.35 7.74
kinesin light chain 3 Klc3 7.34 7.35
MAP/microtubule affinity-regulating kinase 4 Mark4 7.34 7.79
CAP-GLY domain containing linker protein 2 Clip2 7.32 7.50
microtubule-associated protein, RP/EB family, member 3 Mapre3 7.30 7.07
microtubule-associated protein tau Mapt 7.12 8.73
tubulin tyrosine ligase-like family, member 10 Ttll10 7.03 7.58
dynein, axonemal, heavy chain 11 Dnahc11 6.92 7.54
dynein cytoplasmic 1 light intermediate chain 1 Dync1li1 6.89 7.16
kinesin light chain 1 Klc1 6.87 7.23
dynein, axonemal, heavy chain 7B Dnahc7b 6.79 7.47
WD repeat domain 34 Wdr34 6.73 8.05
kinesin family member 5C Kif5c 6.64 6.89
tubulin, gamma complex associated protein 5 Tubgcp5 6.56 7.09
tubulin, gamma 1 Tubg1 6.55 7.20
tubulin, gamma complex associated protein 2 Tubgcp2 6.54 6.93
WD repeat domain 60 Wdr60 6.50 7.04
tubulin polymerization-promoting protein family member 3 Tppp3 6.48 6.60
microtubule-associated protein 1 A Mtap1a 6.40 6.54
kinesin family member C2 Kifc2 6.37 6.61
CAP-GLY domain containing linker protein family, member 4 Clip4 6.37 5.92
tubulin, gamma complex associated protein 3 Tubgcp3 6.14 6.43
tubulin, beta 4 Tubb4 6.11 5.55*
tubulin tyrosine ligase-like family, member 11 Ttll11 5.99 6.14
kinesin family member 11 Kif11 5.97 6.02
midline 2 Mid2 5.85 6.57
kinesin family member 20B Kif20b 5.75* 5.86
midline 1 Mid1 5.75* 5.86
dynein cytoplasmic 2 heavy chain 1 Dync2h1 5.00* 6.21
dynein light chain roadblock-type 2 Dynlrb2 4.90* 5.91
MAP/microtubule affinity-regulating kinase 1 Mark1 4.90* 6.41
Table 12D. Intermediate filaments and related proteins
keratin 7 Krt7 12.42 12.89
plakophilin 4 Pkp4 11.75 11.73
keratin 18 Krt18 11.13 12.45
keratin 8 Krt8 10.92 11.84
lamin A Lmna 10.68 10.75
plastin 3 (T-isoform) Pls3 10.38 11.37
plakophilin 2 Pkp2 9.51 10.12
keratin 10 Krt10 9.39 9.68
keratin 80 Krt80 8.25 8.54
vimentin Vim 8.17 7.54
keratin 23 Krt23 7.98 9.95
lamin B2 Lmnb2 7.07 7.40
keratin 24 Krt24 6.95 6.00
lamin B1 Lmnb1 6.95 7.02
keratin 34 Krt34 6.72 6.52
keratin 19 Krt19 6.64 7.51
plakophilin 3 Pkp3 6.36 6.71
plastin 1 (I-isoform) Pls1 6.10 6.00
* - the A-value is below the cut-off level 
Supplemental Table 7. Transporters and channels.
Gene Name Gene DCT/CNT CCD
Symbol A_value A_Value
Table 13A. Water channels
aquaporin 3 Aqp3 13.11 13.45
aquaporin 6 Aqp6 11.53 12.84
aquaporin 4 Aqp4 8.16 11.63
aquaporin 11 Aqp11 8.11 6.90
aquaporin 2 Aqp2 7.95 10.25
aquaporin 5 Aqp5 6.51 6.20
aquaporin 1 Aqp1 6.09 6.57
Table 13B. Ion channels and transporters excluding SLC proteins.
ATPase, Na+/K+ transporting, beta 1 polypeptide Atp1b1 13.86 13.87
voltage-dependent anion channel 1 Vdac1 13.73 13.74
ATPase, H+ transporting, lysosomal V1 subunit A Atp6v1a 13.11 13.10
ATPase, H+ transporting, lysosomal V0 subunit C Atp6v0c 12.99 12.66
ATPase, H+ transporting, lysosomal V1 subunit D Atp6v1d 12.99 13.17
ATPase, Na+/K+ transporting, alpha 1 polypeptide Atp1a1 12.76 12.12
VATPase, H+ transporting, lysosomal V1 subunit E1 Atp6v1e1 12.71 12.61
ATPase, H+ transporting, lysosomal V0 subunit D2 Atp6v0d2 12.58 12.78
voltage-dependent anion channel 2 Vdac2 12.54 12.63
potassium inwardly-rectifying channel, subfamily J, member 16 Kcnj16 12.44 12.63
potassium inwardly-rectifying channel, subfamily J, member 1 Kcnj1 12.41 12.69
FXYD domain-containing ion transport regulator 2 Fxyd2 12.40 11.11
ATPase, H+ transporting, lysosomal V1 subunit F Atp6v1f 12.25 12.36
ATPase, H+ transporting, lysosomal V0 subunit B Atp6v0b 12.01 11.93
ATPase, H+ transporting, lysosomal V0 subunit E Atp6v0e 11.90 11.97
sodium channel, nonvoltage-gated 1 gamma Scnn1g 11.54 11.88
potassium voltage-gated channel, subfamily Q, member 1 Kcnq1 11.51 11.68
potassium voltage-gated channel, Isk-related subfamily, member 1 Kcne1 11.47 11.68
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 Atp2a2 11.45 11.61
chloride channel Kb Clcnkb 11.33 11.70
ATPase, H+ transporting, lysosomal V1 subunit H Atp6v1h 11.32 11.64
ATPase, H+ transporting, lysosomal V1 subunit C1 Atp6v1c1 11.27 11.48
ATPase, H+ transporting, lysosomal accessory protein 1 Atp6ap1 11.14 11.33
FXYD domain-containing ion transport regulator 4 Fxyd4 11.09 13.27
expressed sequence BF642829 BF642829 11.09 11.73
chloride channel 5 Clcn5 11.06 10.81
vacuolar protein sorting 25 (yeast) Vps25 10.97 11.32
sodium channel, type IV, beta Scn4b 10.92 8.47
transmembrane protein 16F Tmem16f 10.91 11.18
potassium inwardly-rectifying channel, subfamily J, member 10 Kcnj10 10.85 10.68
sodium channel, nonvoltage-gated 1 beta Scnn1b 10.84 11.39
ATPase, H+ transporting, lysosomal V0 subunit D1 Atp6v0d1 10.80 11.52
voltage-dependent anion channel 3 Vdac3 10.78 11.15
ATPase, Na+/K+ transporting, beta 3 polypeptide Atp1b3 10.60 11.51
ATPase, H+ transporting, lysosomal V1 subunit G1 Atp6v1g1 10.59 11.16
polycystic kidney disease 2 Pkd2 10.43 11.00
ATPase, H+ transporting, lysosomal V1 subunit B1 Atp6v1b1 10.43 10.16
inositol 1,4,5-triphosphate receptor 2 Itpr2 10.40 10.98
chloride channel 3 Clcn3 10.40 10.75
two pore channel 1 Tpcn1 10.22 10.39
ATPase, H+/K+ exchanging, gastric, alpha polypeptide Atp4a 10.15 10.33
inositol 1,4,5-triphosphate receptor 1 Itpr1 10.02 10.62
ATPase, H+ transporting, lysosomal V1 subunit B2 Atp6v1b2 9.97 10.36
ATPase, Ca++ transporting, plasma membrane 2 Atp2b2 9.83 10.17
calcium channel, voltage-dependent, L type, alpha 1D subunit Cacna1d 9.77 10.66
ATPase, Cu++ transporting, alpha polypeptide Atp7a 9.75 10.49
chloride intracellular channel 1 Clic1 9.64 10.71
chloride intracellular channel 4 (mitochondrial) Clic4 9.62 9.55
potassium channel, subfamily K, member 1 (TWIK-1) Kcnk1 9.45 10.45
ATPase, Ca++-sequestering Atp2c1 9.38 10.25
sodium channel, nonvoltage-gated, type I, alpha Scnn1a 9.37 9.54
ATPase, H+ transporting, lysosomal V0 subunit A4 Atp6v0a4 9.27 9.03
purinergic receptor P2X, ligand-gated ion channel 4 P2rx4 9.19 9.29
ATX1 (antioxidant protein 1) homolog 1 (yeast) Atox1 9.09 9.82
transient receptor potential cation channel, subfamily M, member 6 Trpm6 9.09 7.39
chloride channel 4-2 Clcn4-2 8.97 9.67
transient receptor potential cation channel, subfamily C, member 2 Trpc2 8.91 9.87
ATPase, H+ transporting, lysosomal V1 subunit C2 Atp6v1c2 8.82 8.91
transient receptor potential cation channel, subfamily M, member 7 Trpm7 8.75 9.29
ATPase, H+ transporting, lysosomal V0 subunit A1 Atp6v0a1 8.69 9.13
ATPase, H+ transporting, lysosomal V0 subunit A2 Atp6v0a2 8.41 8.49
chloride channel 7 Clcn7 8.41 9.02
transient receptor potential cation channel, subfamily M, member 4 Trpm4 8.36 9.32
calcium channel, voltage-dependent, beta 4 subunit Cacnb4 8.23 7.89
potassium inwardly rectifying channel, subfamily J, member 11 Kcnj11 8.16 8.44
transmembrane protein 37 Tmem37 8.10 7.69
chloride channel 6 Clcn6 8.04 8.29
mucolipin 1 Mcoln1 7.90 8.66
MRS2-like, magnesium homeostasis factor (S. cerevisiae) Mrs2l 7.88 8.34
transient receptor potential cation channel, subfamily V, member 6 Trpv6 7.86 8.90
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 Abcc4 7.80 8.56
transient receptor potential cation channel, subfamily V, member 5 Trpv5 7.68 5.58*
transmembrane and coiled-coil domains 3 Tmco3 7.66 8.32
stromal interaction molecule 1 Stim1 7.65 7.83
cholinergic receptor, nicotinic, alpha polypeptide 4 Chrna4 7.58 5.12*
potassium voltage-gated channel, subfamily H (eag-related), member 3 Kcnh3 7.57 7.17
calcium channel, voltage-dependent, alpha2/delta subunit 1 Cacna2d1 7.55 6.24
B-box and SPRY domain containing Bspry 7.44 8.37
potassium voltage gated channel, Shaw-related subfamily, member 2 Kcnc2 7.43 8.08
glutamate receptor, ionotropic, NMDA3B Grin3b 7.40 7.25
RIKEN cDNA 2010001E11 gene /// expressed sequence AI317395 2010001E 7.32 6.92
calcium channel, voltage-dependent, gamma subunit 8 Cacng8 7.31 6.72
polycystic kidney disease 2-like 2 Pkd2l2 7.24 7.78
stromal interaction molecule 2 Stim2 7.20 8.06
potassium voltage-gated channel, subfamily Q, member 2 Kcnq2 7.13 6.87
potassium voltage gated channel, Shaw-related subfamily, member 3 Kcnc3 7.12 7.50
calcium channel, voltage-dependent, beta 3 subunit Cacnb3 7.10 7.52
chloride intracellular channel 5 Clic5 7.06 6.39
transient receptor potential cation channel, subfamily V, member 4 Trpv4 6.91 7.55
gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1 Gabrg1 6.77 9.07
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit Cacna1a 6.74 6.61
potassium voltage gated channel, Shaw-related subfamily, member 4 Kcnc4 6.72 6.43
potassium intermediate/small conductance calcium-activated channel Kcnn3 6.69 7.36
subfamily N, member 3
ATPase, H+/K+ exchanging, beta polypeptide Atp4b 6.67 6.22
transmembrane protein 142A Tmem142a 6.66 6.81
calcium channel, voltage-dependent, gamma subunit 2 Cacng2 6.63 6.00
FXYD domain-containing ion transport regulator 1 Fxyd1 6.62 5.88
potassium intermediate/small conductance calcium-activated channel Kcnn1 6.60 6.47
subfamily N, member 1
transient receptor potential cation channel, subfamily C, member 5 Trpc5 6.60 6.40
potassium channel, subfamily K, member 3 Kcnk3 6.60 6.15
FXYD domain-containing ion transport regulator 5 Fxyd5 6.59 6.96
glutamate receptor, ionotropic, kainate 4 Grik4 6.59 6.65
expressed sequence AI317395 AI317395 6.59 5.64*
chloride channel Ka Clcnka 6.59 6.28
cholinergic receptor, nicotinic, gamma polypeptide Chrng 6.56 6.20
claudin 16 Cldn16 6.52 5.79*
glutamate receptor, ionotropic, kainate 5 (gamma 2) Grik5 6.52 6.61
transient receptor potential cation channel, subfamily C, member 4 Trpc4 6.45 5.23*
antigen p97 (melanoma associated) Mfi2 6.43 5.91
sodium channel, voltage-gated, type VIII, alpha Scn8a 6.40 6.01
two pore segment channel 2 Tpcn2 6.36 6.71
transient receptor potential cation channel, subfamily C, member 7 Trpc7 6.36 5.78*
ATPase, H+ transporting, lysosomal V1 subunit G2 Atp6v1g2 6.33 6.33
potassium inwardly-rectifying channel, subfamily J, member 4 Kcnj4 6.33 6.45
potassium channel, subfamily T, member 1 Kcnt1 6.32 6.17
potassium inwardly-rectifying channel, subfamily J, member 15 Kcnj15 6.29 6.37
expressed sequence AI118078 AI118078 6.29 6.23
sodium channel, voltage-gated, type I, beta Scn1b 6.24 5.69*
calcium channel, voltage-dependent, beta 1 subunit Cacnb1 6.23 6.72
sodium channel, voltage-gated, type II, beta Scn2b 6.20 5.80
ATPase, Na+/K+ transporting, beta 2 polypeptide Atp1b2 6.19 5.43*
amiloride-sensitive cation channel 5, intestinal Accn5 6.19 5.84
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 Kcns3 6.19 7.58
purinergic receptor P2X, ligand-gated ion channel, 5 P2rx5 6.15 6.13
calcium channel, voltage-dependent, beta 2 subunit Cacnb2 6.13 6.96
purinergic receptor P2X-like 1, orphan receptor P2rxl1 6.11 5.70*
transient receptor potential cation channel, subfamily V, member 2 Trpv2 6.08 5.49*
amiloride-sensitive cation channel 4, pituitary Accn4 6.07 5.93
transient receptor potential cation channel, subfamily M, member 3 Trpm3 6.07 5.93
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 Atp2a1 6.05 6.20
chloride intracellular channel 3 Clic3 6.05 5.69*
potassium voltage-gated channel, subfamily G, member 2 Kcng2 6.03 5.98
potassium voltage gated channel, Shab-related subfamily, member 1 Kcnb1 6.00 5.74*
transient receptor potential cation channel, subfamily M, member 2 Trpm2 5.97 5.50*
bestrophin 1 Best1 5.96 6.06
potassium voltage gated channel, Shaw-related subfamily, member 1 Kcnc1 5.93 5.47*
cation channel, sperm associated 2 Catsper2 5.93 5.89
calcium channel, voltage-dependent, gamma subunit 4 Cacng4 5.93 5.21*
Kv channel-interacting protein 1 Kcnip1 5.90 5.74*
gamma-aminobutyric acid (GABA-A) receptor, pi Gabrp 5.88 4.75*
calcium channel, voltage-dependent, gamma subunit 1 Cacng1 5.88 4.94*
glutamate receptor, ionotropic, NMDA2B (epsilon 2) Grin2b 5.82 5.54*
potassium voltage-gated channel, shaker-related subfamily, member 7 Kcna7 5.81 5.59*
hydrogen voltage-gated channel 1 Hvcn1 5.75* 6.39
cholinergic receptor, nicotinic, beta polypeptide 4 Chrnb4 5.69* 6.86
amiloride-sensitive cation channel 2, neuronal Accn2 5.47* 5.82
ATPase, H+/K+ transporting, nongastric, alpha polypeptide Atp12a 5.41* 5.89
purinergic receptor P2X, ligand-gated ion channel, 7 P2rx7 5.30* 5.82
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) Chrnb1 5.01* 6.93
FXYD domain-containing ion transport regulator 3 Fxyd3 4.97* 6.55
gamma-aminobutyric acid (GABA-A) receptor, subunit epsilon Gabre 4.68* 6.27
Table 13C. Solute carrier proteins (SLC).
solute carrier family 26, member 4 (pendrin) Slc26a4 13.43 13.45
solute carrier family 25 (mitochondrial carrier, adenine nucleotide Slc25a5 12.88 12.94
translocator), member 5
solute carrier family 2 (urate transporter), member 9 Slc2a9 12.42 10.74
solute carrier family 25 (mitochondrial carrier, adenine nucleotide Slc25a4 12.42 12.54
 translocator), member 4
solute carrier family 16 (monocarboxylic acid transporters), member 7 Slc16a7 12.12 11.52
solute carrier family 2 (facilitated glucose transporter), member 1 (GLUT1) Slc2a1 12.10 12.73
solute carrier family 12, member 3 (NCC) Slc12a3 10.77 5.28*
solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), Slc25a11 10.13 10.66
member 11
solute carrier family 27 (fatty acid transporter), member 1 Slc27a1 10.12 10.46
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), Slc25a20 10.07 10.59
member 20
solute carrier family 25 (mitochondrial carrier; phosphate carrier), Slc25a23 9.76 9.59
member 23
solute carrier family 25 (mitochondrial carrier, Aralar), member 12 Slc25a12 9.48 9.66
solute carrier family 5 (sodium/glucose cotransporter), member 2 (SGLT2) Slc5a2 9.48 9.52
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), Slc25a19 9.48 9.66
member 19
solute carrier family 40 (iron-regulated transporter), member 1 Slc40a1 9.46 9.10
solute carrier family 2 (facilitated glucose transporter), member 4 (GLUT4) Slc2a4 9.32 8.67
solute carrier family 25 (mitochondrial carrier ornithine transporter), Slc25a15 9.25 9.27
 member 15
solute carrier family 25, member 36 Slc25a36 9.16 9.84
solute carrier family 25, member 30 Slc25a30 9.10 8.66
solute carrier family 11 (proton-coupled divalent metal ion transporters), Slc11a2 8.97 9.46
member 2
solute carrier family 25 (mitochondrial carrier, brain), member 14 Slc25a14 8.95 9.60
solute carrier family 16 (monocarboxylic acid transporters), member 10 Slc16a10 8.85 9.08
solute carrier family 5 (inositol transporters), member 3 Slc5a3 8.72 9.03
solute carrier family 25, member 32 Slc25a32 8.69 9.14
solute carrier family 12, member 7 (KCC4) Slc12a7 8.61 8.97
solute carrier family 25 (mitochondrial carrier, phosphate carrier), Slc25a25 8.52 9.07
member 25
solute carrier organic anion transporter family, member 4a1 Slco4a1 8.44 9.03
solute carrier family 15 (H+/peptide transporter), member 2 (PEPT2) Slc15a2 8.43 8.65
solute carrier family 22 (organic cation transporter), member 5 Slc22a5 8.42 8.77
solute carrier family 22 (organic anion/cation transporter), member 12 Slc22a12 8.33 7.89
solute carrier family 25, member 44 Slc25a44 8.30 8.56
solute carrier family 12, member 2 (NKCC1) Slc12a2 8.28 8.96
solute carrier organic anion transporter family, member 3a1 Slco3a1 8.24 9.10
solute carrier family 37 (glucose-6-phosphate transporter), member 4 Slc37a4 8.20 8.05
solute carrier family 37 (glycerol-3-phosphate transporter), member 3 Slc37a3 8.19 8.81
solute carrier family 2 (facilitated glucose transporter), member 12 Slc2a12 8.13 7.88
solute carrier family 25 (mitochondrial carrier, adenine nucleotide Slc25a13 8.09 8.76
translocator), member 13
solute carrier family 16 (monocarboxylic acid transporters), member 9 Slc16a9 7.98 8.37
solute carrier family 16 (monocarboxylic acid transporters), member 13 Slc16a13 7.95 8.06
solute carrier family 25 (mitochondrial carrier, citrate transporter), Slc25a1 7.91 8.49
member 1
solute carrier family 13 (sodium-dependent dicarboxylate transporter), Slc13a3 7.78 7.54
member 3
solute carrier family 16 (monocarboxylic acid transporters), member 11 Slc16a11 7.71 7.30
solute carrier family 18 (vesicular monoamine), member 1 Slc18a1 7.71 7.84
solute carrier family 27 (fatty acid transporter), member 4 Slc27a4 7.71 8.17
solute carrier family 34 (sodium phosphate), member 1 Slc34a1 7.68 7.72
solute carrier family 2, (facilitated glucose transporter), member 8 Slc2a8 7.64 8.29
solute carrier family 12, member 1 (NKCC2) Slc12a1 7.64 6.83
solute carrier family 25 (mitochondrial carrier, peroxisomal membrane Slc25a17 7.50 8.11
protein), member 17
solute carrier family 15, member 4 Slc15a4 7.46 8.45
solute carrier family 25, member 34 Slc25a34 7.36 7.62
solute carrier family 23 (nucleobase transporters), member 2 Slc23a2 7.34 7.72
solute carrier family 46, member 1 Slc46a1 7.28 7.79
solute carrier family 17 (anion/sugar transporter), member 5 Slc17a5 7.25 7.79
solute carrier family 22 (organic anion transporter), member 6 Slc22a6 7.21 7.72
solute carrier family 16 (monocarboxylic acid transporters), member 8 Slc16a8 7.08 7.01
solute carrier family 12, member 6 (KCC3) Slc12a6 7.07 7.75
solute carrier family 5 (sodium/glucose cotransporter), member 1 (SGLT1) Slc5a1 6.94 6.42
solute carrier family 17 (sodium phosphate), member 1 (NPT1) Slc17a1 6.90 7.08
solute carrier family 17 (sodium phosphate), member 3 (NPT4) Slc17a3 6.90 7.47
solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine Slc25a29 6.86 7.47
transporter), member 29
solute carrier family 22 (organic cation transporter), member 17 Slc22a17 6.84 8.13
solute carrier family 15 (oligopeptide transporter), member 1 Slc15a1 6.81 4.73*
solute carrier family 26 (sulfate transporter), member 2 Slc26a2 6.81 8.09
solute carrier family 16 (monocarboxylic acid transporters), member 6 Slc16a6 6.73 7.52
solute carrier family 16 (monocarboxylic acid transporters), member 14 Slc16a14 6.71 6.16
solute carrier organic anion transporter family, member 1a1 Slco1a1 6.70 6.74
solute carrier family 18 (vesicular monoamine), member 2 Slc18a2 6.67 6.64
solute carrier family 25, member 45 Slc25a45 6.59 7.21
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 Slc37a1 6.59 7.00
solute carrier family 22 (organic anion transporter), member 8 Slc22a8 6.56 6.43
solute carrier family 22 (organic cation transporter), member 13 Slc22a13 6.50 6.60
solute carrier family 6 (neurotransmitter transporter), member 18 Slc6a18 6.49 6.63
solute carrier organic anion transporter family, member 2b1 Slco2b1 6.41 6.49
solute carrier organic anion transporter family, member 4C1 Slco4c1 6.40 7.78
solute carrier family 22 (organic cation transporter), member 2 Slc22a2 6.39 6.47
solute carrier family 5 (sodium/glucose cotransporter), member 10 Slc5a10 6.30 6.42
solute carrier family 37 (glycerol-3-phosphate transporter), member 2 Slc37a2 6.25 5.98
solute carrier family 22 (organic cation transporter), member 18 Slc22a18 6.24 6.34
solute carrier family 16 (monocarboxylic acid transporters), member 2 Slc16a2 6.24 6.41
solute carrier family 22 (organic cation transporter), member 3 Slc22a3 6.24 5.14
solute carrier family 22 (organic cation transporter), member 1 Slc22a1 6.21 6.31
solute carrier family 22 (organic anion transporter), member 7 Slc22a7 6.20 6.40
solute carrier family 26, member 11 Slc26a11 6.16 6.30
solute carrier family 22 (organic anion/cation transporter), member 15 Slc22a15 6.13 6.16
solute carrier family 2 (facilitated glucose transporter), member 5 Slc2a5 6.10 5.56*
solute carrier family 15, member 3 Slc15a3 6.06 5.30*
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 Slc25a22 6.06 5.85
solute carrier family 12, member 4 Slc12a4 5.91 6.32
solute carrier family 25, member 27 Slc25a27 5.91 6.09
solute carrier family 16 (monocarboxylic acid transporters), member 4 Slc16a4 5.89 6.79
solute carrier organic anion transporter family, member 2a1 Slco2a1 5.88 5.28*
solute carrier family 23 (nucleobase transporters), member 1 Slc23a1 5.88 6.31
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 Slc5a6 5.84 6.05
solute carrier family 22 (organic cation transporter), member 4 Slc22a4 5.72* 5.88
solute carrier family 16 (monocarboxylic acid transporters), member 12 Slc16a12 5.63* 5.92
solute carrier family 6 (neurotransmitter transporter), member 20 Slc6a20 5.59* 6.33
solute carrier family 26, member 7 Slc26a7 5.29* 7.77
solute carrier family 5 (iodide transporter), member 8 Slc5a8 5.10* 5.82
* - the A-value is below the cut-off level 
Supplemental Table 8. Transcription factors
Gene Name Gene DCT/CNT CCD
Symbol A_Value A_Value
zinc finger protein 526 Zfp526 13.23 13.31
ring-box 1 Rbx1 13.04 13.19
pituitary tumor-transforming gene 1 Pttg1 12.79 12.76
mortality factor 4 like 1 Morf4l1 12.76 13.05
Jun proto-oncogene related gene d Jund 12.74 12.75
homeo box D8 Hoxd8 12.66 12.80
early growth response 1 Egr1 12.64 13.46
TSC22 domain family, member 1 Tsc22d1 12.38 12.51
homeo box D9 Hoxd9 12.37 12.50
Jun oncogene Jun 12.28 12.83
FBJ osteosarcoma oncogene Fos 12.25 12.85
nascent polypeptide-associated complex alpha polypeptide Naca 12.17 12.64
endothelial differentiation-related factor 1 Edf1 12.14 12.37
SUB1 homolog (S. cerevisiae) Sub1 11.81 12.28
ring finger protein 7 Rnf7 11.67 12.20
ecotropic viral integration site 1 Evi1 11.64 12.07
pleiomorphic adenoma gene-like 1 Plagl1 11.62 11.83
MPN domain containing Mpnd 11.57 11.89
peroxisome proliferative activated receptor, gamma, coactivator 1 a Ppargc1a 11.55 11.37
Kruppel-like factor 9 Klf9 11.52 11.44
cAMP responsive element binding protein 3 Creb3 11.45 11.92
fusion, derived from t(12;16) malignant liposarcoma (human) Fus 11.43 11.79
eukaryotic translation initiation factor 3, subunit H Eif3h 11.42 11.79
transcription factor CP2-like 1 Tcfcp2l1 11.41 11.91
thyroid hormone receptor associated protein 3 Thrap3 11.40 11.56
mortality factor 4 like 2 Morf4l2 11.35 11.61
transcriptional regulator, SIN3B (yeast) Sin3b 11.32 11.44
vitamin D receptor Vdr 11.31 9.46
proliferation-associated 2G4 Pa2g4 11.31 11.85
hypoxia inducible factor 1, alpha subunit Hif1a 11.30 11.95
PR domain containing 16 Prdm16 11.29 11.71
POU domain, class 3, transcription factor 3 Pou3f3 11.27 12.11
zinc finger, HIT domain containing 1 Znhit1 11.22 11.52
nuclear receptor co-repressor 1 Ncor1 11.21 11.55
amino-terminal enhancer of split Aes 11.13 11.49
transformation related protein 53 binding protein 1 Trp53bp1 11.13 11.76
zinc finger, matrin type 2 Zmat2 11.11 11.42
leucine rich repeat (in FLII) interacting protein 1 Lrrfip1 11.11 11.66
BUD31 homolog (yeast) Bud31 11.09 10.85
GATA binding protein 2 Gata2 11.08 12.22
estrogen-related receptor gamma Esrrg 11.08 11.05
transcription elongation factor A (SII) 1 Tcea1 11.07 11.37
zinc finger, MYND domain containing 11 Zmynd11 11.06 11.35
zinc finger CCCH-type containing 15 Zc3h15 11.04 10.95
endothelial PAS domain protein 1 Epas1 11.02 11.08
jagged 1 Jag1 11.01 11.47
Cbp/p300-interacting transactivator Cited2 10.95 11.44
LPS-induced TN factor Litaf 10.91 11.85
forkhead box I1 Foxi1 10.89 11.54
ring finger protein 11 Rnf11 10.89 11.22
nuclear factor, erythroid derived 2, like 2 Nfe2l2 10.88 11.28
AF4/FMR2 family, member 1 Aff1 10.88 11.58
Kruppel-like factor 6 Klf6 10.88 11.73
GATA zinc finger domain containing 1 Gatad1 10.84 11.01
AT rich interactive domain 4B (RBP1-like) Arid4b 10.84 11.22
WW domain binding protein 5 Wbp5 10.84 11.84
replication initiator 1 Repin1 10.81 10.87
BCL2-associated transcription factor 1 Bclaf1 10.80 10.99
activating transcription factor 4 Atf4 10.78 10.78
ets homologous factor Ehf 10.78 11.84
serum deprivation response Sdpr 10.73 10.56
forkhead box O3 Foxo3 10.73 10.93
leucine rich repeat (in FLII) interacting protein 2 Lrrfip2 10.73 10.83
SNW domain containing 1 Snw1 10.72 10.81
PHD finger protein 17 Phf17 10.71 10.70
purine rich element binding protein B Purb 10.70 11.04
forkhead box J3 Foxj3 10.68 11.23
TAF13 RNA polymerase II Taf13 10.67 10.69
general transcription factor II I Gtf2i 10.65 11.14
male-specific lethal 3 homolog (Drosophila) Msl3 10.63 11.01
TAR DNA binding protein Tardbp 10.62 11.03
homeo box D10 Hoxd10 10.59 7.40
CCAAT/enhancer binding protein zeta Cebpz 10.58 11.12
biogenesis of lysosome-related organelles complex-1, subunit 1 Bloc1s1 10.57 10.74
yes-associated protein 1 Yap1 10.55 10.63
nuclear receptor subfamily 2, group F, member 6 Nr2f6 10.54 10.72
homeo box A9 Hoxa9 10.53 6.80
E26 avian leukemia oncogene 2, 3' domain Ets2 10.43 11.01
cold shock domain protein A Csda 10.43 10.78
praja 2, RING-H2 motif containing Pja2 10.42 10.72
general transcription factor IIF, polypeptide 1 Gtf2f1 10.37 10.92
CCCTC-binding factor Ctcf 10.36 10.59
ELK4, member of ETS oncogene family Elk4 10.34 11.04
forkhead box N3 Foxn3 10.33 10.85
YY1 transcription factor Yy1 10.32 10.67
activating transcription factor 2 Atf2 10.32 11.15
forkhead box K1 Foxk1 10.32 10.93
leucine-zipper-like transcriptional regulator, 1 Lztr1 10.32 10.36
basic helix-loop-helix family, member e40 Bhlhe40 10.29 11.37
nuclear factor, erythroid derived 2,-like 1 Nfe2l1 10.28 10.77
MAD homolog 1 (Drosophila) Smad1 10.28 10.99
TAF10 RNA polymerase II Taf10 10.28 10.76
zinc finger, CCHC domain containing 3 Zcchc3 10.27 11.21
nuclear factor I/C Nfic 10.27 10.17
interferon-induced protein 35 Ifi35 10.27 10.94
c-myc binding protein Mycbp 10.26 10.36
D site albumin promoter binding protein Dbp 10.25 10.62
prefoldin 1 Pfdn1 10.23 10.70
cAMP responsive element binding protein 3-like 2 Creb3l2 10.23 10.88
Ring finger protein 185 (Rnf185), mRNA Rnf185 10.22 10.68
AF4/FMR2 family, member 4 Aff4 10.21 11.04
zinc finger protein 422 Zfp422 10.21 10.65
PHD finger protein 14 Phf14 10.21 10.87
GA repeat binding protein, alpha Gabpa 10.18 10.32
homeo box D11 Hoxd11 10.16 6.59
forkhead box P1 Foxp1 10.15 10.79
zinc finger and BTB domain containing 7a Zbtb7a 10.15 10.81
nuclear receptor coactivator 2 Ncoa2 10.14 10.69
forkhead box O1 Foxo1 10.13 10.01
polyglutamine binding protein 1 Pqbp1 10.13 10.60
HLA-B associated transcript 2 Bat2 10.13 10.81
RIKEN cDNA 9030612M13 gene 9030612M13Rik 10.13 10.45
CREB binding protein Crebbp 10.13 11.11
transcription elongation factor B (SIII), polypeptide 2 Tceb2 10.12 10.70
COP9 (constitutive photomorphogenic) homolog, subunit 5 Cops5 10.12 10.77
inhibitor of DNA binding 2 Id2 10.11 10.77
zinc finger protein 238 Zfp238 10.10 10.62
aryl hydrocarbon receptor nuclear translocator Arnt 10.10 10.61
FBJ osteosarcoma oncogene B Fosb 10.08 10.24
nuclear receptor coactivator 4 Ncoa4 10.08 10.74
signal transducer and activator of transcription 3 Stat3 10.06 10.75
ring finger protein 114 Rnf114 10.06 10.99
zinc finger and BTB domain containing 4 Zbtb4 10.06 10.39
scaffold attachment factor B Safb 10.05 10.52
zinc finger and BTB domain containing 20 Zbtb20 10.03 10.66
homeo box B7 /// homeo box B8 Hoxb7 /// Hoxb8 10.03 10.29
zinc finger homeobox 3 Zfhx3 10.03 10.52
Ngfi-A binding protein 1 Nab1 10.02 10.49
CCR4-NOT transcription complex, subunit 4 Cnot4 9.99 10.46
zinc finger protein 251 Zfp251 9.98 10.64
GLIS family zinc finger 2 Glis2 9.97 10.74
retinoblastoma binding protein 8 Rbbp8 9.96 10.23
MAD homolog 4 (Drosophila) Smad4 9.95 10.54
zinc finger protein 809 Zfp809 9.95 10.43
chromatin modifying protein 4B /// similar to zinc finger protein 341 Chmp4b /// LOC6 9.95 10.55
GLIS family zinc finger 3 Glis3 9.94 10.57
forkhead box Q1 Foxq1 9.93 9.48
AE binding protein 2 Aebp2 9.93 10.67
zinc finger CCCH type containing 11A Zc3h11a 9.91 10.49
RIKEN cDNA 2010315B03 gene 2010315B03Rik 9.91 10.05
THO complex 2 Thoc2 9.91 10.49
CCAAT/enhancer binding protein (C/EBP), gamma Cebpg 9.90 10.42
zinc finger protein 664 Zfp664 9.90 10.68
homeo box C10 Hoxc10 9.89 5.53*
microphthalmia-associated transcription factor Mitf 9.89 10.30
trans-acting transcription factor 1 Sp1 9.88 10.99
RIKEN cDNA 0610009B22 gene 0610009B22Rik 9.87 10.38
nuclear factor I/X Nfix 9.87 11.35
methyltransferase like 14 Mettl14 9.87 10.46
ring finger protein 4 Rnf4 9.86 10.39
polymerase (RNA) II (DNA directed) polypeptide G Polr2g 9.84 10.08
expressed sequence C80913 C80913 9.84 9.92
suppressor of Ty 16 homolog (S. cerevisiae) Supt16h 9.84 10.35
zinc fingers and homeoboxes 3 Zhx3 9.84 10.48
Zinc finger protein 358 (Zfp358), mRNA Zfp358 9.83 10.18
Shwachman-Bodian-Diamond syndrome homolog (human) Sbds 9.82 10.12
zinc finger protein 161 Zfp161 9.82 10.28
RUN and FYVE domain containing 3 Rufy3 9.81 9.98
structure specific recognition protein 1 Ssrp1 9.81 10.40
SAP domain containing ribonucleoprotein Sarnp 9.81 9.61
nuclear receptor subfamily 2, group F, member 2 Nr2f2 9.79 10.14
ring finger protein 14 Rnf14 9.79 10.10
AT rich interactive domain 4A (RBP1-like) Arid4a 9.79 9.84
YEATS domain containing 4 Yeats4 9.77 10.04
cell division cycle 5-like (S. pombe) Cdc5l 9.77 10.05
nuclear transcription factor, X-box binding 1 Nfx1 9.77 9.87
zinc finger with KRAB and SCAN domains 1 Zkscan1 9.77 10.28
signal transducer and activator of transcription 6 Stat6 9.75 10.03
C1D nuclear receptor co-repressor C1d 9.75 9.91
activating transcription factor 6 Atf6 9.75 9.82
TEA domain family member 1 Tead1 9.73 10.79
zinc finger protein 219 Zfp219 9.70 10.13
high mobility group box transcription factor 1 Hbp1 9.69 10.34
BAT2 domain containing 1 Bat2d 9.68 10.49
activating transcription factor 1 Atf1 9.66 10.76
XPA binding protein 2 Xab2 9.66 10.17
TAF15 RNA polymerase II Taf15 9.65 9.52
family with sequence similarity 48, member A Fam48a 9.64 10.05
speckle-type POZ protein Spop 9.61 10.10
interferon regulatory factor 6 Irf6 9.59 10.84
cAMP responsive element binding protein 1 Creb1 9.59 10.32
CCR4-NOT transcription complex, subunit 1 Cnot1 9.59 10.63
LIM domain binding 1 Ldb1 9.59 9.93
CCR4-NOT transcription complex, subunit 2 Cnot2 9.57 10.40
nuclear receptor subfamily 2, group C, member 2 Nr2c2 9.57 10.35
C-terminal binding protein 2 Ctbp2 9.55 9.86
Max interacting protein 1 Mxi1 9.54 9.80
purine rich element binding protein A Pura 9.53 10.03
enhancer of rudimentary homolog (Drosophila) Erh 9.53 10.28
zinc finger protein 329 Zfp329 9.51 9.44
Jumonji domain containing 3, mRNA (cDNA clone IMAGE:1378940) Kdm6b 9.50 10.39
myeloid/lymphoid or mixed-lineage leukemia 3 Mll3 9.50 9.88
ZXD family zinc finger C Zxdc 9.48 10.01
nuclear factor I/B Nfib 9.48 10.86
E74-like factor 2 Elf2 9.47 9.88
bromodomain containing 1 Brd1 9.47 10.04
myoneurin Mynn 9.46 10.14
transcription factor 20 Tcf20 9.45 10.55
similar to Zinc finger BED domain containing protein 4 LOC667118 9.45 9.97
kelch-like ECH-associated protein 1 Keap1 9.44 9.83
upstream binding transcription factor, RNA polymerase I Ubtf 9.44 10.51
suppressor of Ty 5 homolog (S. cerevisiae) Supt5h 9.43 9.69
Max dimerization protein 3 Mxd3 9.43 9.35
RAR-related orphan receptor gamma Rorc 9.42 9.93
empty spiracles homolog 2 (Drosophila) Emx2 9.42 10.90
transcriptional regulator, SIN3A (yeast) Sin3a 9.41 9.78
core binding factor beta Cbfb 9.41 9.66
RIKEN cDNA 5830417I10 gene 5830417I10Rik 9.40 9.48
UTP6, small subunit (SSU) processome component, homolog Utp6 9.40 10.31
interleukin enhancer binding factor 2 Ilf2 9.39 10.20
zinc finger and SCAN domain containing 21 Zscan21 9.39 10.46
transducin-like enhancer of split 3, homolog of Drosophila E(spl) Tle3 9.38 9.78
MYST histone acetyltransferase (monocytic leukemia) 3 Myst3 9.38 9.97
zinc finger protein 217 Zfp217 9.37 10.13
homeo box B4 Hoxb4 9.37 9.98
inhibitor of DNA binding 3 Id3 9.36 10.15
nuclear receptor subfamily 1, group D, member 2 Nr1d2 9.35 9.39
zinc finger protein 187 Zfp187 9.35 10.41
zinc finger protein 191 Zfp191 9.34 10.18
dachshund 1 (Drosophila) Dach1 9.34 9.08
transcription factor AP-2 beta Tcfap2b 9.34 9.48
RE1-silencing transcription factor Rest 9.33 10.27
predicted gene, EG382639 EG382639 9.33 10.01
TAF9 RNA polymerase II Taf9 9.32 9.44
GATA binding protein 3 Gata3 9.32 10.52
scaffold attachment factor B2 Safb2 9.32 9.95
homeo box B5 Hoxb5 9.31 9.97
family with sequence similarity 164, member A Fam164a 9.31 10.23
cyclin L1 Ccnl1 9.30 9.89
TSC22 domain family, member 2 Tsc22d2 9.30 9.24
ring finger protein 1 Ring1 9.29 9.38
zinc finger, ZZ domain containing 3 Zzz3 9.29 9.52
anaphase promoting complex subunit 11 Anapc11 9.28 9.12
SERTA domain containing 1 Sertad1 9.27 9.69
remodeling and spacing factor 1 Rsf1 9.27 9.85
zinc finger protein 553 Zfp553 9.26 9.53
zinc finger protein 644 Zfp644 9.26 9.78
paternally expressed 3 Peg3 9.24 8.40
grainyhead-like 2 (Drosophila) Grhl2 9.24 9.94
general transcription factor II A, 1 Gtf2a1 9.24 9.81
LIM domains containing 1 Limd1 9.23 10.09
transcription factor Dp 2 Tfdp2 9.23 9.23
zinc finger protein 263 Zfp263 9.23 9.58
zinc and ring finger 2 Znrf2 9.23 9.83
ras responsive element binding protein 1 Rreb1 9.22 9.87
sprouty homolog 2 (Drosophila) Spry2 9.22 10.59
MAD homolog 5 (Drosophila) Smad5 9.21 9.49
transcription factor Dp 1 Tfdp1 9.20 9.70
ets variant gene 3 Etv3 9.19 9.43
forkhead box K2 Foxk2 9.18 9.70
PHD finger protein 10 Phf10 9.18 9.77
Dr1 associated protein 1 (negative cofactor 2 alpha) Drap1 9.18 9.38
CCAAT/enhancer binding protein (C/EBP), alpha Cebpa 9.17 9.53
ataxin 3 Atxn3 9.17 9.62
zinc finger protein 260 Zfp260 9.17 9.61
zinc finger protein 629 Zfp629 9.16 9.03
zinc finger protein 408 Zfp408 9.16 9.52
SRY-box containing gene 4 Sox4 9.15 10.65
fos-like antigen 2 /// similar to fos-like antigen 2 Fosl2 9.15 10.18
zinc finger and BTB domain containing 1 Zbtb1 9.13 10.17
programmed cell death 2-like Pdcd2l 9.13 9.53
vascular endothelial zinc finger 1 Vezf1 9.13 9.87
paired box gene 8 Pax8 9.12 10.14
myeloid/lymphoid or mixed-lineage leukemia Mllt3 9.12 9.33
X-box binding protein 1, mRNA Xbp1 9.11 10.03
thyrotroph embryonic factor Tef 9.11 9.63
zinc finger, MYND-type containing 8 Zmynd8 9.11 9.71
nucleus accumbens associated 2 Nacc2 9.11 9.65
D4, zinc and double PHD fingers family 2 Dpf2 9.10 9.30
ski sarcoma viral oncogene homolog (avian) Ski 9.10 9.68
serum response factor Srf 9.09 9.83
ring finger protein, LIM domain interacting Rlim 9.09 9.66
polycomb group ring finger 2 Pcgf2 9.08 9.40
down-regulator of transcription 1 Dr1 9.07 9.76
pre B-cell leukemia transcription factor 2 Pbx2 9.07 9.77
cut-like homeobox 1 Cux1 9.07 9.48
zinc finger and BTB domain containing 43 Zbtb43 9.06 9.65
MAD homolog 3 (Drosophila) Smad3 9.06 9.07
RIKEN cDNA 1810007M14 gene 1810007M14Rik 9.04 10.02
ring finger protein 2 Rnf2 9.04 9.62
zinc finger protein 768 Zfp768 9.03 8.57
nuclear receptor subfamily 3, group C, member 2 Nr3c2 9.03 9.53
delta-like 1 (Drosophila) Dll1 9.02 9.92
zinc finger protein 397 Zfp397 9.00 9.31
RING1 and YY1 binding protein Rybp 8.99 9.13
RIKEN cDNA 5730601F06 gene 5730601F06Rik 8.99 9.60
CCR4-NOT transcription complex, subunit 7 Cnot7 8.97 9.46
cyclin T2 Ccnt2 8.97 9.58
sal-like 1 (Drosophila) Sall1 8.97 5.57*
zinc finger protein 740 Zfp740 8.95 9.27
tripartite motif-containing 28 Trim28 8.93 9.75
ring finger protein 5 Rnf5 8.93 9.69
zinc finger and BTB domain containing 6 Zbtb6 8.93 9.47
MAF1 homolog (S. cerevisiae) (Maf1), mRNA Maf1 8.92 9.87
jumonji, AT rich interactive domain 2 Jarid2 8.92 9.50
lysine (K)-specific demethylase 5D Kdm5d 8.92 9.25
MAD homolog 2 (Drosophila) Smad2 8.91 9.84
nuclear transcription factor-Y beta Nfyb 8.90 9.50
circadian locomoter output cycles kaput Clock 8.89 9.48
serum response factor binding protein 1 Srfbp1 8.89 9.08
zinc finger protein 516 Zfp516 8.89 9.31
HLA-B associated transcript 2-like Bat2l 8.88 9.64
SKI-like Skil 8.88 9.71
prostate tumor over expressed gene 1 Ptov1 8.87 9.17
transcription factor 12 Tcf12 8.87 9.56
inhibitor of growth family, member 2 Ing2 8.86 9.36
myeloid/lymphoid or mixed-lineage leukemia Mllt6 8.86 9.67
nuclear receptor interacting protein 1 Nrip1 8.86 9.42
transcription factor 4 Tcf4 8.85 9.34
RIKEN cDNA 1700023B02 gene 1700023B02Rik 8.85 8.75
zinc finger protein 617 Zfp617 8.85 9.42
bromodomain and PHD finger containing, 3 Brpf3 8.85 8.61
RAR-related orphan receptor alpha Rora 8.83 9.69
general transcription factor IIB Gtf2b 8.83 9.47
T-box 2 Tbx2 8.82 9.07
hairy and enhancer of split 6 (Drosophila) Hes6 8.82 9.30
upstream binding protein 1 Ubp1 8.82 9.24
lysine (K)-specific demethylase 5B Kdm5b 8.81 9.41
zinc finger protein 398 Zfp398 8.81 9.51
nuclear factor of activated T-cells 5 Nfat5 8.81 9.76
nuclear receptor coactivator 3 Ncoa3 8.80 9.67
zinc finger, RAN-binding domain containing 2 Zranb2 8.80 9.14
zinc finger protein 445 Zfp445 8.80 9.23
ELK3, member of ETS oncogene family Elk3 8.79 8.83
thyroid hormone receptor alpha Thra 8.79 9.62
AS42 oncogene homolog Maf 8.79 9.02
nuclear factor of activated T-cells, cytoplasmic Nfatc3 8.77 9.16
Kruppel-like factor 10 Klf10 8.76 9.63
homeodomain leucine zipper-encoding gene Homez 8.76 8.86
zinc finger protein 281 Zfp281 8.75 8.70
TAF1 RNA polymerase II Taf1 8.75 9.37
zinc finger protein 687 Zfp687 8.74 8.26
RIKEN cDNA 4930529C04 gene 4930529C04Rik 8.74 8.59
polyhomeotic-like 1 (Drosophila) Phc1 8.73 9.25
expressed sequence AI987944 /// expressed sequence AW146154 AI987944 8.73 9.40
SRY-box containing gene 6 Sox6 8.72 9.66
inhibitor of growth family, member 1 Ing1 8.72 9.15
zinc finger protein 606 Zfp606 8.71 9.00
zinc finger and BTB domain containing 2 Zbtb2 8.70 9.39
TOX high mobility group box family member 4 Tox4 8.69 9.02
HNF1 homeobox B Hnf1b 8.68 9.56
homeo box A10 Hoxa10 8.67 6.66
zinc finger protein 3 Zfp3 8.67 9.11
interferon regulatory factor 1 Irf1 8.67 9.37
zinc finger protein 292 Zfp292 8.66 9.05
myocyte enhancer factor 2A Mef2a 8.65 9.50
cullin associated and neddylation disassociated 1 Cand1 8.65 9.63
zinc finger protein 507 Zfp507 8.65 8.88
regulatory factor X, 1 (influences HLA class II expression) Rfx1 8.65 9.66
general transcription factor II A, 2 Gtf2a2 8.64 9.66
single-minded homolog 1 (Drosophila) Sim1 8.64 9.56
Scm-like with four mbt domains 1 Sfmbt1 8.64 8.77
AT hook containing transcription factor 1 Ahctf1 8.62 8.67
RIKEN cDNA 5730507C01 gene 5730507C01Rik 8.62 8.27
ash2 (absent, small, or homeotic)-like (Drosophila) Ash2l 8.61 9.14
retinoblastoma-like 2 Rbl2 8.61 9.16
TOX high mobility group box family member 3 Tox3 8.61 9.20
zinc finger protein 467 Zfp467 8.61 8.57
suppressor of Ty 6 homolog (S. cerevisiae) Supt6h 8.60 9.54
retinoid X receptor alpha Rxra 8.60 8.84
regulatory factor X, 5 (influences HLA class II expression) Rfx5 8.59 9.00
nuclear receptor coactivator 1 Ncoa1 8.59 9.08
mediator complex subunit 14 Med14 8.59 9.50
zinc finger protein 707 Zfp707 8.59 9.28
SAP30 binding protein Sap30bp 8.59 9.03
SRY-box containing gene 12 Sox12 8.58 8.81
4lysine (K)-specific demethylase 6A Kdm6a 8.57 9.30
transcription factor E3 Tcfe3 8.57 8.75
zinc finger and BTB domain containing 38 Zbtb38 8.57 8.77
nuclear factor I/A Nfia 8.56 10.65
human immunodeficiency virus type I enhancer binding protein 2 Hivep2 8.55 9.37
mediator of RNA polymerase II transcription, subunit 4 homolog Med4 8.54 8.72
hepatoma-derived growth factor, related protein 2 Hdgfrp2 8.53 9.20
retinoid X receptor beta Rxrb 8.53 8.65
activating transcription factor 3 Atf3 8.53 8.87
transcription factor AP-2, alpha Tcfap2a 8.52 9.18
N-myc (and STAT) interactor Nmi 8.52 9.31
activating transcription factor 5 Atf5 8.52 9.13
general transcription factor III A Gtf3a 8.52 8.97
RIKEN cDNA 1300003B13 gene 1300003B13Rik 8.52 8.39
inhibitor of growth family, member 5 Ing5 8.52 8.74
N-acetylglucosamine-1-phosphate transferase, alpha and beta Gnptab 8.52 9.14
castor homolog 1, zinc finger (Drosophila) Casz1 8.52 8.56
cyclin T1 Ccnt1 8.50 9.43
zinc finger protein 821 Zfp821 8.49 9.08
GA repeat binding protein, beta 2 Gabpb2 8.49 8.57
RB1-inducible coiled-coil 1 Rb1cc1 8.49 9.12
chromobox homolog 4 (Drosophila Pc class) Cbx4 8.48 9.61
zinc finger protein 672 Zfp672 8.48 8.84
empty spiracles homolog 1 (Drosophila) Emx1 8.48 6.85
homeo box A3 Hoxa3 8.48 7.05
apoptosis antagonizing transcription factor Aatf 8.47 9.29
zinc finger protein 384 Zfp384 8.47 8.64
deltex 2 homolog (Drosophila) Dtx2 8.47 8.43
PHD finger protein 12 Phf12 8.47 8.87
zinc finger protein 775 Zfp775 8.47 8.40
BTB and CNC homology 1 Bach1 8.46 8.98
RIKEN cDNA 6720457D02 gene 6720457D02Rik 8.45 8.25
zinc finger protein 763 Zfp763 8.44 9.01
K(lysine) acetyltransferase 5 Kat5 8.43 8.93
transducin-like enhancer of split 4, homolog of Drosophila E(spl) Tle4 8.43 9.19
neural proliferation, differentiation and control gene 1 Npdc1 8.42 8.53
TAF2 RNA polymerase II Taf2 8.41 9.14
forkhead box J2 Foxj2 8.39 8.74
staphylococcal nuclease and tudor domain containing 1 Snd1 8.38 9.24
lysine (K)-specific demethylase 5C Kdm5c 8.38 8.95
nuclear receptor subfamily 3, group C, member 1 Nr3c1 8.38 8.33
PWP1 homolog (S. cerevisiae) Pwp1 8.37 9.03
transcription factor EB Tcfeb 8.37 8.61
MAX gene associated Mga 8.37 9.01
zinc finger protein 62 Zfp62 8.37 8.85
mastermind like 1 (Drosophila) Maml1 8.36 8.89
zinc finger protein 560 Zfp560 8.36 9.18
Kruppel-like factor 15 Klf15 8.36 8.27
Pbx/knotted 1 homeobox Pknox1 8.36 8.58
thyroid hormone receptor interactor 4 Trip4 8.35 8.32
zinc fingers and homeoboxes 1 Zhx1 8.35 9.21
zinc finger protein 787 Zfp787 8.34 8.85
zinc finger protein 827 Zfp827 8.33 9.14
zinc finger protein 148 Zfp148 8.33 9.31
Bmi1 polycomb ring finger oncogene Bmi1 8.32 8.92
WW domain containing transcription regulator 1 Wwtr1 8.32 8.83
MYST histone acetyltransferase 2 Myst2 8.32 8.41
regulatory factor X, 7 Rfx7 8.32 8.55
general transcription factor IIF, polypeptide 2 Gtf2f2 8.31 8.74
zinc finger protein 369 Zfp369 8.31 8.60
E2F transcription factor 3 E2f3 8.31 8.88
RIKEN cDNA 9130019O22 gene 9130019O22Rik 8.31 8.50
transcription elongation factor A (SII)-like 1 Tceal1 8.29 9.12
signal transducer and activator of transcription 1 Stat1 8.29 9.16
lysine (K)-specific demethylase 5A Kdm5a 8.29 8.91
RIKEN cDNA D330038O06 gene D330038O06Rik 8.29 8.75
zinc finger, BED domain containing 4 Zbed4 8.27 8.97
ets variant gene 6 (TEL oncogene) Etv6 8.27 9.35
CREB/ATF bZIP transcription factor Crebzf 8.27 8.83
cyclin D binding myb-like transcription factor 1 Dmtf1 8.26 9.12
mediator complex subunit 21 Med21 8.26 8.95
cDNA sequence BC049349 BC049349 8.26 8.49
core-binding factor, runt domain, alpha subunit 2, translocated to, 2 Cbfa2t2 8.26 8.81
period homolog 1 (Drosophila) Per1 8.26 9.09
zinc finger and BTB domain containing 41 homolog Zbtb41 8.25 8.76
transcription elongation factor A (SII)-like 3 Tceal3 8.25 9.44
zinc and ring finger 1 Znrf1 8.24 8.98
cAMP responsive element modulator Crem 8.22 8.65
nuclear transcription factor-Y alpha Nfya 8.22 8.43
zinc finger and BTB domain containing 40 Zbtb40 8.22 8.65
interferon regulatory factor 3 Irf3 8.21 8.85
zinc finger and SCAN domain containing 12 Zscan12 8.21 9.00
period homolog 2 (Drosophila) Per2 8.20 8.27
zinc finger protein 362 Zfp362 8.19 8.54
mbt domain containing 1 Mbtd1 8.19 8.61
general transcription factor II E, polypeptide 2 (beta subunit) Gtf2e2 8.19 8.61
RuvB-like protein 2 Ruvbl2 8.18 9.23
jumonji domain containing 1C Jmjd1c 8.18 8.76
zinc finger protein 612 Zfp612 8.18 8.64
hepatic leukemia factor Hlf 8.18 7.14
CCR4-NOT transcription complex, subunit 3 Cnot3 8.18 8.64
RIKEN cDNA 5730403B10 gene 5730403B10Rik 8.18 8.65
human immunodeficiency virus type I enhancer binding protein 1 Hivep1 8.17 8.67
PHD finger protein 20-like 1 Phf20l1 8.17 8.82
heat shock factor 1 Hsf1 8.16 8.49
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G Mafg 8.16 8.32
zinc finger protein 46 Zfp46 8.15 8.81
YY1 associated factor 2 Yaf2 8.15 8.60
menage a trois 1 Mnat1 8.15 8.86
Sp2 transcription factor Sp2 8.14 7.96
zinc finger protein 655 Zfp655 8.14 8.57
TAF5-like RNA polymerase II Taf5l 8.14 8.18
homeo box C9 Hoxc9 8.14 6.70
estrogen related receptor, alpha Esrra 8.14 8.59
recombination signal binding protein for immunoglobulin kappa J Rbpj 8.13 8.19
PHD finger protein 20 Phf20 8.13 8.78
TAF11 RNA polymerase II Taf11 8.13 8.75
expressed sequence AW146020 AW146020 8.12 8.29
peroxisome proliferative activated receptor, gamma Ppargc1b 8.12 8.61
coactivator 1 beta
POU domain, class 6, transcription factor 1 Pou6f1 8.12 8.59
zinc finger protein 367 Zfp367 8.11 9.00
programmed cell death 2 Pdcd2 8.10 7.97
zinc finger with KRAB and SCAN domains 6 Zkscan6 8.10 8.62
zinc finger protein 746 Zfp746 8.09 8.83
zinc finger protein 592 Zfp592 8.09 8.53
zinc finger protein 704 Zfp704 8.08 8.29
RIKEN cDNA 2310001H12 gene 2310001H12Rik 8.08 8.46
metal response element binding transcription factor 2 Mtf2 8.07 8.76
zinc finger protein 764 Zfp764 8.07 8.43
transcription elongation factor B (SIII), polypeptide 3 Tceb3 8.07 8.69
Zinc finger protein 212 Zfp212 8.07 8.58
myocyte enhancer factor 2D Mef2d 8.06 8.25
nuclear receptor subfamily 4, group A, member 1 Nr4a1 8.05 9.19
pleckstrin homology domain containing, family F member 2 Plekhf2 8.05 8.79
transcription elongation regulator 1 (CA150) Tcerg1 8.05 8.78
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K Mafk 8.04 8.56
zinc finger protein 111 Zfp111 8.04 8.64
zinc finger protein 84 Zfp84 8.04 8.34
MYC-associated zinc finger protein Maz 8.04 8.66
zinc finger protein 661 Zfp661 8.04 7.69
activating transcription factor 7 Atf7 8.04 8.53
TSC22 domain family, member 3 Tsc22d3 8.01 8.79
glucocorticoid modulatory element binding protein 1 Gmeb1 8.01 8.78
l(3)mbt-like 2 (Drosophila) L3mbtl2 8.01 8.74
trichorhinophalangeal syndrome I (human) Trps1 8.01 7.68
zinc fingerprotein 618 Zfp618 8.01 8.57
zinc finger protein 651 Zfp651 8.00 8.21
PC4 and SFRS1 interacting protein 1 Psip1 7.99 8.60
tripartite motif-containing 33 Trim33 7.99 8.11
E74-like factor 3 Elf3 7.97 8.92
nuclear receptor co-repressor 2 Ncor2 7.97 8.58
RuvB-like protein 1 Ruvbl1 7.96 8.78
Max dimerization protein 4 Mxd4 7.96 8.45
predicted gene, EG631624 EG631624 7.95 8.11
zinc finger matrin type 3 Zmat3 7.95 7.95
zinc finger protein 688 Zfp688 7.95 7.79
RRN3 RNA polymerase I transcription factor homolog (yeast) Rrn3 7.94 8.56
Zinc finger protein 498, mRNA Zfp498 7.94 8.12
retinoblastoma 1 Rb1 7.93 8.10
upstream transcription factor 2 Usf2 7.93 8.35
CCAAT/enhancer binding protein (C/EBP), beta Cebpb 7.93 8.34
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 Nfkb2 7.93 7.80
zinc fingers and homeoboxes 2 Zhx2 7.92 9.01
signal transducer and activator of transcription 5B Stat5b 7.91 7.82
RUN and FYVE domain containing 1 Rufy1 7.91 8.16
IKAROS family zinc finger 5 Ikzf5 7.91 8.14
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B Mafb 7.91 7.89
homeo box B6 Hoxb6 7.90 9.07
RIKEN cDNA 2810021G02 gene 2810021G02Rik 7.89 8.38
metal response element binding transcription factor 1 Mtf1 7.89 8.46
zinc finger protein 7 Zfp7 7.89 8.74
sterol regulatory element binding factor 2 Srebf2 7.89 8.15
deformed epidermal autoregulatory factor 1 (Drosophila) Deaf1 7.88 8.44
deoxynucleotidyltransferase, terminal, interacting protein 1 Dnttip1 7.87 8.24
zinc finger and BTB domain containing 24 Zbtb24 7.87 7.91
cDNA sequence BC018101 /// zinc finger protein 97 BC018101 7.87 8.48
zinc finger protein 236 Zfp236 7.87 8.09
Kruppel-like factor 4 (gut) Klf4 7.86 7.60
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F Maff 7.86 8.65
AT rich interactive domain 5B (MRF1-like) Arid5b 7.86 8.47
zinc finger protein 639 Zfp639 7.86 7.91
membrane-bound transcription factor peptidase, site 2 Mbtps2 7.86 7.89
POU domain, class 2, transcription factor 1 Pou2f1 7.85 7.89
cut-like homeobox 2 Cux2 7.85 8.10
general transcription factor II I repeat domain-containing 1 Gtf2ird1 7.85 8.14
H6 homeo box 2 Hmx2 7.84 8.47
nuclear factor related to kappa B binding protein Nfrkb 7.84 8.11
zinc finger protein 192 Zfp192 7.84 8.49
zinc finger with KRAB and SCAN domains 3 Zkscan3 7.83 8.36
teashirt zinc finger family member 1 Tshz1 7.83 7.96
PR domain containing 4 Prdm4 7.83 8.86
zinc finger and BTB domain containing 17 Zbtb17 7.81 7.66
zinc finger protein 146 Zfp146 7.81 8.26
elongation factor RNA polymerase II 2 Ell2 7.81 8.52
RUN and FYVE domain-containing 2 Rufy2 7.81 8.11
timeless interacting protein Tipin 7.80 8.32
zinc finger and BTB domain containing 33 Zbtb33 7.80 8.73
zinc finger protein 317 Zfp317 7.80 8.61
polymerase I and transcript release factor Ptrf 7.78 8.88
nuclear receptor subfamily 1, group D, member 1 Nr1d1 7.78 8.80
zinc finger protein 322A Zfp322a 7.78 7.87
sex determining region of Chr Y Sry 7.77 7.48
KDM3B lysine (K)-specific demethylase 3B Kdm3b 7.76 8.18
E2F transcription factor 6 E2f6 7.76 7.75
zinc finger protein 512 Zfp512 7.76 8.64
cyclin C Ccnc 7.76 8.04
transcriptional adaptor 3 (NGG1 homolog, yeast)-like Tada3l 7.75 8.38
purine-rich element binding protein G Purg 7.75 7.40
E74-like factor 1 Elf1 7.74 8.68
zinc finger protein 26 Zfp26 7.74 8.48
Homeo box B2 (Hoxb2), mRNA Hoxb2 7.74 7.61
zinc finger protein 810 Zfp810 7.74 8.52
gene trap locus 3 Gtl3 7.74 8.19
transcription factor CP2 Tcfcp2 7.73 8.75
suppressor of Ty 3 homolog (S. cerevisiae) Supt3h 7.73 7.76
zinc fingr protein 551 Zfp551 7.73 8.35
LIM domain only 4 Lmo4 7.72 9.44
retinoblastoma binding protein 5 Rbbp5 7.71 7.79
SERTA domain containing 2 Sertad2 7.70 8.36
GTF2I repeat domain containing 2 Gtf2ird2 7.70 7.91
CCAAT/enhancer binding protein (C/EBP), delta Cebpd 7.70 7.67
avian erythroblastosis virus E-26 (v-ets) oncogene related Erg 7.70 7.64
YEATS domain containing 2 Yeats2 7.70 7.74
TSC22 domain family, member 4 Tsc22d4 7.70 8.33
RIKEN cDNA 2810021J22 gene 2810021J22Rik 7.70 7.93
sterol regulatory element binding transcription factor 1 Srebf1 7.69 8.00
zinc finger, ZZ-type with EF hand domain 1 Zzef1 7.69 7.72
nuclear respiratory factor 1 Nrf1 7.68 9.22
activating transcription factor 6 beta Atf6b 7.66 8.12
zinc finger protein (C2H2 type) 276 Zfp276 7.66 7.50
mediator of RNA polymerase II transcription, subunit 25 homolog Med25 7.66 8.62
RIKEN cDNA C920016K16 gene C920016K16Rik 7.66 7.80
four and a half LIM domains 1 Fhl1 7.65 7.63
trans-acting transcription factor 3 Sp3 7.65 8.13
B-cell leukemia/lymphoma 6 Bcl6 7.64 8.54
zinc finger protein 410 Zfp410 7.64 8.16
E26 avian leukemia oncogene 1, 5' domain Ets1 7.63 7.80
expressed sequence AI854703 AI854703 7.63 7.27
putative homeodomain transcription factor 1 Phtf1 7.63 7.94
PR domain containing 2, with ZNF domain Prdm2 7.63 7.90
trans-acting transcription factor 4 Sp4 7.62 8.45
zinc finger protein 68 Zfp68 7.62 8.31
upstream transcription factor 1 Usf1 7.62 7.83
MyoD family inhibitor domain containing Mdfic 7.61 9.09
ring finger protein 25 Rnf25 7.61 8.22
zinc finger protein 30 Zfp30 7.61 7.42
zinc finger, HIT domain containing 2 Znhit2 7.60 8.26
zinc finger protein 710 Zfp710 7.60 7.96
ring finger protein 138 Rnf138 7.60 8.05
LIM domain only 2 Lmo2 7.59 7.97
RB-associated KRAB repressor Rbak 7.59 8.03
transducin-like enhancer of split 1, homolog of Drosophila E(spl) Tle1 7.58 8.13
MLX interacting protein Mlxip 7.58 8.02
zinc finger and BTB domain containing 7C Zbtb7c 7.58 7.79
zinc finger and BTB domain containing 16 Zbtb16 7.58 8.36
lin-9 homolog (C. elegans) Lin9 7.57 7.72
nuclear receptor binding factor 2 Nrbf2 7.57 7.40
interferon activated gene 203 Ifi203 7.57 7.34
ELK1, member of ETS oncogene family Elk1 7.54 7.86
transcriptional adaptor 2 (ADA2 homolog, yeast)-like Tada2l 7.54 7.66
nuclear receptor subfamily 1, group H, member 2 Nr1h2 7.53 7.94
zinc finger protein 715 Zfp715 7.53 7.59
zinc finger, FYVE domain containing 19 Zfyve19 7.53 8.05
zinc finger protein 652 Zfp652 7.53 8.31
Melanin concentrating hormone receptor interacting zinc finger protein Zmynd19 7.51 7.36
sal-like 2 (Drosophila) Sall2 7.50 7.48
polymerase (RNA) II (DNA directed) polypeptide D Polr2d 7.50 8.27
zinc finger protein 59 Zfp59 7.50 7.67
peroxisome proliferator activated receptor alpha Ppara 7.50 7.97
MAD homolog 7 (Drosophila) Smad7 7.49 8.67
general transcription factor II H, polypeptide 4 Gtf2h4 7.49 7.98
MMS19 (MET18 S. cerevisiae) Mms19 7.48 8.03
Zinc finger protein 458 (Zfp458), mRNA Zfp458 7.48 8.39
RIKEN cDNA 6720487G11 gene 6720487G11Rik 7.47 7.79
transcription factor E2a Tcfe2a 7.47 7.53
core-binding factor, runt domain, alpha subunit 2, translocated to, 3 Cbfa2t3 7.47 7.69
zinc finger protein 1 Zfp1 7.46 7.96
BRF2, subunit of RNA polymerase III transcription initiation factor Brf2 7.46 7.26
RIKEN cDNA C330011K17 gene C330011K17Rik 7.46 8.28
zinc finger with KRAB and SCAN domains 14 Zkscan14 7.45 7.62
RIKEN cDNA 5830417I10 gene /// similar to Dingo protein isoform 2 5830417I10Rik 7.45 8.00
ankyrin repeat, family A (RFXANK-like), 2 Ankra2 7.45 7.34
tumor suppressor candidate 4 Tusc4 7.43 8.03
mediator complex subunit 17 Med17 7.43 8.07
early growth response 2 Egr2 7.43 8.31
zinc finger protein 574 Zfp574 7.43 8.04
zinc finger protein 386 (Kruppel-like) Zfp386 7.43 8.38
myeloid/lymphoid or mixed-lineage leukemia 1 Mll1 7.41 8.73
zinc finger protein 784 Zfp784 7.41 7.64
snail homolog 2 (Drosophila) Snai2 7.41 6.90
SCAN domain-containing 1 Scand1 7.41 7.58
zinc finger protein 35 Zfp35 7.40 7.67
transformation related protein 53 Trp53 7.40 7.63
ring finger protein 166 Rnf166 7.40 7.05
hairy/enhancer-of-split related with YRPW motif-like Heyl 7.39 8.23
zinc finger protein 277 Zfp277 7.38 8.12
TAF5 RNA polymerase II Taf5 7.38 7.90
zinc finger protein 235 Zfp235 7.37 8.07
zinc finger protein 110 Zfp110 7.37 8.00
TAF6 RNA polymerase II Taf6 7.36 8.07
predicted gene, EG240038 EG240038 7.36 7.67
DCP1 decapping enzyme homolog A (S. cerevisiae) Dcp1a 7.35 7.69
zinc finger protein 12 Zfp12 7.35 6.95
RIKEN cDNA 4933403O03 gene /// predicted gene, EG245263 4933403O03Rik 7.35 6.17
regulatory factor X-associated ankyrin-containing protein Rfxank 7.34 7.51
signal transducer and activator of transcription 5A Stat5a 7.34 8.35
LIM homeobox protein 1 Lhx1 7.34 7.81
TGFB-induced factor homeobox 1 Tgif1 7.34 7.81
zinc finger protein X-linked Zfx 7.34 8.07
sine oculis-related homeobox 4 homolog (Drosophila) Six4 7.33 7.98
mediator complex subunit 27 Med27 7.33 7.76
peroxisome proliferative activated receptor, gamma Pprc1 7.32 7.45
rearranged L-myc fusion sequence Rlf 7.32 7.64
RIKEN cDNA 1200003I07 gene 1200003I07Rik 7.32 7.94
homeo box A7 Hoxa7 7.32 6.59
zinc finger protein 426 Zfp426 7.31 7.98
BRF1 homolog, subunit of RNA polymerase III transcription initiation faBrf1 7.30 7.56
special AT-rich sequence binding protein 1 Satb1 7.29 8.05
zinc finger protein 87 Zfp87 7.29 7.64
TAF9B RNA polymerase II Taf9b 7.29 7.84
estrogen receptor 1 (alpha) Esr1 7.29 5.63*
zinc finger protein 383 Zfp383 7.29 7.39
polymerase (DNA directed), epsilon 3 (p17 subunit) Pole3 7.28 7.68
POZ (BTB) and AT hook containing zinc finger 1 Patz1 7.28 8.39
TGFB-induced factor homeobox 2 Tgif2 7.28 7.51
transducin-like enhancer of split 2, homolog of Drosophila E(spl) Tle2 7.28 7.83
homeo box B9 Hoxb9 7.28 8.73
SET and MYND domain containing 2 Smyd2 7.27 8.19
speckle-type POZ protein-like Spopl 7.27 8.05
myeloid/lymphoid or mixed-lineage leukemia Mllt10 7.26 7.96
zinc finger protein 280C Zfp280c 7.26 7.74
myeloid/lymphoid or mixed-lineage leukemia Mllt1 7.25 8.32
RIKEN cDNA 9430025M13 gene 9430025M13Rik 7.25 7.43
HNF1 homeobox A Hnf1a 7.24 6.94
zinc finger protein 790 Zfp790 7.24 8.11
homeo box C6 Hoxc6 7.24 6.12
zinc finger protein, autosomal /// zinc finger protein X-linked Zfa /// Zfx 7.24 7.64
B-cell CLL/lymphoma 6, member B Bcl6b 7.23 7.39
sine oculis-related homeobox 5 homolog (Drosophila) Six5 7.23 7.94
mediator of RNA polymerase II transcription, subunit 12 homolog Med12 7.22 8.14
zinc finger protein 579 Zfp579 7.22 7.56
zinc finger protein 799 Zfp799 7.22 7.96
MAX dimerization protein 1 Mxd1 7.22 7.75
zinc finger protein 454 Zfp454 7.22 7.72
bromodomain and PHD finger containing, 1 Brpf1 7.22 7.86
hairy and enhancer of split 1 (Drosophila) Hes1 7.21 8.44
zinc finger protein 90 Zfp90 7.21 7.28
zinc finger protein 282 Zfp282 7.20 7.46
CCR4-NOT transcription complex, subunit 8 Cnot8 7.20 8.22
RIKEN cDNA 1700049G17 gene 1700049G17Rik 7.19 7.87
suppressor of hairy wing homolog 4 (Drosophila) Suhw4 7.18 8.04
RIKEN cDNA 6430526N21 gene 6430526N21Rik 7.18 7.69
zinc finger protein 646 Zfp646 7.18 7.38
RIKEN cDNA 9630025I21 gene 9630025I21Rik 7.18 7.49
l(3)mbt-like 3 (Drosophila) L3mbtl3 7.17 7.48
mediator complex subunit 26 Med26 7.17 7.08
ubiquitin-like, containing PHD and RING finger domains, 1 Uhrf1 7.16 7.49
zinc finger protein 385B Zfp385b 7.16 7.24
tripartite motif-containing 24 Trim24 7.15 7.74
zinc finger protein 316 Zfp316 7.15 7.23
general transcription factor II H, polypeptide 1 Gtf2h1 7.15 7.44
mediator of RNA polymerase II transcription, subunit 6 homolog Med6 7.13 7.86
zinc finger protein 39 Zfp39 7.13 7.87
zinc finger with KRAB and SCAN domains 17 Zkscan17 7.13 6.99
SET and MYND domain containing 3 Smyd3 7.13 8.00
zinc finger protein 788 Zfp788 7.12 7.71
RIKEN cDNA 2810047C21 gene 1 /// predicted gene, EG665577 2810047C21Rik1 7.12 6.99
IKAROS family zinc finger 4 Ikzf4 7.12 7.62
zinc finger protein 2 Zfp2 7.11 8.02
peroxisome proliferator activator receptor delta Ppard 7.09 7.55
zinc finger and BTB domain containing 26 Zbtb26 7.09 7.40
zinc finger protein 512B Znf512b 7.09 7.77
forkhead box N2 Foxn2 7.08 7.70
zinc finger protein 93 Zfp93 7.07 7.28
expressed sequence AI894139 AI894139 7.07 7.21
PHD finger protein 15 Phf15 7.07 7.28
WT1-interacting protein Wtip 7.06 7.71
zinc finger protein 319 Zfp319 7.06 7.49
zinc finger protein 691 Zfp691 7.06 7.35
zinc finger protein 182 Zfp182 7.05 7.90
zinc finger protein 113 Zfp113 7.04 7.21
ubiquitin-like, containing PHD and RING finger domains 2 Uhrf2 7.04 7.90
AT rich interactive domain 3A (BRIGHT-like) Arid3a 7.04 6.93
zinc finger protein 64 Zfp64 7.03 7.35
polycomb group ring finger 6 Pcgf6 7.03 7.27
CREB regulated transcription coactivator 2 Crtc2 7.03 7.38
Jun-B oncogene Junb 7.02 8.13
transcription elongation factor A (SII), 3 Tcea3 7.02 6.84
zinc finger protein 532 Zfp532 7.02 6.44
Kruppel-like factor 13 Klf13 7.02 7.79
cDNA sequence D10627 D10627 7.01 7.22
Inhibitor of DNA binding 4 (Id4), mRNA Id4 7.01 8.44
zinc finger like protein 1 Zfpl1 7.00 7.52
interferon regulatory factor 9 Irf9 7.00 8.02
homeo box C4 Hoxc4 7.00 3.34*
lysine (K)-specific demethylase 3A Kdm3a 7.00 7.36
RIKEN cDNA 2810047C21 gene 1 2810047C21Rik1 7.00 6.75
zinc finger protein 451 Zfp451 7.00 7.43
zinc finger, HIT type 3 Znhit3 6.99 7.40
expressed sequence AA987161 AA987161 6.99 7.88
MAX-like protein X Mlx 6.98 7.15
zinc finger protein 623 Zfp623 6.98 7.59
RIKEN cDNA 2610008E11 gene 2610008E11Rik 6.97 7.19
aryl-hydrocarbon receptor Ahr 6.97 7.48
zinc finger protein 637 Zfp637 6.96 7.44
general transcription factor IIH, polypeptide 3 Gtf2h3 6.96 7.08
GDNF-inducible zinc finger protein 1 Gzf1 6.94 7.40
predicted gene, OTTMUSG00000010657 OTTMUSG00000 6.94 7.42
zinc finger protein 462 Zfp462 6.93 8.10
putative homeodomain transcription factor 2 Phtf2 6.92 7.11
MYST histone acetyltransferase 1 Myst1 6.91 7.51
interferon regulatory factor 2 Irf2 6.90 8.09
period homolog 3 (Drosophila) Per3 6.90 7.74
RIKEN cDNA 4930422I07 gene 4930422I07Rik 6.90 7.23
neuronal PAS domain protein 2 Npas2 6.89 6.43
nuclear factor of activated T-cells, cytoplasmic Nfatc4 6.89 7.03
zinc finger protein 180 Zfp180 6.89 7.06
zinc finger, FYVE domain containing 1 Zfyve1 6.89 7.30
predicted gene, EG330503 EG330503 6.89 6.79
SRY-box containing gene 18 Sox18 6.88 6.88
Flt3 interacting zinc finger protein 1 Fiz1 6.87 7.64
forkhead box P4 Foxp4 6.87 6.77
Ets2 repressor factor Erf 6.87 7.44
zinc finger protein 395 Zfp395 6.87 7.80
RIKEN cDNA 4930422I07 gene 4930422I07Rik 6.87 7.47
RIKEN cDNA 4933426I21 gene 4933426I21Rik 6.86 6.58
MKL (megakaryoblastic leukemia)/myocardin-like 1 Mkl1 6.86 7.18
pleiomorphic adenoma gene-like 2 Plagl2 6.85 7.46
cDNA sequence BC023179 BC023179 6.84 7.18
forkhead box P3 Foxp3 6.84 6.52
zinc finger protein 518B Zfp518b 6.83 7.10
E4F transcription factor 1 E4f1 6.83 7.12
zinc finger protein 518 Zfp518 6.82 7.27
general transcription factor II H, polypeptide 2 Gtf2h2 6.82 7.47
RIKEN cDNA 6330416L07 gene 6330416L07Rik 6.81 7.21
calmodulin binding transcription activator 2 Camta2 6.81 6.97
SET and MYND domain containing 5 Smyd5 6.81 7.27
ubiquitously transcribed tetratricopeptide repeat gene Uty 6.79 6.33
progesterone receptor Pgr 6.79 8.06
cell division cycle associated 4 Cdca4 6.78 7.44
Kruppel-like factor 11 Klf11 6.78 7.59
homeo box D3 Hoxd3 6.78 8.09
zinc finger protein 668 Zfp668 6.78 7.16
nuclear receptor subfamily 5, group A, member 1 Nr5a1 6.76 5.94
candidate tumor suppressor in ovarian cancer 2 RP23-143A14.5 6.76 7.62
cDNA sequence BC066028 BC066028 6.76 5.93
zinc finger protein 74 Zfp74 6.76 6.44
zinc finger E-box binding homeobox 1 Zeb1 6.75 6.88
thyroid hormone receptor beta Thrb 6.75 6.86
DCP1 decapping enzyme homolog b (S. cerevisiae) Dcp1b 6.75 7.00
mesenchyme homeobox 1 Meox1 6.74 6.34
NK6 homeobox 2 Nkx6-2 6.73 6.45
ring finger protein 125 Rnf125 6.73 6.40
POU domain, class 4, transcription factor 1 Pou4f1 6.73 6.20
inhibitor of growth family, member 4 Ing4 6.73 6.99
brain expressed myelocytomatosis oncogene Bmyc 6.72 6.59
zinc finger protein 667 Zfp667 6.71 7.53
IKAROS family zinc finger 2 Ikzf2 6.70 7.84
human immunodeficiency virus type I enhancer binding protein 3 Hivep3 6.70 6.16
calmodulin binding transcription activator 1 Camta1 6.70 6.61
CREB regulated transcription coactivator 1 Crtc1 6.70 7.24
RIKEN cDNA 5730403M16 gene 5730403M16Rik 6.69 7.03
zinc finger protein 563 Zfp563 6.69 7.45
retinoic acid induced 1 Rai1 6.69 6.69
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Nfkb1 6.68 7.54
SRY-box containing gene 5 Sox5 6.68 6.77
zinc finger protein 41 Zfp41 6.67 6.57
heat shock factor 2 Hsf2 6.66 6.31
v-rel reticuloendotheliosis viral oncogene homolog A (avian) Rela 6.65 7.23
MKL/myocardin-like 2 Mkl2 6.63 8.18
E1A binding protein p300 Ep300 6.63 7.49
RIKEN cDNA A530054K11 gene A530054K11Rik 6.62 6.62
zinc finger protein 692 Zfp692 6.61 7.90
homeo box D4 Hoxd4 6.61 6.94
zinc finger protein 109 Zfp109 6.60 6.73
polycomb group ring finger 3 Pcgf3 6.60 7.38
zinc finger protein 748 Zfp748 6.60 7.05
nuclear receptor subfamily 4, group A, member 2 Nr4a2 6.60 6.61
trafficking protein particle complex 2 Trappc2 6.59 7.22
zinc finger protein 213 Zfp213 6.59 6.70
zinc finger protein 128 Zfp128 6.59 6.81
RIKEN cDNA A630033E08 gene A630033E08Rik 6.59 6.47
zinc finger protein 157 Zfp157 6.59 6.83
polycomb group ring finger 5 Pcgf5 6.59 7.08
zinc finger protein 94 Zfp94 6.59 6.82
RIKEN cDNA 9230108I15 gene 9230108I15Rik 6.58 6.11
heart and neural crest derivatives expressed transcript 1 Hand1 6.58 6.41
PR domain containing 15 Prdm15 6.58 7.50
zinc finger E-box binding homeobox 2 Zeb2 6.57 6.18
zinc finger protein 142 Zfp142 6.57 6.69
mastermind like 2 (Drosophila) Maml2 6.57 6.68
zinc finger protein 825 Zfp825 6.57 7.07
transformation related protein 63 Trp63 6.57 7.45
Zinc finger protein 120, mRNA (cDNA clone IMAGE:4222737) Zfp844 6.57 6.59
nuclear receptor subfamily 2, group C, member 1 Nr2c1 6.56 7.38
nuclear factor of activated T-cells, cytoplasmic Nfatc2 6.56 6.29
GA repeat binding protein, beta 1 Gabpb1 6.56 7.50
zinc finger protein 760 Zfp760 6.56 6.79
SRY-box containing gene 13 Sox13 6.56 6.68
zinc finger protein 143 Zfp143 6.55 6.93
TAF7 RNA polymerase II Taf7 6.55 6.62
homeo box A5 Hoxa5 6.55 5.14*
four and a half LIM domains 2 Fhl2 6.53 6.31
teashirt zinc finger family member 2 Tshz2 6.53 6.17
zinc finger protein 295 Zfp295 6.52 7.30
zinc finger protein 324 Zfp324 6.52 6.88
Kruppel-like factor 16 Klf16 6.50 7.24
retinoic acid receptor, gamma Rarg 6.49 7.36
zinc finger protein 628 Zfp628 6.49 7.02
RIKEN cDNA E430024I08 gene E430024I08Rik 6.47 6.84
Kruppel-like factor 2 (lung) Klf2 6.47 6.84
interferon activated gene 205 Ifi205 /// Mnda 6.46 5.74*
glucocorticoid modulatory element binding protein 2 Gmeb2 6.46 6.84
Jun dimerization protein 2 Jdp2 6.44 6.99
RIKEN cDNA 4930452B06 gene 4930452B06Rik 6.43 6.94
expressed sequence AU041133 AU041133 6.43 7.00
transcription elongation factor A (SII), 2 Tcea2 6.42 7.13
predicted gene, ENSMUSG00000053512 ENSMUSG00000 6.42 6.40
general transcription factor II E, polypeptide 1 (alpha subunit) Gtf2e1 6.42 6.92
myocyte enhancer factor 2C Mef2c 6.42 6.31
RNA binding motif protein 38 Rbm38 6.42 6.12
zinc finger protein 346 Zfp346 6.41 6.65
zinc finger protein 697 Zfp697 6.40 6.61
zinc finger protein 280B Zfp280b 6.40 7.13
RIKEN cDNA A630033E08 gene A630033E08Rik 6.40 6.88
transducin-like enhancer of split 6, homolog of Drosophila E(spl) Tle6 6.39 6.40
sex comb on midleg homolog 1 Scmh1 6.38 7.14
zinc finger and BTB domain containing 39 Zbtb39 6.38 7.35
zinc finger protein 273 /// zinc finger protein 85, related sequence 1 Zfp273 6.38 6.88
zinc finger protein 334 Zfp334 6.37 6.35
zinc finger protein 169 Zfp169 6.36 6.90
basonuclin 2 Bnc2 6.35 6.35
zinc finger protein 28 Zfp28 6.35 6.87
small nuclear RNA activating complex, polypeptide 4 Snapc4 6.34 7.06
hairy/enhancer-of-split related with YRPW motif 2 Hey2 6.33 6.32
E2F transcription factor 5 E2f5 6.33 6.96
zinc finger protein 444 Zfp444 6.32 6.24
zinc finger and BTB domain containing 3 Zbtb3 6.32 6.17
zinc finger protein 37 Zfp37 6.32 7.21
AT rich interactive domain 3B (BRIGHT-like) Arid3b 6.32 6.25
zinc finger protein 653 Zfp653 6.32 6.65
Ngfi-A binding protein 2 Nab2 6.31 7.38
teashirt zinc finger family member 3 Tshz3 6.31 7.28
MYST histone acetyltransferase monocytic leukemia 4 Myst4 6.30 6.86
inhibitor of DNA binding 1 Id1 6.30 7.77
atonal homolog 7 (Drosophila) Atoh7 6.30 6.53
NK2 transcription factor related, locus 6 (Drosophila) Nkx2-6 6.30 5.88
RIKEN cDNA 4930432O21 gene 4930432O21Rik 6.28 6.23
RAR-related orphan receptor beta Rorb 6.28 8.23
Meis homeobox 3 Meis3 6.26 6.54
zinc finger protein 418 Zfp418 6.25 6.68
zinc finger protein Zfp229 6.25 6.62
scratch homolog 2, zinc finger protein (Drosophila) Scrt2 6.25 6.30
T-box 3 Tbx3 6.25 8.29
zinc finger protein 108 Zfp108 6.25 6.54
zinc finger and BTB domain containing 48 Zbtb48 6.23 6.26
RIKEN cDNA 6720489N17 gene, mRNA 6720489N17Rik 6.23 7.27
RIKEN cDNA A430033K04 gene A430033K04Rik 6.23 6.90
basic helix-loop-helix family, member e22 Bhlhe22 6.22 8.22
elongation factor RNA polymerase II Ell 6.22 6.59
SRY-box containing gene 11 Sox11 6.21 5.41
zinc finger protein 101 Zfp101 6.21 6.56
regulatory factor X, 2 (influences HLA class II expression) Rfx2 6.20 6.06
zinc finger and SCAN domain containing 4F  Zscan4f 6.20 4.24*
occludin/ELL domain containing 1 Ocel1 6.20 6.54
zinc finger protein 341 Zfp341 6.20 6.61
transcription factor AP4 Tcfap4 6.19 6.15
Friend leukemia integration 1 Fli1 6.18 5.84
retinoblastoma-like 1 (p107) Rbl1 6.18 7.17
zinc finger protein 689 Zfp689 6.18 6.49
CDNA sequence BC038328, mRNA (cDNA clone IMAGE:1531884) Zfp708 6.18 6.87
predicted gene, OTTMUSG00000003825 OTTMUSG 6.18 6.11
delta-like 4 (Drosophila) Dll4 6.17 6.89
nuclear factor of activated T-cells, cytoplasmic Nfatc1 6.17 6.55
zinc finger protein 120 Zfp120 6.14 6.60
pleckstrin homology domain containing, family F member 1 Plekhf1 6.13 6.69
zinc finger protein 446 Zfp446 6.13 6.24
LIM domain binding 2 Ldb2 6.12 5.89
nuclear receptor subfamily 1, group H, member 4 Nr1h4 6.11 6.10
forkhead box P2 Foxp2 6.11 4.96*
Kruppel-like factor 7 (ubiquitous) Klf7 6.10 8.52
caspase 8 associated protein 2 Casp8ap2 6.10 7.20
ets variant gene 5 Etv5 6.10 4.90*
zinc finger protein 597 Zfp597 6.09 6.34
zinc finger and BTB domain containing 5 Zbtb5 6.09 6.33
nuclear receptor interacting protein 2 Nrip2 6.09 5.09*
zinc finger protein 287 Zfp287 6.08 6.67
SET and MYND domain containing 4 Smyd4 6.08 6.53
zinc finger protein 709 Zfp709 6.08 7.37
PHD finger protein 1 Phf1 6.05 6.16
Meis homeobox 2 Meis2 6.05 6.25
ethanol induced 1 Etohi1 6.05 6.33
E2F transcription factor 2 E2f2 6.05 7.65
zinc finger protein 248 Zfp248 6.05 6.67
cDNA sequence AB182283 AB182283 6.05 6.05
zinc finger protein 354C Zfp354c 6.04 6.86
transcription factor EC Tcfec 6.03 5.59*
zinc finger and BTB domain containing 7B Zbtb7b 6.03 6.51
transcription elongation factor A (SII) Tceanc 5.99 6.31
CREB regulated transcription coactivator 3 Crtc3 5.99 6.09
ets variant gene 4 (E1A enhancer binding protein, E1AF) Etv4 5.97 5.00*
zinc finger and AT hook domain containing Zfat 5.96 6.11
jagged 2 Jag2 5.94 5.76*
transcription factor 15 Tcf15 5.94 5.73*
zinc finger protein 60 Zfp60 5.93 5.95
zinc finger protein 493 Zfp493 5.93 6.29
nucleus accumbens associated 1 Nacc1 5.92 5.76*
E74-like factor 5 Elf5 5.91 9.57
SERTA domain containing 3 Sertad3 5.90 6.75
nuclear receptor subfamily 6, group A, member 1 Nr6a1 5.90 6.84
zinc finger protein 654 Zfp654 5.90 6.49
zinc finger protein 595 Zfp595 5.90 6.67
zinc finger protein 160 Zfp160 5.89 6.34
zinc finger protein 407 Zfp407 5.89 6.88
runt related transcription factor 1 Runx1 5.87 5.81
zinc finger protein 52 Zfp52 5.87 6.18
H6 homeo box 3 Hmx3 5.86 7.50
RIKEN cDNA A830023I12 gene A830023I12Rik 5.86 5.85
Zinc finger protein 40 (Zfp40), mRNA Zfp40 5.86 6.20
interferon regulatory factor 5 Irf5 5.86 5.87
aryl hydrocarbon receptor nuclear translocator-like Arntl 5.85 6.17
zinc finger protein 385C Zfp385c 5.84 5.44*
nuclear receptor subfamily 0, group B, member 2 Nr0b2 5.84 6.25
ovo-like 2 (Drosophila) Ovol2 5.83 6.43
hypermethylated in cancer 2 Hic2 5.81 5.50*
zinc finger protein 275 Zfp275 5.80 5.92
zinc finger protein 568 Zfp568 5.79* 6.25
RIKEN cDNA 1700029I01 gene 1700029I01Rik 5.79* 6.69
expressed sequence AI987944 AI987944 5.78* 6.71
zinc finger, FYVE domain containing 26 Zfyve26 5.75* 6.79
zinc finger with KRAB and SCAN domains 5 Zkscan5 5.70* 6.42
zinc finger protein 711 Zfp711 5.70* 7.66
similar to SRF-dependent transcription regulation associated protein LOC636713 5.68* 6.31
TEA domain family member 3 Tead3 5.63* 5.92
signal transducer and activator of transcription 2 Stat2 5.63* 6.06
zinc finger and SCAN domain containing 22 Zscan22 5.62* 5.90
CDNA sequence BC062115, mRNA BC062115 5.62* 5.84
zinc finger protein 53 Zfp53 5.6* 6.77
avian reticuloendotheliosis viral (v-rel) oncogene related B Relb 5.59* 6.10
E2F transcription factor 1 E2f1 5.59* 6.22
zinc finger protein 11 Zfp11 5.55* 5.82
MAD homolog 6 (Drosophila) Smad6 5.54* 6.26
ets variant gene 1 Etv1 5.53* 5.99
interferon regulatory factor 8 Irf8 5.49* 5.91
predicted gene, 380850 380850 5.48* 6.05
zinc finger protein 61 Zfp61 5.46* 6.06
zinc finger protein 758 Zfp758 5.46* 6.19
RIKEN cDNA 3110052M02 gene 3110052M02Rik 5.45* 6.69
zinc finger protein 472 Zfp472 5.44* 6.07
zinc finger protein 202 Zfp202 5.44* 5.93
OVO homolog-like 1 (Drosophila) Ovol1 5.40* 6.24
myelocytomatosis oncogene Myc 5.36* 6.92
zinc finger protein 51 Zfp51 5.35* 6.32
zinc finger protein 719 Zfp719 5.33* 6.20
zinc finger protein 513 Zfp513 5.33* 6.17
zinc finger protein 429 Zfp429 5.31* 6.41
zinc finger protein 239 Zfp239 5.30* 5.91
cAMP responsive element binding protein 3-like 4 Creb3l4 5.30* 5.82
general transcription factor IIIC, polypeptide 3 Gtf3c3 5.30* 5.96
zinc finger and BTB domain containing 34 Zbtb34 5.29* 6.67
scleraxis Scx 5.25* 6.79
v-myc myelocytomatosis viral related oncogene Mycn 5.24* 6.53
filamin binding LIM protein 1 Fblim1 5.24* 6.16
predicted gene, EG434179 EG434179 5.23* 6.00
zinc finger protein 335 Zfp335 5.19* 6.36
pre B-cell leukemia transcription factor 3 Pbx3 5.15* 7.30
cDNA sequence BC066107 BC066107 5.13* 5.90
zinc finger protein 438 Zfp438 5.13* 5.89
twist homolog 1 (Drosophila) Twist1 5.07* 6.34
cullin-associated and neddylation-dissociated 2 (putative) Cand2 4.92* 6.44
RIKEN cDNA 2210010B09 gene 2210010B09Rik 4.89* 5.84
expressed sequence AI449175 AI449175 4.86* 6.17
Kruppel-like factor 5 Klf5 4.6* 6.46
* - the A_value is below the cut-off level
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